"Rank","Title","Status","Study Results","Conditions","Interventions","Locations","URL"
1,"Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza","Completed","Has Results","Influenza","Drug: Nitazoxanide|Drug: Placebo","Health Sciences Research Center, Elmira, New York, United States","https://ClinicalTrials.gov/show/NCT01227421"
2,"Influenza A 2009 H1N1 Challenge Study in Healthy Adults","Completed","Has Results","Influenza","Biological: Ca/04/2009/H1N1 Vero Grown Challenge Virus","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01646138"
3,"Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults","Completed","No Results Available","Influenza","Biological: Influenza A/H7N7 Vaccine|Drug: Placebo","Baylor College of Medicine - Department of Molecular Virology and Microbiology, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00546585"
4,"Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults","Completed","No Results Available","Influenza","Biological: Influenza A/H9N2 vaccine|Drug: MF59 adjuvant","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00133471"
5,"A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza","Completed","No Results Available","Influenza","Biological: AVX502|Biological: Placebo","Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00706732"
6,"A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza","Completed","No Results Available","Influenza","Biological: AVX502|Biological: Placebo","Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00440362"
7,"Nontypeable H. Influenzae in Healthy Adults","Completed","No Results Available","Haemophilus Influenzae (NTHI)","Biological: NTHi Strain 2019","University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT00905385"
8,"A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001","Completed","No Results Available","Influenza","Biological: Fluzone® (2010/2011 Inactivated Trivalent Influenza Vaccine)|Biological: LIQ001 (0.45mg)|Biological: LIQ001 (1.8mg)","Accelovance - Melbourne, Melbourne, Florida, United States","https://ClinicalTrials.gov/show/NCT01224262"
9,"T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza","Completed","No Results Available","Influenza","Drug: Placebo|Drug: Favipiravir","Miami Research Associates, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT01728753"
10,"Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People","Completed","Has Results","Influenza","Biological: Ca/04/2009/H1N1r Challenge Virus","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01971255"
11,"Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age","Completed","No Results Available","Inactivated Influenza Vaccine","Biological: 2005-2006 trivalent inactivated influenza vaccine","Seattle Children's Hospital and Regional Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00242424"
12,"TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients","Completed","Has Results","Influenza","Drug: TCAD|Drug: Zanamivir or Oseltamivir|Other: Open label treatment with TCAD","Seattle Children's, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00867139"
13,"Influenza Antiviral DAS181-F03","Completed","No Results Available","Influenza","Drug: Placebo|Drug: DAS181","Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01173224"
14,"Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home","Completed","Has Results","Influenza","Drug: Influenzae vaccine","Akron Children's Hospital, Akron, Ohio, United States","https://ClinicalTrials.gov/show/NCT00812110"
15,"B-cell Immunity to Influenza (SLVP017)- Year 1, 2009","Completed","Has Results","Influenza","Biological: Fluzone® 2009-2010 Formula|Biological: FluMist® 2009-2010 Formula","Stanford LPCH Vaccine Program, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT02133781"
16,"Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting","Completed","Has Results","Influenza","Biological: High Dose Inactivated Influenza Vaccine|Biological: Standard Dose Inactivated Influenza Vaccine","University of Pittsburgh, Division of Geriatric Medicine, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01654224"
17,"Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults","Completed","Has Results","Influenza","Biological: VAX102","Jean Brown Research, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00921947"
18,"Influenza Immunity Against Pandemic Respiratory Virus","Completed","No Results Available","Influenza","Biological: FluMist|Biological: Fluzone","Stanford University, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT00138281"
19,"St. Jude Open Label H5 Trial","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00311675"
20,"Higher Dose Intradermal H5 Vaccine","Completed","Has Results","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1|Drug: Placebo (IM)|Drug: Placebo (ID)","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00439335"
21,"Proteomic Profiling for Influenza Vaccination - FluMist","Completed","No Results Available","Influenza","Biological: FluMist","Eastern Virginia Medical School, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00385281"
22,"Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally","Completed","Has Results","Influenza","Biological: Trivalent inactivated influenza virus vaccine (2006-2007 formulation)|Biological: Type 1 interferon","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00436046"
23,"Immunogenicity and Safety of Different Doses of Fluzone® Influenza","Completed","No Results Available","Influenza","Biological: Fluzone® (IM)|Biological: Fluzone®","Saint Louis University, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00253734"
24,"Safety Study of an Oral Vaccine to Prevent Seasonal Influenza","Completed","No Results Available","Influenza","Biological: VXA-A1.1 Oral Vaccine|Biological: VXA Placebo Tablet","WCCT, Cypress, California, United States","https://ClinicalTrials.gov/show/NCT01688297"
25,"Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)","Completed","Has Results","Influenza","Biological: Fluzone® (IM)|Biological: Fluzone® Intradermal (ID)|Biological: 2011-2012 FluMist®","Stanford LPCH Vaccine Program, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT02141581"
26,"Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza","Completed","No Results Available","Influenza, Human","Biological: TCN-032|Biological: Placebo","SNBL Clinical Pharmacology Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01390025"
27,"Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine","Completed","No Results Available","Influenza","Biological: Influenza A/Vietnam/1203/2004 (H5N1; sanofi pasteur)","University of Rochester, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00240903"
28,"Influenza Antiviral DAS-181-F04 in Healthy Adults","Completed","No Results Available","Influenza","Drug: DAS181|Other: Placebo","Johns Hopkins Bayview Medical Center - Infectious Diseases, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01651494"
29,"T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009","Completed","Has Results","Influenza","Biological: Fluzone® (intramuscular)|Biological: FluMist® (intranasal)","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01987349"
30,"Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)","Completed","Has Results","Influenza","Biological: Trivalent, inactivated influenza vaccine (TIV)|Biological: Quadrivalent, inactivated influenza vaccine (IIV4)|Biological: High-Dose Trivalent, inactivated influenza vaccine (TIV High-Dose)","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01827462"
31,"A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination","Completed","Has Results","Influenza","Biological: Split, Inactivated, Trivalent Influenza vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00743275"
32,"A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination","Completed","Has Results","Influenza","Biological: Influenza virus vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00835926"
33,"The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination","Completed","Has Results","Influenza","Biological: 2016-2017 Influenza Vaccine","The Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia, United States","https://ClinicalTrials.gov/show/NCT02876159"
34,"Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle","Completed","Has Results","Influenza","Biological: Inactivated influenza vaccine|Other: Placebo","The Hope Clinic, Decatur, Georgia, United States","https://ClinicalTrials.gov/show/NCT02438423"
35,"Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection","Completed","No Results Available","Influenza","Biological: LAIV|Other: Saline","UCLA, Los Angeles, California, United States","https://ClinicalTrials.gov/show/NCT02597647"
36,"Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses","Completed","No Results Available","Influenza","Biological: 2 mg/kg CR8020|Biological: 5 mg/kg CR8020|Biological: 15 mg/kg CR8020|Biological: 30 mg/kg CR8020|Biological: 50 mg/kg CR8020|Biological: Placebo","Quintiles Early Clinical Development, Overland Park, Kansas, United States","https://ClinicalTrials.gov/show/NCT01756950"
37,"H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...","Completed","No Results Available","Influenza","Biological: A/Shanghai/02/2013 (H7N9) MIV|Biological: VRC-FLUDNA071-00-VP","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT02206464"
38,"Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus","Completed","No Results Available","Influenza","Biological: CR6261 2 mg/kg|Biological: CR6261 5 mg/kg|Biological: CR6261 15 mg/kg|Biological: CR6261 30 mg/kg|Biological: CR6261 50 mg/kg|Biological: Placebo","Quintiles Early Clinical Development, Overland Park, Kansas, United States","https://ClinicalTrials.gov/show/NCT01406418"
39,"Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00389532"
40,"Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine","Completed","No Results Available","Influenza","Biological: VAX125","University of Rochester, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00730457"
41,"Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Fluzone®: Influenza Virus Vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00258830"
42,"Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly","Completed","No Results Available","Influenza","Biological: Synbiotic AKSB","Mayo Clinic, Rochester, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01304771"
43,"Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7","Completed","No Results Available","Influenza A","Biological: Influenza A H7N7 vaccine","University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00922259"
44,"Self-Administered Nasal Influenza Feasibility Study","Completed","Has Results","Influenza","Drug: FluMist","Naval Medical Center San Diego, San Diego, California, United States|San Antonio Military Health System, Fort Sam Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01933048"
45,"Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Fluzone®: Influenza virus vaccine 2004-2005 formulation","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00831987"
46,"Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)","Completed","Has Results","Influenza","Biological: Flublok® Quadrivalent Influenza Virus Vaccine|Biological: Fluarix Quadrivalent® Influenza Virus Vaccine","Maine Research Associates, LLC, Auburn, Maine, United States","https://ClinicalTrials.gov/show/NCT01959945"
47,"Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®","Completed","Has Results","Influenza","Biological: Influenza virus vaccine (Pediatric formulation)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00836953"
48,"Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza","Completed","No Results Available","Influenza","Drug: DAS181-F02 formulation|Drug: DAS181-F04 formulation|Drug: Placebo","Nexbio, San Diego, California, United States","https://ClinicalTrials.gov/show/NCT01740063"
49,"Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00258817"
50,"Trial to Describe the Safety and Immunogenicity of Fluzone®","Completed","Has Results","Influenza","Biological: Inactivated, Split-Virion Influenza Virus","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00524940"
51,"Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations","Completed","Has Results","Influenza","Biological: Fluzone Quadrivalent vaccine, 2016-2017 formulation, No Preservative|Biological: Fluzone High-Dose, vaccine, 2016-2017 formulation","Bardstown, Kentucky, United States|Metairie, Louisiana, United States","https://ClinicalTrials.gov/show/NCT02908269"
52,"Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects","Completed","No Results Available","Seasonal Influenza","Biological: Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011","Cambridge, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01161264"
53,"Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children","Completed","Has Results","Influenza","Biological: Fluzone® Quadrivalent Influenza Vaccine, No Preservative","Bardstown, Kentucky, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02539108"
54,"Study of Safety and Immunogenicity of Fluzone® in Healthy Children","Completed","Has Results","Influenza","Biological: Influenza Vaccine 2004-2005 Paediatric Formulation","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00831675"
55,"Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: 2007-2008 Influenza Virus Vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00561002"
56,"Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine","Completed","Has Results","Influenza","Biological: Fluzone® Quadrivalent Influenza Virus Vaccine, No Preservative","Bardstown, Kentucky, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01946425"
57,"Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49","Completed","No Results Available","Influenza","Biological: VAX161C vaccine","Miami Research Associates, South Miami, Florida, United States|Johnson County Clinical Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT01658800"
58,"Safety Study of an Oral Vaccine to Prevent Avian Influenza","Completed","No Results Available","Avian Influenza|Bird Flu","Biological: ND1.1|Biological: Placebo control","San Diego, California, United States","https://ClinicalTrials.gov/show/NCT01335347"
59,"Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma","Completed","No Results Available","Influenza","Biological: Trivalent inactivated influenza vaccine|Biological: Trivalent Baculovirus-expressed Influenza HA vaccine","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00307177"
60,"Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)","Completed","Has Results","Influenza A Virus, H5N1 Subtype","Biological: H5N1 vaccine plus AS03 adjuvant|Biological: H5N1 vaccine without adjuvant","The Hope Clinic - Emory Vaccine Center, Decatur, Georgia, United States","https://ClinicalTrials.gov/show/NCT01910519"
61,"Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe","Completed","Has Results","Influenza Prophylaxis","Device: Stratis Jet Injector|Device: Needle and Syringe|Biological: 2011-2012 Fluzone trivalent inactivated influenza vaccine","Bel-Rea Institute, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT01644149"
62,"Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine","Completed","Has Results","Influenza","Biological: Fluzone® Quadrivalent Influenza Vaccine, No Preservative","Bardstown, Kentucky, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02222870"
63,"Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults","Completed","No Results Available","Influenza","Biological: VAX128|Biological: Placebo","Miami Research Associates, Miami, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT01172054"
64,"Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines","Completed","No Results Available","Influenza, Human","Biological: A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca)|Biological: A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca)|Biological: 2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®)|Biological: Vaccine placebo (Leibovitz-15 [L-15])|Biological: Vaccine placebo (FluMist®)","University of Rochester Medical Center: Facility for Evaluation of Flu Vaccines, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01674205"
65,"Effects of Age on Response to the 2009 H1N1 Virus Vaccine","Completed","Has Results","2009 H1N1 Influenza Virus","Biological: 2009 H1N1 Virus Vaccine","University of Rochester Medical Center, Vaccine Research Unit, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01055184"
66,"Half vs Full Dose Influenza Vaccine","Completed","No Results Available","Influenza","Biological: Fluzone® (Aventis Pasteur inactivated influenza vaccine)","Pentagon, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT00283283"
67,"Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)","Completed","Has Results","Influenza","Biological: Fluzone®: Influenza Virus Vaccine, No Preservative: Pediatric Dose|Biological: Fluzone®; Influenza Virus Vaccine, No Preservative","Bardstown, Kentucky, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01691326"
68,"Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.","Completed","No Results Available","Influenza","Biological: CAIV-T|Biological: TIV|Biological: Placebo","David M. Radin, MD, Stamford, Connecticut, United States","https://ClinicalTrials.gov/show/NCT00192309"
69,"REDucing Influenza Among University Students, University of California at Berkeley","Completed","No Results Available","Influenza-like Illness|Influenza","Behavioral: Online education","University of California, Berkeley, Berkeley, California, United States","https://ClinicalTrials.gov/show/NCT00448773"
70,"Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years","Completed","No Results Available","Influenza","Biological: VAX161 [STF2.HA5 H5N1]","Miami Research Associates, Miami, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT01560793"
71,"Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age","Completed","No Results Available","Influenza","Biological: Fluzone","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00231920"
72,"High Dose Influenza Vaccine in Nursing Home - Pilot Study","Completed","Has Results","Influenza","Biological: HD Fluzone Vaccine|Biological: SD Fluzone Vaccine","Brown Univeristy, Providence, Rhode Island, United States|Insight Therapeutics, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT01720277"
73,"Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old","Completed","No Results Available","Influenza A Virus, H7N9 Subtype","Biological: H7N9 Anhui 2013/AA ca|Biological: Inactivated subvirion H7N9 vaccine","University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT02274545"
74,"VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...","Completed","No Results Available","Influenza, Human","Drug: VRC-FLUDNA047-00-VP|Drug: Flulaval (Registered) Seasonal Influenza Vaccine","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00858611"
75,"Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults","Completed","No Results Available","Influenza A Virus, H7N9 Subtype","Biological: Live attenuated H7N9 A/Anhui/13 ca influenza virus vaccine|Biological: Inactivated subvirion H7N9 influenza vaccine","University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01995695"
76,"Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children","Completed","Has Results","Influenza","Biological: Live attenuated Influenza vaccine|Biological: Trivalent Influenza Vaccine|Biological: TIV followed by LAIV|Biological: LAIV followed by TIV","Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Vaccine Research Unit Room 3-5000, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01246999"
77,"Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals","Completed","No Results Available","Influenza A Virus, H7N9 Subtype","Biological: H7N9 A/Anhui/13 ca influenza virus vaccine|Biological: Inactivated subvirion H7N9 vaccine","Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT02151344"
78,"Safety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults","Completed","No Results Available","Influenza","Biological: VAX102|Biological: Placebo","Johnson County Clin Trials, Lenexa, Kansas, United States|Vanderbilt Clinical Trials Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00921973"
79,"Vaccine for Prevention of Bird Flu","Completed","No Results Available","Influenza, Human","Drug: Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005|Drug: VRC-AViDNA036-00-VP","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00776711"
80,"Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults","Completed","No Results Available","Flu","Biological: Dose given at Day 0","Accelovance, Rockville, Maryland, United States","https://ClinicalTrials.gov/show/NCT01302990"
81,"Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults","Completed","No Results Available","Influenza Infection","Biological: VAX102 [Flagellin.HuM2e]|Biological: Placebo","Johnson County Clinical Trials, Lenexa, Kansas, United States|Sealy Vaccine Center, UTMB, Galveston, Texas, United States","https://ClinicalTrials.gov/show/NCT00603811"
82,"H7N9 Boost in Healthy Adults","Completed","No Results Available","Influenza","Biological: Monovalent influenza A/H7N9 virus vaccine","Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02586792"
83,"Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum","Completed","No Results Available","Seasonal Influenza","Biological: VXA-A1.1","Scintipharma, Lexington, Kentucky, United States","https://ClinicalTrials.gov/show/NCT01761123"
84,"An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...","Completed","No Results Available","Influenza A Virus, H5N1 Subtype","Biological: VRC-AVIDNA036-00-VP|Biological: Monovalent Influenza Subunit Virion (Inactive H5N1) Vaccine","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01086657"
85,"Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine","Completed","No Results Available","H5N1 Influenza","Biological: H5N1 Vaccine","Centers for Immunization Research (CIR) - John Hopkins Bloomburg School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01443663"
86,"A Study of VIS410 to Assess Safety and Pharmacokinetics","Completed","No Results Available","Influenza","Drug: VIS410|Drug: Placebo","DaVita Clinical Research, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT02045472"
87,"Safety, Reactogenicity and Immunogenicity of an H5N1 VLP","Completed","No Results Available","Pandemic Influenza","Biological: H5N1 VLP Vaccine|Biological: Placebo","Healthcare Discoveries, Inc., San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00519389"
88,"Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine","Completed","No Results Available","Influenza|Virus Diseases","Biological: H2N2 1960 AA ca recombinant vaccine","Johns Hopkins Bayview Medical Center, CIR Unit at the Mason F Lord Building, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00722774"
89,"H5N1 Vaccination With and Without AS03: Systems Biology Analysis","Completed","No Results Available","Influenza","Drug: ASO3 Adjuvant|Biological: Influenza A/H5N1 Vaccine","Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01573312"
90,"Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix","Completed","Has Results","Influenza","Biological: Trivalent influenza vaccine GSK 138842A|Biological: Fluarix","GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00693706"
91,"Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients","Completed","No Results Available","Influenza|Gammopathy","Drug: Fluzone","Yale University, New Haven, Connecticut, United States","https://ClinicalTrials.gov/show/NCT02267733"
92,"Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine","Completed","No Results Available","Influenza|Virus Diseases","Biological: H6N1 Teal HK 97/AA ca recombinant vaccine","Johns Hopkins Bayview Medical Center, CIR Unit at the Mason F Lord Building, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00734175"
93,"Control of Epidemic Influenza Through a School-based Influenza Vaccination Program","Completed","Has Results","Influenza","Biological: live attenuated and inactivated influenza vaccines","Scott & White Hospital and Clinic, Temple, Texas, United States|Scott & White Hospital and Clinic, Waco, Texas, United States","https://ClinicalTrials.gov/show/NCT00138294"
94,"Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.","Completed","No Results Available","Influenza A Subtype H5N1 Infection","Biological: Pandemic Influenza Vaccine|Biological: Placebo","Alabama Vaccine Research Center (UAB), Birmingham, Alabama, United States","https://ClinicalTrials.gov/show/NCT00755703"
95,"Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine","Completed","No Results Available","Healthy|Influenza","Biological: Lactobacillus rhamnosus GG ATCC 53103 (LGG)|Biological: Placebo|Biological: Live attenuated influenza vaccine","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01545349"
96,"Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults","Completed","Has Results","Influenza","Biological: Fluzone: Influenza virus vaccine","Grove City, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00623181"
97,"H9 Priming Study in Healthy Adults","Completed","No Results Available","Influenza","Biological: Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00617331"
98,"Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults","Completed","No Results Available","Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine","Drug: GelVac™ nasal powder H5N1 influenza vaccine.|Drug: Placebo","Florida Research Network, LLC, Gainesville, Florida, United States","https://ClinicalTrials.gov/show/NCT01258062"
99,"H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00310206"
100,"Trial to Collect Safety Data and Sera for Immunogenicity Testing","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00389857"
101,"Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant","Completed","No Results Available","Influenza","Biological: Fluzone vaccine with JVRS-100 adjuvant|Biological: Fluzone vaccine","Miami Research Associates, Miami, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00662272"
102,"Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine","Completed","Has Results","Influenza","Biological: A/California/07/09 live monovalent H1N1 vaccine","Vaccine Research Unit Room 3-5000, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01023776"
103,"Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children","Completed","No Results Available","Influenza","Biological: CAIV-T 10^7|Biological: CAIVT 10^5|Biological: Placebo|Biological: TIV","Suncoast Clinical Research, Inc., New Port Richey, Florida, United States|Division of Allergy Immunology and Infectious Disease, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00192322"
104,"Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)","Completed","No Results Available","Seasonal Influenza","Biological: Influenza VLP Vaccine|Biological: Placebo","University Clinical Research, Inc., Pembroke Pines, Florida, United States|SNBL Clinical Pharmacology Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00903552"
105,"VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years","Completed","No Results Available","Influenza, Human","Biological: VRC-FLUDNA056-00VP","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Clinical Alliance for Research and Education, Annandale, Virginia, United States","https://ClinicalTrials.gov/show/NCT00995982"
106,"Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.","Completed","No Results Available","Influenza, Human|Transplantation Infection","Biological: influenza trivalent inactive vaccine|Biological: influenza trivalent inactive vaccine high dose","Inova Fairfax Hospital, Falls Church, Virginia, United States","https://ClinicalTrials.gov/show/NCT01808456"
107,"Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 Influenza","Completed","No Results Available","Influenza A Virus Infection","Biological: H2N3 MO 2003/AA ca Vaccine","University of Rochester Medical Center, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01175122"
108,"Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1","Sanofi Pasteur, Swiftwater, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00311649"
109,"Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults","Completed","No Results Available","Influenza|Virus Diseases","Biological: Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca)","University of Rochester Vaccine Evaluation Isolation Unit, St. Mary's Hospital, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00853255"
110,"Safety and Dose Study of Peramivir for Influenza Treatment","Completed","No Results Available","Influenza","Drug: Peramivir","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00297050"
111,"Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults","Completed","No Results Available","Influenza","Biological: VAX102","Universite of Colorado, Denver, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT00921206"
112,"Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults","Completed","No Results Available","Influenza|Virus Diseases","Biological: Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca)","Center for Immunization Research Inpatient Unit, Mason F. Lord Building, 4940 Eastern Avenue, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00516035"
113,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)","Completed","No Results Available","Influenza|Virus Diseases","Biological: H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)","Center for Immunization Research Inpatient Unit, Mason F. Lord Building, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00380237"
114,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults","Completed","No Results Available","Influenza|Virus Diseases","Biological: H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca)","Center of Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00347672"
115,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)","Completed","No Results Available","Influenza|Virus Diseases","Biological: H9N2 (6-2) AA ca Reassortant (A/chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)","Johns Hopkins School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00110279"
116,"Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®","Completed","Has Results","Influenza|Orthomyxoviridae Infections","Biological: Influenza Virus Vaccine No Preservative: Pediatric Dose","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00755274"
117,"Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program","Completed","No Results Available","Influenza","Biological: FluMist","Division of General Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States|Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00192218"
118,"Testing the AVI-7100 Flu Drug in Healthy Volunteers","Completed","No Results Available","Influenza","Drug: AVI-7100 versus placebo","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01747148"
119,"VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old","Completed","No Results Available","Influenza A Virus, H1N1 Subtype|Novel Swine-Origin","Biological: VRC-FLUDNA057-00-VP","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00973895"
120,"Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents","Completed","Has Results","Immune Response to Influenza Vaccine|Influenza A Virus Infection|Influenza B Virus Infection","Biological: LAIV|Biological: IIV","Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT02250274"
121,"Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.","Completed","No Results Available","Influenza","Drug: Oseltamivir|Drug: Probenecid","VA Palo Alto Health Care System, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT00304434"
122,"The Influence of Chronic CMV Infection on Influenza Vaccine Responses","Completed","Has Results","Cytomegalovirus Infections|Influenza","Biological: Fluzone® 2012-2013 Formula NDC No 498281-012-50","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT02134184"
123,"Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults","Completed","No Results Available","Influenza","Biological: Influenza Vaccine, recombinant Hemagglutinin","Rochester Medical Center, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00328107"
124,"Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics","Completed","No Results Available","Influenza","Biological: Influenza Vaccination","Kentucky pediatric /Adult Research, Bardstown, Kentucky, United States|Saint Louis University, Saint Louis, Missouri, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00336453"
125,"Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults","Completed","No Results Available","Influenza","Drug: MEDI8852|Drug: Placebo","Research Site, Overland Park, Kansas, United States","https://ClinicalTrials.gov/show/NCT02350751"
126,"Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects","Completed","No Results Available","Influenza","Drug: Flufirvitide 3|Drug: Placebo for Flufirvitide-3","Spartanburg Medical Research, Spartanburg, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01990846"
127,"Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant","Completed","Has Results","Influenza","Biological: H5N1 vaccine plus AS03 adjuvant|Biological: H5N1 vaccine without adjuvant","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT01578317"
128,"Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy","Completed","Has Results","Cancer|Influenza Viral Infections","Biological: Standard Trivalent Influenza Vaccine|Biological: High-Dose Influenza Vaccine","Rochester General Hospital, Rochester, New York, United States|Lipson Cancer Center Linden Oaks Medical Campus, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01666782"
129,"Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults","Completed","No Results Available","Influenza A Subtype H7N7 Infection","Biological: Monovalent Influenza Subvirion Vaccine, H7N7","University of Rochester, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01534468"
130,"FluMist in Egg Allergic Patients","Completed","No Results Available","Egg Allergy|Eligible for Vaccination Against Influenza","Biological: FluMist intranasal influenza vaccine|Biological: Intramuscular influenza injection (""flu shot"")","Walter Reed Army Medical Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT01248208"
131,"Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines","Completed","No Results Available","Influenza","Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005","University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT01086566"
132,"Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)","Completed","No Results Available","Influenza","Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_25%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_50%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_100%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_0%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_25%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_50%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 7.5_100%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_0%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_25%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_50%MF59|Biological: Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 15_100%MF59","Baylor College of Medicine, Houston, Texas, United States|Universitätsklinikum Gießen und Marburg GmbH, Gießen, Germany","https://ClinicalTrials.gov/show/NCT00812019"
133,"Single Dose Escalating Study of DAS181 in Adults","Completed","No Results Available","Influenza","Drug: DAS181|Drug: Placebo","Comprehensive Phase One, Miramar, Florida, United States","https://ClinicalTrials.gov/show/NCT00527865"
134,"Immunogenicity of ND1.1 by Delivery Directly to the Ileum","Completed","No Results Available","Avian Influenza","Biological: ND1.1","Scintipharma, Lexington, Kentucky, United States","https://ClinicalTrials.gov/show/NCT01698060"
135,"Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects","Completed","No Results Available","Influenza","Drug: Flufirvitide-3 0.05 mg single dose|Drug: Flufirvitide-3, 0.1 mg single dose|Drug: Flufirvitide-3, 0.2 mg single dose|Drug: Flufirvitide-3, 0.4 mg single dose|Other: Placebo","Quintiles Phase One Services, Overland Park, Kansas, United States","https://ClinicalTrials.gov/show/NCT01313962"
136,"A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers","Completed","No Results Available","Influenza, Human","Drug: over-encapsulated oseltamivir|Drug: oseltamivir","GSK Investigational Site, Buffalo, New York, United States","https://ClinicalTrials.gov/show/NCT01258530"
137,"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults","Completed","Has Results","Influenza","Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted","GSK Investigational Site, Mesa, Arizona, United States","https://ClinicalTrials.gov/show/NCT01416571"
138,"A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults","Completed","Has Results","Influenza","Biological: Trivalent Influenza Virus Vaccine|Other: Placebo","Research Site, Miami, Florida, United States|Research Site, Stockbridge, Georgia, United States|Research Site, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01579916"
139,"Open-Label Study of H5 Vaccine in Participants of Protocol 04-077","Completed","Has Results","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00402649"
140,"Jet Injection for Influenza","Completed","Has Results","Influenza, Human","Biological: AFLURIA vaccine (2012-2013 formulation)|Device: Needle-Syringe|Device: Stratis needle-free injection device","Poudre Valley Hospital, Fort Collins, Colorado, United States|University of Colorado Health Harmony Campus, Fort Collins, Colorado, United States|Medical Center of the Rockies, Loveland, Colorado, United States","https://ClinicalTrials.gov/show/NCT01688921"
141,"Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations","Completed","Has Results","Influenza","Biological: Inactivated H1N1 Vaccine","University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Duke Translational Medicine Institute - Clinical Vaccine Unit, Durham, North Carolina, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00943631"
142,"Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age","Completed","Has Results","Influenza","Biological: VAX125","JCCT, Lanexa, Kansas, United States|Univ of Rochester, Rochester, New York, United States|Coastal Carolina Research Center, Charleston, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00966238"
143,"Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults","Completed","Has Results","Influenza","Biological: GSK Biologicals' FluLaval®|Biological: Placebo (saline)|Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A|Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A","GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Salisbury, North Carolina, United States|GSK Investigational Site, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01059617"
144,"Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV","Completed","Has Results","HIV|Cancer","Biological: Fluzone High Dose Vaccine|Biological: Fluzone Standard Dose Vaccine","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01205581"
145,"Pandemic Influenza Plasmid DNA Vaccines (Needle)","Completed","No Results Available","Influenza","Biological: VCL-IPT1|Biological: VCL-IPM1|Biological: PBS","Accelovance, San Diego, California, United States|SNBL, Baltimore, Maryland, United States|SUNY at Stonybrook, Stony Brook Medical Center, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT00709800"
146,"A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine","Completed","Has Results","Influenza","Biological: Trivalent influenza virus vaccine|Biological: Placebo","Covance, Daytona Beach, Daytona Beach, Florida, United States|Covance, Portland, Portland, Oregon, United States|Covance, Austin, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT00677820"
147,"Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)","Completed","No Results Available","Influenza","Biological: VCL-IPM1|Biological: VCL-IPT1|Biological: PBS","Accelovance, San Diego, California, United States|SNBL, Baltimore, Maryland, United States|SUNY at Stonybrook, Stony Brook Medical Center, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT00694213"
148,"A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers","Completed","No Results Available","Influenza, Human","Drug: 600 mg zanamivir + moxifloxacin placebo|Drug: 1200 mg zanamivir + moxifloxacin placebo|Drug: zanamivir placebo + moxifloxacin placebo|Drug: zanamivir placebo + 400 mg moxifloxacin","GSK Investigational Site, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT01353729"
149,"A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist","Completed","No Results Available","Influenza","Biological: FluMist|Biological: Fluzone","Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00231907"
150,"A Study of a Live Intranasal Influenza Vaccine in Children With Cancer","Completed","No Results Available","Cancer","Biological: FluMist|Biological: Inactivated influenza vaccine","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00906750"
151,"Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults","Completed","Has Results","Influenza","Biological: Influenza A Vaccine: ACAM FLU-A|Biological: Saline placebo","Miami Research Associates, Miami, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Northwest Kinetics, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00819013"
152,"Safety Study of Seasonal Influenza Vaccine by Jet Injection","Completed","No Results Available","Healthy Adults","Device: LectraJet|Device: TIV by jet injection|Biological: Seasonal Trivalent Influenza Vaccine","University of Maryland College Park Health Center, College Park, Maryland, United States","https://ClinicalTrials.gov/show/NCT00987350"
153,"Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days","Completed","No Results Available","Influenza A Virus, H1N1 Subtype","Drug: Zanamivir","GSK Investigational Site, Minneapolis, Minnesota, United States","https://ClinicalTrials.gov/show/NCT00989404"
154,"Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season","Completed","Has Results","Influenza|Healthy","Biological: Trivalent Influenza Vaccine|Other: Placebo","Research Site, South Miami, Florida, United States|Research Site, Stockbridge, Georgia, United States|Research Site, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02473510"
155,"Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season","Completed","Has Results","Influenza|Healthy","Biological: Monovalent Influenza Vaccine|Other: Placebo","Research Site, South Miami, Florida, United States|Research Site, Stockbridge, Georgia, United States|Research Site, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT02743117"
156,"Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults","Completed","Has Results","Influenza|Healthy","Biological: Trivalent Influenza Vaccine|Other: Placebo","Research Site, Miami, Florida, United States|Research Site, Stockbridge, Georgia, United States|Research Site, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01859143"
157,"Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma","Completed","No Results Available","Lymphoma","Biological: Trivalent Baculovirus-expressed Influenza HA vaccine","U.T.M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00307710"
158,"TIV and High Dose TIV in Subjects With Rheumatoid Arthritis","Completed","Has Results","Influenza","Biological: Trivalent inactivated influenza vaccine","University of Iowa - Vaccine Research & Education Unit, Iowa City, Iowa, United States","https://ClinicalTrials.gov/show/NCT01436370"
159,"Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine","Completed","No Results Available","Healthy|Elderly","Biological: Lactobacillus rhamnosus GG ATCC 53103 (LGG)|Biological: Placebo","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01368029"
160,"A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001","Completed","No Results Available","Healthy","Biological: INO-3401 + EP","Vince and Associates Clinical Research, Overland Park, Kansas, United States|Accelovance, Rockville, Maryland, United States","https://ClinicalTrials.gov/show/NCT01403155"
161,"Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults","Completed","No Results Available","Healthy","Biological: VGX-3400X","Vince & Associates, Overland Park, Kansas, United States|Accelovance, Rockville, Maryland, United States","https://ClinicalTrials.gov/show/NCT01142362"
162,"Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults","Completed","Has Results","Influenza","Biological: 0.5mL Intramuscular Injection","Vince and Associates Clinical Research, Overland Park, Kansas, United States|Meridian Clinical Research, Omaha, Nebraska, United States|University of Rochester, Rochester, New York, United States|Benchmark Research, Fort Worth, Texas, United States","https://ClinicalTrials.gov/show/NCT01147068"
163,"H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers","Completed","No Results Available","Influenza A Subtype H5N1 Infection","Biological: H5-VLP + GLA-AF|Biological: H5-VLP alone|Biological: H5-VLP + Alhydrogel(R)|Biological: Licensed H5N1 vaccine","Covance, Inc., Daytona Beach, Florida, United States|Covance, Inc., Dallas, Texas, United States|Covance, Inc., Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01657929"
164,"Inactivated Influenza A/H5N1 Vaccine in the Elderly","Completed","No Results Available","Influenza","Biological: Influenza A/H5N1 Vaccine|Drug: Placebo","UCLA Center For Vaccine Research, Torrance, California, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00230750"
165,"H5 Booster After a Two Dose Schedule","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00240968"
166,"H5 Adult - Chiron Study of Bird Flu Vaccine","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (Chiron)|Biological: MF-59|Drug: Placebo","Stanford University, Stanford, California, United States|Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00280033"
167,"Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults","Completed","No Results Available","Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections","Biological: Low dose of quadrivalent VLP vaccine|Biological: Medium dose of quadrivalent VLP vaccine|Biological: High dose of quadrivalent VLP vaccine|Biological: Placebo","Miami Research Associates, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT01991587"
168,"Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations","Completed","No Results Available","Influenza","Biological: Influenza A/H3N2 variant Vaccine","Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Research Institute - Seattle, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01746082"
169,"Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults","Completed","Has Results","Influenza","Biological: Fluzone Quadrivalent vaccine, 2015-2016 formulation, No Preservative|Biological: Fluzone Intradermal Quadrivalent vaccine, 2015-2016 formulation|Biological: Fluzone High-Dose vaccine, 2015-2016 formulation","Santa Rosa, California, United States|Council Bluffs, Iowa, United States|Metairie, Louisiana, United States|Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT02563093"
170,"Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults","Completed","Has Results","Influenza","Biological: Fluzone® Quadrivalent vaccine, 2014-2015 formulation|Biological: Fluzone I®ntradermal vaccine, 2014-2015 formulation|Biological: Fluzone High Dose vaccine, 2014-2015 formulation","Santa Rosa, California, United States|Council Bluffs, Iowa, United States|Metairie, Louisiana, United States|Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT02258334"
171,"CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations","Completed","Has Results","Influenza","Biological: Inactivated H1N1 Vaccine","University of Iowa, Iowa City, Iowa, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Group Health Cooperative, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00943488"
172,"Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults","Completed","Has Results","Influenza","Biological: Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),|Biological: Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),|Biological: Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)","Santa Rosa, California, United States|Council Bluffs, Iowa, United States|Metairie, Louisiana, United States|Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT01946438"
173,"A Study of Influenza Virus Vaccines in Children and Adults","Completed","Has Results","Influenza","Biological: 2009-2010 Trivalent Influenza Virus Vaccine|Biological: 2008-2009 Trivalent Influenza Virus Vaccine|Biological: Quadrivalent Influenza Virus Vaccine","Durham, North Carolina, United States|Cincinnati, Ohio, United States|Jefferson Hills, Pennsylvania, United States|Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00988143"
174,"A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine","Completed","Has Results","Healthy","Biological: Monovalent influenza virus vaccine|Biological: Placebo","Covance CRU, Inc., Daytona Beach, Florida, United States|Covance CRU, Inc, Portland, Oregon, United States|Covance CRU, Inc, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT00873912"
175,"Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)","Completed","No Results Available","Influenza","Biological: AV024|Other: Placebo","SFBC International Inc, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT00240877"
176,"H5 Vaccine Alone or With Adjuvant in Healthy Adults","Completed","No Results Available","Influenza","Drug: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur pre-adsorbed)","University of Maryland Baltimore, Baltimore, Maryland, United States|University of Rochester, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00296634"
177,"Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old","Completed","No Results Available","Influenza","Biological: GSK Biologicals' investigational vaccine GSK2590066A|Biological: GSK Biologicals' investigational vaccine GSK2592984A|Biological: GSK Biologicals' investigational vaccine GSK2340274A|Biological: GSK Biologicals' investigational vaccine GSK2340273A|Other: Placebo","GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT01236040"
178,"A/H5N1 Vaccine in Healthy Children Aged 2-9 Years","Completed","No Results Available","Influenza","Biological: Influenza A/H5N1 Vaccine|Drug: Placebo","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00133536"
179,"Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone","Completed","No Results Available","Influenza","Biological: DNA vaccine|Biological: TIV","Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States|St. Louis University - Doisy Research Center, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01498718"
180,"Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine: Fluzone® 2012-2013 Formulation|Biological: Influenza Virus Vaccine: Fluzone® Intradermal 2012-2013 Formulation|Biological: Influenza Virus Vaccine: Fluzone® High-Dose 2012-2013 Formulation","Boca Raton, Florida, United States|South Miami, Florida, United States|Council Bluffs, Iowa, United States|Metairie, Louisiana, United States","https://ClinicalTrials.gov/show/NCT01691339"
181,"Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4","Completed","Has Results","Influenza","Biological: Fluzone|Biological: Flumist|Other: Physiologic saline","University of Michigan School of Public Heatlh, Ann Arbor, Michigan, United States|Western Michigan University Health Services, Kalamazoo, Michigan, United States|Central Michigan University Health Services, Mount Pleasant, Michigan, United States|Eastern Michigan University Health Services, Ypsilanti, Michigan, United States","https://ClinicalTrials.gov/show/NCT00538512"
182,"Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years","Completed","No Results Available","Influenza","Biological: Seasonal Influenza DNA vaccine|Biological: TIV","Stanford University School of Medicine, Stanford, California, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Saint Louis University - Doisy Research Center, St. Louis, Missouri, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT01676402"
183,"Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults","Completed","Has Results","Influenza Disease; Flu","Biological: Influenza Virus Vaccine","Bardstown, Kentucky, United States|Pittsburgh, Pennsylvania, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00264576"
184,"Study of the Safety and Immunogenicity of H1N1 Vaccine","Completed","No Results Available","H1N1 Flu","Biological: HAC1 Vaccine","Walter Reed Army Institute of Research (WRAIR), Silver Spring, Maryland, United States","https://ClinicalTrials.gov/show/NCT01177202"
185,"Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age","Completed","No Results Available","Influenza","Biological: Investigational H9N2 vaccine GSK2654911A|Biological: Investigational H9N2 vaccine GSK2654909A|Biological: Placebo","GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Edison, New Jersey, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01659086"
186,"Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults","Completed","No Results Available","Influenza","Biological: Influenza VLP Vaccine (recombinant)|Biological: Placebo","University Clinical Research, Pembroke Pines, Florida, United States|The Center for Pharmacuetical Research, Kansas City, Missouri, United States|Omega Medical Research, Warwick, Rhode Island, United States|Benchmark Research, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT00754455"
187,"Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1","Completed","No Results Available","Bird Flu|Influenza","Other: Placebo|Biological: Ad4-H5-Vtn|Biological: Sanofi Pasteur Influenza Virus Vaccine, H5N1","University of Kentucky, Lexington, Kentucky, United States|The Center for Pharmaceutical Research, Kansas City, Missouri, United States|University of Rochester, Rochester, New York, United States|Coastal Carolina Research Center, Inc., Mount Pleasant, South Carolina, United States","https://ClinicalTrials.gov/show/NCT01006798"
188,"Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers","Completed","No Results Available","Response of Viral Infection to Woodsmoke","Other: wood smoke|Other: clean air","center for envionmental medicine asthma an lung biology at the EPA, Chapel Hill, North Carolina, United States","https://ClinicalTrials.gov/show/NCT02183753"
189,"H7N9 Mix and Match With MF59 in Healthy Adults","Completed","No Results Available","Influenza","Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013|Drug: MF59","Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston, Galveston, Texas, United States","https://ClinicalTrials.gov/show/NCT01938742"
190,"Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals","Completed","Has Results","HIV Infection","Biological: Fluzone®","Clinical Trials Unit. University of Pennsylvania, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01262846"
191,"H5N1 Mix and Match With AS03","Completed","No Results Available","Influenza","Drug: AS03 Adjuvant|Other: Phosphate Buffered Saline (PBS) diluent|Biological: Sanofi H5N1 Antigen","University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Research Institute - Seattle, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01317758"
192,"A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus","Completed","No Results Available","Healthy","Biological: INO-3605|Biological: INO-3609|Biological: INO-3401|Biological: INO-3605 AND INO-3609|Biological: INO-3510|Biological: Seasonal Influenza vaccine","Miami Research Associates, Miami, Florida, United States|Vince and Associates, Overland Park, Kansas, United States|SNBL, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT01405885"
193,"Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults","Completed","No Results Available","Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections","Biological: Low dose of quadrivalent VLP vaccine|Biological: Medium dose of quadrivalent VLP vaccine|Biological: High dose of quadrivalent VLP vaccine|Biological: Placebo","Broward Research Group, Hollywood, Florida, United States|Miami Research Associates, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT02233816"
194,"Alternative Oseltamivir Dosing Strategies","Completed","No Results Available","Influenza","Drug: Oseltamivir","VA Greater Los Angeles Healthcare System, Los Angeles, California, United States|VA Palo Alto Health Care System, Palo Alto, California, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Brooke Army Medical Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00334529"
195,"Strategies for Enhancing Mucosal Immunity to Influenza Vaccine","Completed","No Results Available","Mucosal Immunity","Drug: Fluzone","Duke University Medical Center, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01385215"
196,"Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients","Completed","No Results Available","Pediatric Solid Organ Transplant Patients","Drug: High-Dose trivalent inactivated influenza vaccine|Drug: Standard dose trivalent inactivated influenza vaccine","Monroe Carell Jr. Children's Hospital at Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01525004"
197,"Duration of Immune Response to Influenza Vaccination in Patients With RA","Completed","No Results Available","Rheumatoid Arthritis","Biological: Influenza vaccine","Bassett Healthcare Network, Cooperstown, New York, United States","https://ClinicalTrials.gov/show/NCT02311855"
198,"H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients","Completed","Has Results","HIV Infections","Biological: H1N1 vaccination","University of Pennsylvania. Clinical Trials Unit, Philadelphia, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT01111162"
199,"Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults","Completed","Has Results","Human Immunodeficiency Virus (HIV)","Biological: Quadrivalent Live Attenuated Influenza Vaccine","University of Colorado Denver, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT02474901"
200,"Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older","Completed","Has Results","Breast Cancer|Lung Cancer|Prostate Cancer","Biological: inactivated influenza vaccine and the 23- valent pneumococcal vaccine|Biological: inactivated influenza vaccine and the PPV23 vaccine (Pneumovax)","Memorial Sloan-Kettering Cancer Center, New York, New York, United States","https://ClinicalTrials.gov/show/NCT00741039"
201,"High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors","Completed","No Results Available","Central Nervous System Neoplasm","Biological: trivalent influenza vaccine|Other: laboratory biomarker analysis","Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, Maryland, United States|Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01941758"
202,"Reverse Genetic H9N2 Influenza Vaccine Study in Adults","Completed","No Results Available","Influenza","Biological: Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine","Accelovance, Huntsville, Alabama, United States|Accelovance, Melbourne, Florida, United States|Accelovance, Peoria, Illinois, United States|Accelovance, South Bend, Indiana, United States|Accelovance, Rockville, Maryland, United States","https://ClinicalTrials.gov/show/NCT01320696"
203,"Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults","Completed","No Results Available","Healthy","Biological: HAI-05 Influenza Vaccine|Other: Saline","Heartland Research Associates, LLC, Wichita, Kansas, United States|The Center for Pharmaceutical Research, Kansas City, Missouri, United States","https://ClinicalTrials.gov/show/NCT01250795"
204,"Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults","Completed","Has Results","Influenza","Biological: PanBlok|Biological: rHA adjuvant","Meridian Clinical Research, Omaha, Nebraska, United States|University of Rochester Center for Vaccine Studies, Rochester, New York, United States|Benchmark Reseach, Austin, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Jean Brown Research, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01612000"
205,"Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot","Completed","No Results Available","Atopic Dermatitis","Drug: Fluzone® Intradermal (Sanofi Pasteur Inc.)","National Jewish Health, Denver, Colorado, United States","https://ClinicalTrials.gov/show/NCT01518478"
206,"Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008","Completed","No Results Available","Healthy Adult Volunteers","Biological: NB-1008|Other: Control","Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT01333462"
207,"2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women","Completed","Has Results","Influenza","Biological: Trivalent inactivated influenza vaccine","Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Duke University Medical Center - Duke Perinatal Clinic, Durham, North Carolina, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Research Institute - Seattle, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01173211"
208,"Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults","Completed","Has Results","Solid Organ Transplant Recipient (Liver, Kidney, Heart)|Rheumatologic Disorder|Human Immunodeficiency Virus (HIV)|Bone Marrow Transplant (BMT)|Dialysis","Biological: Fluzone High Dose|Biological: Fluzone","Children's Hospital Colorado, Aurora, Colorado, United States","https://ClinicalTrials.gov/show/NCT01685372"
209,"A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age","Completed","Has Results","Influenza","Biological: High-Dose Trivalent Inactivated Influenza Vaccine|Biological: Trivalent Inactivated Influenza Vaccine","Idaho Falls, Idaho, United States|Columbia, Maryland, United States|Ellicott City, Maryland, United States|Missoula, Montana, United States|Cleveland, Ohio, United States","https://ClinicalTrials.gov/show/NCT01258595"
210,"Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents","Completed","No Results Available","Influenza","Biological: Seasonal Influenza DNA vaccine|Biological: TIV","Emory Children's Center, Atlanta, Georgia, United States|Saint Louis University - Doisy Research Center, Saint Louis, Missouri, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|The Gamble Program for Clinical Studies, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01609998"
211,"Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults","Completed","No Results Available","Influenza","Biological: Quadrivalent VLP Vaccine|Biological: Comparator TIV","Anaheim Clinical Trials, Anaheim, California, United States|Miami Research Associates, Miami, Florida, United States|Johnson County Clin Trials, Lenexa, Kansas, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Clinical Trials of Texas, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT02307851"
212,"Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients","Completed","Has Results","Pediatric Patients With Acute Lymphoblastic Leukemia","Drug: High-dose trivalent inactivated influenza vaccine|Drug: Standard dose trivalent inactivated influenza vaccine","Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01216332"
213,"Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients","Completed","Has Results","Adult Stem Cell Hematopoetic Transplant","Biological: High-Dose Trivalent Inactivated Influenza Vaccine (HD-TIV)|Biological: Standard Dose Trivalent Inactivated Flu Vaccine","Vanderbilt-Ingram Cancer Center, Clinical Trials Information Program, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01215734"
214,"Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine, Fluzone®","Layton, Utah, United States|Pleasant Grove, Utah, United States|Provo, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00390884"
215,"Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)","Completed","No Results Available","Influenza","Biological: CAIV-T|Other: TIV","Wee Care Pediatrics, Layton, Utah, United States|Bear Care Pediatrics, Ogden, Utah, United States|Alpine Pediatrics, Pleasant Grove, Utah, United States|Utah Valley Pediatrics, Provo, Utah, United States|Families First Pediatrics, South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00111579"
216,"H7N9 Mix and Match With AS03 and MF59 in Healthy Adults","Completed","No Results Available","Influenza","Drug: AS03|Drug: MF59|Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013","University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Research Institute - Seattle - Vaccines and Infectious Diseases, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01942265"
217,"A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant","Completed","No Results Available","Influenza (Pandemic)","Biological: Monovalent Avian Influenza VLP (H7N9)|Biological: Matrix-M1™ adjuvant|Biological: Placebo","Diablo Clinical Research, Walnut Creek, California, United States|Miami Research Associates, Miami, Florida, United States|Advanced Clinical Research, Meridian, Idaho, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Coastal Carolina Research, Mt. Pleasant, South Carolina, United States","https://ClinicalTrials.gov/show/NCT02078674"
218,"Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV","Completed","Has Results","Influenza","Biological: FluBlok Influenza Vaccination|Biological: TIV (Fluzone) Influenza Vaccination","Kaiser Permanente Pediatric Clinic - Fresno, Fresno, California, United States|Kaiser Permanente Pediatric Clinic - Hayward, Hayward, California, United States|Kaiser Permanente Pediatric Clinic - Roseville, Roseville, California, United States|Kaiser Permanente Pediatric Clinic - Sacramento, Sacramento, California, United States|Kaiser Permanente, Honolulu, Hawaii, United States","https://ClinicalTrials.gov/show/NCT00539864"
219,"H5N1 Mix and Match With MF59","Completed","No Results Available","Influenza","Other: Phosphate Buffered Saline (PBS) diluent|Drug: MF59 Adjuvant|Biological: H5N1 Antigen","Emory Children's Center - Division of Pediatric Infectious Diseases, Atlanta, Georgia, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT01317745"
220,"H1N1 Vaccine in Pregnant Women","Completed","Has Results","Influenza","Biological: Inactivated H1N1 Vaccine","Saint Louis University - Center for Vaccine Development, St. Louis, Missouri, United States|Duke University Medical Center, Durham, North Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine - Department of Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Cooperative, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00963430"
221,"Sanofi H1N1 + TIV - Adults and Elderly","Completed","Has Results","Influenza","Biological: Trivalent inactivated influenza vaccine|Biological: Inactivated H1N1 Vaccine|Drug: Placebo","Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Saint Louis University Hospital - Internal Medicine - Infectious Diseases, Allergy & Immunology, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00943878"
222,"H5N1 Priming and Boosting Strategies","Completed","Has Results","Influenza","Biological: A/Vietnam/1203/04|Biological: A/Indonesia/05/05","The Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States|Mayo Clinic, Rochester - Vaccine Research Group, Rochester, Minnesota, United States|Saint Louis University, St. Louis, Missouri, United States|Group Health Cooperative, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00703053"
223,"Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Vero cell based whole virus influenza A/H5N1|Drug: Placebo","Stanford University, Stanford, California, United States|UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00382980"
224,"Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older","Completed","Has Results","Influenza","Biological: GSK Biologicals' influenza vaccine GSK2186877A|Biological: GSK Biologicals' Fluarix","GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Marid, Spain","https://ClinicalTrials.gov/show/NCT00765076"
225,"A Clinical Study to Assess the Safety of a New Influenza Vaccine","Completed","Has Results","Healthy","Biological: Monovalent Frozen FluMist®|Other: Placebo","Miami Research Associates, South Miami, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Columbia Research Group, Inc, Portland, Oregon, United States","https://ClinicalTrials.gov/show/NCT01104493"
226,"Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2","Completed","No Results Available","HIV Infections","Drug: Interleukin-2","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Hvidovre University Hospital@@@Copenhagen, Denmark, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT00050726"
227,"A/H5N1 Dose Ranging Study With Adjuvant Patch","Completed","No Results Available","Pandemic Influenza","Biological: A/H5N1|Biological: Placebo","Solano Clinical Research, Vallejo, California, United States|Miami Research Associates, Miami, Florida, United States|Quintiles Phase One Services, Kansas City, Kansas, United States|Jean Brown Research, Salt Lake City, Utah, United States|Northwest Kinetics, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00532792"
228,"A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2","Completed","No Results Available","Influenza (Pandemic)","Biological: Monovalent Avian Influenza VLP (H5N1)|Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant|Biological: Saline Placebo","Anaheim Clinical Trials, Anaheim, California, United States|Miami Research Associates, Miami, Florida, United States|Broward Research Group, Pembroke Pines, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Clinical Trials of Texas, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT01596725"
229,"A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1","Completed","No Results Available","Influenza (Pandemic)","Biological: Monovalent Avian Influenza VLP (H5N1)|Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant|Biological: Saline placebo","Anaheim Clinical Trials, Anaheim, California, United States|Miami Research Associates, Miami, Florida, United States|Broward Research Group, Pembroke Pines, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Clinical Trials of Texas, San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT01594320"
230,"A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers","Completed","No Results Available","Healthy Volunteers","Drug: Avonex","Research Site, Saint Paul, Minnesota, United States","https://ClinicalTrials.gov/show/NCT01119677"
231,"Rapid Empiric Treatment With Oseltamivir Study (RETOS)","Completed","Has Results","Influenza|Pneumonia","Drug: oseltamivir","Jewish Hospital, Louisville, Kentucky, United States|Norton Hospital, Louisville, Kentucky, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Rex Robley VA Medical Center, Louisville, Kentucky, United States|Baptist Hospital East, Louisville, Kentucky, United States","https://ClinicalTrials.gov/show/NCT01248715"
232,"Inactivated Influenza Via Jet Injection","Completed","Has Results","Influenza, Human","Biological: Influenza Vaccine","Optimal Research LLC, Huntsville, Alabama, United States|Optimal Research, LLC, San Diego, California, United States|Optimal Research, LLC, Melbourne, Florida, United States|Optimal Research, LLC, Peoria, Illinois, United States|Optimal Reserach, LLC, Mishawaka, Indiana, United States|Optimal Research, LLC, Rockville, Maryland, United States","https://ClinicalTrials.gov/show/NCT02290691"
233,"Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)","Completed","Has Results","MELAS Syndrome","Biological: Fluzone®","Stanford University School of Medicine, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT01831934"
234,"Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women","Completed","Has Results","Influenza","Other: Placebo|Biological: Cold-adapted live attenuated influenza virus vaccine, trivalent|Biological: Trivalent inactivated influenza vaccine","Washington Hospital Center - Obstetrics and Gynecology, Washington, District of Columbia, United States|Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Duke Translational Medicine Institute - Clinical Vaccine Unit, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Group Health Research Institute - Seattle, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT01181323"
235,"Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine: Fluzone® 2011-2012 Formulation|Biological: Influenza Virus Vaccine: Fluzone® High-Dose 2011-2012 Formulation","Colorado Springs, Colorado, United States|Council Buffs, Iowa, United States|Metairie, Louisiana, United States|Springfield, Missouri, United States|Bensalem, Pennsylvania, United States|Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT01430819"
236,"Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure","Completed","Has Results","Influenza","Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)","GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Rockville, Maryland, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Seattle, Washington, United States|GSK Investigational Site, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01788228"
237,"Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years","Completed","Has Results","H7N9 Influenza","Biological: H7N9c low dose with adjuvant|Biological: H7N9c medium dose with adjuvant|Biological: H7N9c high dose with adjuvant|Biological: H7N9c high dose without adjuvant","Site 04: Accelovance, San Diego, California, United States|Site 01: Accelovance, Melbourne, Florida, United States|Site 02: Accelovance, Peoria, Illinois, United States|Site 03: Accelovance, Rockville, Maryland, United States|Site 05: Janet Lewis, Salt Lake City, Utah, United States|Site 06: Janet Lewis, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01928472"
238,"FLU-VACS Comparative Study in Adults","Completed","No Results Available","Influenza","Biological: Cold-adapted live attenuated influenza virus vaccine, trivalent|Other: Placebo|Biological: Trivalent inactivated influenza vaccine","Ann Arbor West, Ann Arbor, Michigan, United States|University of Michigan, Ann Arbor, Michigan, United States|Western Michigan University Health Services, Kalamazoo, Michigan, United States|Livonia East, Livonia, Michigan, United States|Central Michigan University Health Services, Mt. Pleasant, Michigan, United States|Eastern Michigan University Health Services, Ypsilanti, Michigan, United States","https://ClinicalTrials.gov/show/NCT00133523"
239,"Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine","Little Rock, Arkansas, United States|Marietta, Georgia, United States|Durham, North Carolina, United States|Dayton, Ohio, United States|Pittsburgh, Pennsylvania, United States|Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00885105"
240,"Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults","Completed","No Results Available","Influenza","Biological: Influenza VLP Vaccine|Biological: TIV","Universtity Clinical Research, Pembroke Pines, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Brown University, Providence, Rhode Island, United States|Coastal Carolina Research Center, Mt. Pleasant, South Carolina, United States|Research Across America, Dallas, Texas, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT01014806"
241,"Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)","Completed","No Results Available","Influenza|Pandemic Influenza","Biological: H5N1 Influenza Vaccine, Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted (reverse genetic reassortant/H5N1 hemagglutinin antigen)","Heartland Research Associates, LLC, Wichita, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|The Center for Pharmaceutical Research, Kansas City, Missouri, United States|Rochester Clinical Research, Rochester, New York, United States|Omega Medical Research, Warwick, Rhode Island, United States|Research Across America, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT00783926"
242,"A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.","Completed","No Results Available","Influenza","Drug: oseltamivir [Tamiflu]","West Palm Beach, Florida, United States|Pittsburgh, Pennsylvania, United States|Jackson, Tennessee, United States|El Paso, Texas, United States|Coquitlam, British Columbia, Canada|Aalborg, Denmark","https://ClinicalTrials.gov/show/NCT00412555"
243,"Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant","Completed","No Results Available","A/Vietnam/H5N1 Influenza Virus","Biological: 7.5 mcg H5N1 (stored as monobulk)|Biological: 15 mcg H5N1 (stored as monobulk)|Biological: 90 mcg H5N1 (stored as monobulk)|Biological: 90 mcg H5N1 (stored in vials)|Other: MF59|Other: MF59 (stored as monobulk)","Radiant Research, Inc., Atlanta, Georgia, United States|Clinical Research Advantage, Inc./Ridge Family Practice, Council Bluffs, Iowa, United States|Johnson County Clin-Trials, Inc., Lenexa, Kansas, United States|Central Kentucky Researcch Associates, Inc., Lexington, Kentucky, United States|Radiant Research, Inc., Edina, Minnesota, United States|Rochester Clinical Research, Inc., Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT02680002"
244,"H1N1 Vaccine at Two Dose Levels in HIV Positive Adults","Completed","Has Results","Influenza","Biological: Inactivated Influenza H1N1 vaccine","University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore - Institute of Human Virology, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Baylor College of Medicine, Houston, Texas, United States|University of Washington, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00992433"
245,"Novartis H1N1 Vaccine in Pregnant Women","Completed","Has Results","Influenza","Biological: Inactivated H1N1 Vaccine","University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University - Center for Vaccine Development, St. Louis, Missouri, United States|Duke University Medical Center, Durham, North Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine - Department of Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Cooperative, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00992719"
246,"A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza","Completed","Has Results","Influenza","Drug: Oseltamivir|Drug: MEDI8852|Drug: Placebo","Research Site, Canoga Park, California, United States|Research Site, Long Beach, California, United States|Research Site, Los Angeles, California, United States|Research Site, Upland, California, United States|Research Site, Hialeah, Florida, United States|Research Site, Hialeah, Florida, United States|Research Site, Hialeah, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, North Miami Beach, Florida, United States|Research Site, Avon, Indiana, United States|Research Site, Muncie, Indiana, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Troy, Michigan, United States|Research Site, Butte, Montana, United States|Research Site, Hickory, North Carolina, United States|Research Site, Shelby, North Carolina, United States|Research Site, Smithfield, Pennsylvania, United States|Research Site, San Antonio, Texas, United States|Research Site, Clinton, Utah, United States|Research Site, Brandfort, South Africa|Research Site, Durban, South Africa|Research Site, Johannesburg, South Africa|Research Site, Pretoria, South Africa|Research Site, Pretoria, South Africa|Research Site, Pretoria, South Africa|Research Site, Pretoria, South Africa|Research Site, Thabazimbi, South Africa|Research Site, Welkom, South Africa","https://ClinicalTrials.gov/show/NCT02603952"
247,"Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age","Completed","Has Results","Influenza","Biological: Influenza virus vaccine (2004-2005 Formulation)","Little Rock, Arkansas, United States|Marietta, Georgia, United States|Durham, North Carolina, United States|Akron, Ohio, United States|Dayton, Ohio, United States|Pittsburgh, Pennsylvania, United States|Norfolk, Virginia, United States|Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00858468"
248,"Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine","Completed","No Results Available","Influenza|Orthomyxoviridae Infections","Biological: Monovalent subvirion H5N1 influenza vaccine|Biological: Physiological saline","San Diego, California, United States|South Miami, Florida, United States|Springfield, Missouri, United States|Cincinnati, Ohio, United States|Cincinnati, Ohio, United States|Knoxville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00664417"
249,"Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza","Completed","Has Results","Influenza","Drug: oseltamivir (Tamiflu®)","University of Alabama at Birmingham, Birmingham, Alabama, United States|Arkansas Children's Hospital - Infectious Diseases, Little Rock, Arkansas, United States|Miller Children's Hospital Long Beach - Bickerstaff Family Center, Long Beach, California, United States|Children's Hospital of Orange County, Orange, California, United States|Rady Children's Hospital San Diego, San Diego, California, United States|Children's Hospital Colorado - Infectious Disease, Aurora, Colorado, United States|Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease, Washington, District of Columbia, United States|University of Florida - Shands Children's Hospital, Gainesville, Florida, United States|University of South Florida - Tampa General Hospital - Pediatrics, Tampa, Florida, United States|Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|Louisiana State University Health Shreveport - Pediatrics, Shreveport, Louisiana, United States|University of Mississippi - Children's Infectious Diseases, Jackson, Mississippi, United States|Washington University School of Medicine in St. Louis - Center for Clinical Studies, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Children's Hospital and Medical Center - Infectious Diseases, Omaha, Nebraska, United States|Cohen Children's Medical Center - Pediatric Infectious Diseases, Manhasset, New York, United States|University of Rochester, Rochester, New York, United States|SUNY Upstate Medical University Hospital - Pediatrics, Syracuse, New York, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|MetroHealth Medical Center - Pediatric Infectious Disease, Cleveland, Ohio, United States|Children's Hospital of Philadelphia - The Center for Pediatric Clinical Effectiveness, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC - General Academic Pediatric, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital - Pediatrics, Providence, Rhode Island, United States|Vanderbilt University - Pediatric - Infectious Diseases, Nashville, Tennessee, United States|Parkland Memorial Hospital, Dallas, Texas, United States|The University of Texas Southwestern Medical Center, Dallas, Texas, United States|Cook Children's Infectious Disease Services, Fort Worth, Texas, United States|University of Utah - Pediatric Pharmacology Program, Salt Lake City, Utah, United States|Seattle Children's Hospital - Infectious Diseases, Seattle, Washington, United States|University of Alberta Hospital - Pediatrics, Edmonton, Alberta, Canada|The Hospital for Sick Children - Infectious Diseases, Toronto, Ontario, Canada|Centre Hospitalier de l'Universite Laval/ CHUQ, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00391768"
250,"Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old","Completed","Has Results","Influenza","Biological: Trivalent influenza vaccine (TIVc)|Biological: Trivalent influenza vaccine-licensed","Site 116, Phoenix, Arizona, United States|Site 119, Tucson, Arizona, United States|Site 109, Little Rock, Arkansas, United States|Site 112, Long Beach, California, United States|Site 113, Ontario, California, United States|Site 117, San Diego, California, United States|Site 114, West Covina, California, United States|Site 107, Thornton, Colorado, United States|Site 108, Miami Beach, Florida, United States|Site 111, Miami, Florida, United States|Site 121, Gainesville, Georgia, United States|Site 101, Omaha, Nebraska, United States|Site 104, Omaha, Nebraska, United States|Site 105, Omaha, Nebraska, United States|Site 106, Omaha, Nebraska, United States|Site 103, Youngstown, Ohio, United States|Site 102, Charleston, South Carolina, United States|Site 115, Houston, Texas, United States|Site 118, Saint George, Utah, United States|Site 110, Salt Lake City, Utah, United States|Site 120, Spokane, Washington, United States|Site 502, Kuopio, Finland|Site 506, Tampere, Finland|Site 301, Manila, Philippines|Site 302, Muntinlupa, Philippines|Site 201, Bangkok, Thailand|Site 202, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT02035696"
251,"RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly","Completed","No Results Available","Respiratory Syncytial Virus (RSV)","Biological: Low dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)|Biological: Low dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & day 28)|Biological: High dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)|Biological: High dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)|Biological: Placebo (Day 0 & Day 28); Seasonal TIV (Day 0)","Genova Clinical Research, Tucson, Arizona, United States|Accelovance, Melbourne, Florida, United States|Research Across America, Dallas, Texas, United States|Jean Brown Research, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01709019"
252,"Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months","Completed","Has Results","Influenza","Biological: MF59-eH1N1_f","Bentonville, Arkansas, United States|Fort Smith, Arkansas, United States|Canoga Park, California, United States|Dinuba, California, United States|Fresno, California, United States|Long Beach, California, United States|Los Angeles, California, United States|Madera, California, United States|Torrance, California, United States|New Albany, Indiana, United States|Newton, Kansas, United States|Wichita, Kansas, United States|Bardstown, Kentucky, United States|Woburn, Massachusetts, United States|Fargo, North Dakota, United States|Dayton, Ohio, United States|Huber Heights, Ohio, United States|Oklahoma City, Oklahoma, United States|Charleston, South Carolina, United States|Spartanburg, South Carolina, United States|Lebanon, Tennessee, United States|Dallas, Texas, United States|Houston, Texas, United States|Provo, Utah, United States|Saint George, Utah, United States|South Jordan, Utah, United States|West Jordan, Utah, United States|Charlottesville, Virginia, United States|Delegacion Tlalpan, Mexico","https://ClinicalTrials.gov/show/NCT00996307"
253,"Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents","Completed","Has Results","Influenza","Biological: Cell culture-derived influenza subunit vaccine (cTIV)|Biological: Egg derived influenza subunit vaccine (eTIV)","Site 09, Fayetteville, Arkansas, United States|Site 10, Downey, California, United States|Site 02, Bardstown, Kentucky, United States|Site 14, Metairie, Louisiana, United States|Site 01, St. Louis, Missouri, United States|Site 11, Omaha, Nebraska, United States|Site 04, Edison, New Jersey, United States|Site 05, Endwell, New York, United States|Site 16, Fort Worth, Texas, United States|Site 13, San Angelo, Texas, United States|Site 12, San Antonio, Texas, United States|Site 08, Bountiful, Utah, United States|Site 07, Salt Lake City, Utah, United States|Site 03, Salt Lake City, Utah, United States|Site 06, Burke, Virginia, United States|Site 15, Spokane, Washington, United States|Site 44:Spec. Pediatric Dispensary, Dakovo, Croatia|Site 83, Ljudevita Gaja 2, Djakovo, Croatia|Site 43: Spec. Pediatric Dispensary, Sisak, Croatia|Site 27:Institute of Public Health, Zagreb, Croatia|Site 29: Institute of Public Health, Zagreb, Croatia|Site 40:Spec. Pediatric Dispensary, Zagreb, Croatia|Site 49: Spec. Pediatric Dispensary, Zagreb, Croatia|Site 50: Spec. Pediatric Dispensary, Zagreb, Croatia|Site 86: Spec. Pediatric Dispensary, Zagreb, Croatia|Site 70: Espoon rokotetutkimusklinikka, Heikintori, Espoo, Finland|Site 79: Kokkola Vaccine Research Clinic, Rantakatu 7, Kokkola, Finland|Site 78: Kuopio Vaccine Research Clinic, Microkatu 1,Osa/Section A, 3rd floor PL1188, Kuopio, Finland|Site 71: Etelä-Helsingin rokotetutkimusklinikka, Helsinki, Finland|Site 72: Itä-Helsingin rokotetutkimusklinikka, Helsinki, Finland|Site 76: Järvenpään rokotetutkimusklinikka, Järvenpää, Finland|Site 77: Kotkan rokotetutkimusklinikka, Kotka, Finland|Site 67: Lahden rokotetutkimusklinikka, Lahti, Finland|Site 75: Oulun rokotetutkimusklinikka, Oulu, Finland|Site 68: Porin rokotetutkimusklinikka, Pori, Finland|Site 66: Tampereen rokotetutkimusklinikka, Tampere, Finland|Site 69: Turun rokotetutkimusklinikka, Turku, Finland|Site 73: Itä-Vantaan rokotetutkimusklinikka, Vantaa, Finland|Site 74: Länsi-Vantaan rokotetutkimusklinikka, Vantaa, Finland|Site 57: Házi Gyermekorvosi Rendelő, Budapest, Hungary|Site 53: Heim Pál Gyermekkórház, Budapest, Hungary|Site 52: Ferencvárosi Gyermekorvos Kft., Budapest, Hungary|Site 56: Házi Gyermekorvosi Rendelő, Budapest, Hungary|Site 54: Házi Gyermekorvosi Rendelő, Budapest, Hungary|Site 51: 5053. számú Gyermekorvosi Rendelő, Miskolc, Hungary|Site 55: Revamed kft., Nyíregyháza, Hungary|Site 59: Vas Megyei Markusovszky Lajos, Általános, Rehabilitációs és Gyógyfürdő Kórház, Egyetemi Oktató Kórház, Szombathely, Hungary|Site 42: Dipartimento di Medicina Clinica e Sperimentale - Sezione di Igiene e Medicina Preventiva, Ferrara, Italy|Site 47: Dipartimento Scienze della Salute, Sezione di Igiene e Medicina Preventiva, Univesità di Genova, Genova, Italy|Site 41: Ospedale Maggiore della Carità-Clinica Pediatrica, Novara, Italy|Site 46: USL 2 Perugia, Distretto del perugino, Centro di Salute n. 4 (Madonna Alta) e n. 6 (Ellera di Corciano del distretto del perugino), Perugia, Italy|Site 45: AUSL 7, Ragusa, Italy|Site 35, Kaunas, Lithuania|Site 36, Vilnius, Lithuania|Site 32, Vilnius, Lithuania|Site 34, Vilnius, Lithuania|Site 31, Vilnius, Lithuania|Site 33, Vilnius, Lithuania|Site 25, Campulung Muscel, Arges, Romania|Site 21, Craiova, Dolj, Romania","https://ClinicalTrials.gov/show/NCT00645411"
254,"Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV","Completed","No Results Available","Fever","Other: Acetaminophen|Other: Placebo","Duke University Health System, Durham, North Carolina, United States","https://ClinicalTrials.gov/show/NCT01946594"
255,"Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)","Completed","Has Results","Influenza","Biological: MF59-eH1N1","Premier Health Research Center, LLC, Downey, California, United States|Madera Family Medical Group, Madera, California, United States|Center for Clincal Trials, LLC, Paramount, California, United States|Center for Clinical Trials, LLC, Paramount, California, United States|Center for Clinical Trials of San Gabriel, West Covina, California, United States|1st International Research Centers, Thornton, Colorado, United States|Pediatrics and Adolescent Medicine, Marietta, Georgia, United States|Pediatrics and Adolescent Medicine, Woodstock, Georgia, United States|Northern Illinois Research Associates, Dekalb, Illinois, United States|Bluegrass Clinical Research, Inc., New Albany, Indiana, United States|Heartland Research Associates LLC, Arkansas City, Kansas, United States|Heartland Research Associates LLC, Newton, Kansas, United States|Bluegrass Clinical Research, Inc (Brownsboro for drug shipment), Louisville, Kentucky, United States|Meridien Clinical Research, Omaha, Nebraska, United States|Clinical Research Center of Nevada, Henderson, Nevada, United States|Capital Pediatrics and Adolescent Ctr., Raleigh, North Carolina, United States|Dr. Senders and Associates, Pediatrics, Cleveland, Ohio, United States|Prestige Clinical Research, Franklin, Ohio, United States|IPS Research, Oklahoma City, Oklahoma, United States|The Portland Clinic LLP, Beaverton, Oregon, United States|Children's Health Care -West, Erie, Pennsylvania, United States|UPMC/Community Medicine (pediatrics), Greenville, Pennsylvania, United States|Pediatric Physicians Research, Inc., Jefferson Hills, Pennsylvania, United States|Pediatric Alliance - Greentree Division (pediatrics), Pittsburgh, Pennsylvania, United States|Omega Clinical Research, Warwick, Rhode Island, United States|Holston Medical Group, Kingsport, Tennessee, United States|Research Across America, Dallas, Texas, United States|West Houston Clinical Research Service, Houston, Texas, United States|Pediatric Healthcare of NW Houston, Tomball, Texas, United States|J.Lewis Research, Inc./Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc./Foothill Family Clinic South, Salt Lake City, Utah, United States|PI-Coor Clinical Research, Burke, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Rockwood Research Center, Spokane, Washington, United States|Instituto Nacional de Ciencias, Tlalpan, Mexico","https://ClinicalTrials.gov/show/NCT00972816"
256,"Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults","Completed","Has Results","Influenza","Biological: MF59-eH1N1_f","Miami Research Associates, Miami, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Meridien Clinical Research, Omaha, Nebraska, United States|Regional Clinical Research, Endwell, New York, United States|Rochester Clinical Research, Inc, Rochester, New York, United States|Triangle Medical Research Associates, Cary, North Carolina, United States|Triangle Medical Research Associates, Raleigh, North Carolina, United States|Carolina Medical Trials, Winston-Salem, North Carolina, United States|Prestige Clinical Research, Franklin, Ohio, United States|IPS Research, Oklahoma City, Oklahoma, United States|West Ridge Family Practice (adult), Erie, Pennsylvania, United States|Primary Physicians Research Inc. (adult), Jefferson Hills, Pennsylvania, United States|Omega Clinical Research, Warwick, Rhode Island, United States|Research Across America, Dallas, Texas, United States|West Houston Clinical Research Service, Houston, Texas, United States|J.Lewis Research, Inc./Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc./Foothill Family Clinic South, Salt Lake City, Utah, United States|PI-Coor Clinical Research, Burke, Virginia, United States|PI Coor Clinical Research, Fairfax, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Instituto Nacional de Ciencias, Tlalpan, Mexico","https://ClinicalTrials.gov/show/NCT00973349"
257,"Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer","Completed","No Results Available","Healthy Adult Volunteers","Biological: NB-1008|Biological: Fluzone IN","Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT01354379"
258,"Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza","Completed","No Results Available","Influenza","Drug: Nitazoxanide|Drug: Placebo","Influence Study Site, Hot Springs, Arkansas, United States|Influence Study Site, Anaheim, California, United States|Influence Study Site, Fresno, California, United States|Influence Study Site, Lomita, California, United States|Influence Study Site, Kissimmee, Florida, United States|Influence Study Site, Lauderdale Lakes, Florida, United States|Influence Study Site, Saint Cloud, Florida, United States|Influence Study Site, Columbus, Georgia, United States|Influence Study Site, Savannah, Georgia, United States|Influence Study Site, Lansdale, Pennsylvania, United States|Influence Study Site, Rapid City, South Dakota, United States|Influence Study Site, Jackson, Tennessee, United States|Influence Study Site, Austin, Texas, United States|Influence Study Site, Houston, Texas, United States|Influence Study Site, Pharr, Texas, United States|Influence Study Site, Plano, Texas, United States|Influence Study Site, Waco, Texas, United States|Influence Study Site, Brookvale, New South Wales, Australia|Influence Study Site, Castle Hill, New South Wales, Australia|Influence Study Site, Mosman, New South Wales, Australia|Influence Study Site, Browns Plains, Queensland, Australia|Influence Study Site, Springfield, Queensland, Australia|Influence Study Site, Berwick, Victoria, Australia|Influence Study Site, Lynbrook, Victoria, Australia|Influence Study Site, Rosebud, Victoria, Australia|Influence Study Site, Tarneit, Victoria, Australia|Influence Study Site, San Juan, Puerto Rico|Influence Study Site, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT02612922"
259,"Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age","Completed","Has Results","Influenza","Biological: Flublok Quadrivalent Influenza Vaccine|Biological: Inactivated Influenza Vaccine","Coastal Clinical Research, Mobile, Alabama, United States|Clinical Research Consortium Arizona, Tempe, Arizona, United States|Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States|Northern California Clinical Research Center, Redding, California, United States|Benchmark Research - Sacramento, Sacramento, California, United States|Benchmark Research - San Francisco, San Francisco, California, United States|Lynn Institute of the Rockies, Colorado Springs, Colorado, United States|Clinical Research Consulting, Milford, Connecticut, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|Avail Clinical Research, DeLand, Florida, United States|Westside Center for Clinical Research, Jacksonville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Progressive Medical Research, Port Orange, Florida, United States|Meridian Research, Savannah, Georgia, United States|ACR - Boise, Meridian, Idaho, United States|Heartland Research Associates, LLC, Wichita, Kansas, United States|Central Kentucky Research Associates, Lexington, Kentucky, United States|Benchmarch Research - New Orleans, Metairie, Louisiana, United States|ActivMed Practices & Research, Methuen, Massachusetts, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|Meridian Research, Bellevue, Nebraska, United States|Meridian Research, Norfolk, Nebraska, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Clinical Research Consortium-Nevada, Las Vegas, Nevada, United States|ActivMed Practices & Research, Newington, New Hampshire, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rochester Clinical Research, Rochester, New York, United States|Wake Research, Raleigh, North Carolina, United States|Rapid Medical Research, Inc., Cleveland, Ohio, United States|Lynn Institute of Norman, Norman, Oklahoma, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, United States|Meridian Research, Dakota Dunes, South Dakota, United States|Clinical Research Associates, Nashville, Tennessee, United States|Benchmark Reseach, Austin, Texas, United States|Benchmark Research - Fort Worth, Fort Worth, Texas, United States|Benchmark Research - San Angelo, San Angelo, Texas, United States|Jean Brown Research, Salt Lake City, Utah, United States|Clinical Research Associates of Tidewater, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT02285998"
260,"A/H5N1/LT Dose Ranging Study","Completed","Has Results","Pandemic Influenza","Biological: A/H5N1|Biological: LT Adjuvant Patch","Advanced Clinical Research Institute, Anaheim, California, United States|Solano Clinical Research, Vallejo, California, United States|Miami Research Associates, Miami, Florida, United States|Accelovance, South Bend, Indiana, United States|Johnson County Clinical Trials, Lenexa, Kansas, United States|Jean Brown Research, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00908687"
261,"Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects","Completed","No Results Available","Influenza A","Drug: VX-787 300 mg|Drug: VX-787 600 mg|Drug: Oseltamivir 75 mg|Drug: Placebo","Athens, Alabama, United States|Birmingham, Alabama, United States|Gulf Shores, Alabama, United States|Huntsville, Alabama, United States|Scottsboro, Alabama, United States|Harrisburg, Arkansas, United States|Phoenix, Arkansas, United States|Anaheim, California, United States|Burbank, California, United States|Canoga Park, California, United States|Chula Vista, California, United States|El Cajon, California, United States|Encino, California, United States|Fresno, California, United States|Garden Grove, California, United States|Harbor City, California, United States|Huntington Beach, California, United States|La Mesa, California, United States|Lomita, California, United States|Long Beach, California, United States|Norwalk, California, United States|Oakland, California, United States|Oceanside, California, United States|Paramount, California, United States|San Diego, California, United States|Santa Monica, California, United States|Tustin, California, United States|Upland, California, United States|Colorado Springs, Colorado, United States|Northglenn, Colorado, United States|Washington, D.C., District of Columbia, United States|Boca Raton, Florida, United States|Boynton Beach, Florida, United States|Bradenton, Florida, United States|Brooksville, Florida, United States|Chiefland, Florida, United States|Clearwater, Florida, United States|Coral Gables, Florida, United States|Doral, Florida, United States|Edgewater, Florida, United States|Fort Myers, Florida, United States|Hialeah, Florida, United States|Homestead, Florida, United States|Jacksonville, Florida, United States|Kissimmee, Florida, United States|Lake Worth, Florida, United States|Lakeland, Florida, United States|Long Beach, Florida, United States|Miami, Florida, United States|New Port Richey, Florida, United States|North Miami Beach, Florida, United States|Orlando, Florida, United States|Ormond Beach, Florida, United States|Pembroke Pines, Florida, United States|Saint Petersburg, Florida, United States|Sarasota, Florida, United States|Tampa, Florida, United States|West Palm Beach, Florida, United States|Atlanta, Georgia, United States|Columbus, Georgia, United States|Anderson, Idaho, United States|Idaho Falls, Idaho, United States|Meridian, Idaho, United States|Anderson, Indiana, United States|Muncie, Indiana, United States|Newburgh, Indiana, United States|Council Bluffs, Iowa, United States|Overland Park, Kansas, United States|Bardstown, Kentucky, United States|Hazard, Kentucky, United States|Eunice, Louisiana, United States|Mandeville, Louisiana, United States|Shreveport, Louisiana, United States|Oxon Hill, Maryland, United States|Worcester, Massachusetts, United States|Belton, Michigan, United States|Niles, Michigan, United States|Troy, Michigan, United States|Saint Louis, Missouri, United States|Fremont, Nebraska, United States|Las Vegas, Nevada, United States|Berlin, New Jersey, United States|Brooklyn, New York, United States|New York, New York, United States|Rochester, New York, United States|Rosedale, New York, United States|Advance, North Carolina, United States|Hickory, North Carolina, United States|Morehead City, North Carolina, United States|Morganton, North Carolina, United States|Salisbury, North Carolina, United States|Akron, Ohio, United States|Dayton, Ohio, United States|Hilliard, Ohio, United States|Huber Heights, Ohio, United States|Tulsa, Oklahoma, United States|Harleysville, Pennsylvania, United States|Jenkintown, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Warminster, Pennsylvania, United States|East Providence, Rhode Island, United States|Johnston, Rhode Island, United States|Greer, South Carolina, United States|Laurens, South Carolina, United States|Mount Pleasant, South Carolina, United States|Rock Hill, South Carolina, United States|Simpsonville, South Carolina, United States|Rapid City, South Dakota, United States|Bristol, Tennessee, United States|Amarillo, Texas, United States|Arlington, Texas, United States|Austin, Texas, United States|Baytown, Texas, United States|Carrollton, Texas, United States|Corpus Christi, Texas, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Humble, Texas, United States|Katy, Texas, United States|Plano, Texas, United States|San Antonio, Texas, United States|Tomball, Texas, United States|Clinton, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States|Alexandria, Virginia, United States|La Crosse, Wisconsin, United States|Milwaukee, Wisconsin, United States|Borgerhout, Belgium|Linkebeek, Belgium|Massemen, Belgium|Wichelen, Belgium|Sofia, Bulgaria|Veliko Turnovo, Bulgaria|Calgary, Alberta, Canada|West Vancouver, British Columbia, Canada|Brampton, Ontario, Canada|Toronto, Ontario, Canada|Mirabel, Quebec, Canada|Montreal, Quebec, Canada|Saint-Jerome, Quebec, Canada|Trois-Rivières, Quebec, Canada|Mount Pearl, Canada|Paide, Estonia|Saku, Estonia|Tallinn, Estonia|Tartu, Estonia|Voru, Estonia|Berlin, Germany|Essen, Germany|Goch, Germany|Hamburg, Germany|Stuhr, Germany|Balvi, Latvia|Daugavpils, Latvia|Jekabpils, Latvia|Jelgava, Latvia|Kuldiga, Latvia|Lielvarde, Latvia|Riga, Latvia|Toa Baja, Puerto Rico","https://ClinicalTrials.gov/show/NCT02342249"
262,"Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza","Completed","No Results Available","Influenza","Drug: Nitazoxanide|Drug: Oseltamivir|Drug: Placebo Oral Tablet|Drug: Placebo Oral Capsule","Influence Study Site, Birmingham, Alabama, United States|Influence Study Site, Dothan, Alabama, United States|Influence Study Site, Hoover, Alabama, United States|Influence Study Site, Mobile, Alabama, United States|Influence Study Site, Mesa, Arizona, United States|Influence Study Site, Mesa, Arizona, United States|Influence Study Site, Tucson, Arizona, United States|Influence Study Site, Hot Springs, Arkansas, United States|Influence Study Site, Jonesboro, Arkansas, United States|Influence Study Site, Anaheim, California, United States|Influence Study Site, Fresno, California, United States|Influence Study Site, Garden Grove, California, United States|Influence Study Site, Harbor City, California, United States|Influence Study Site, Huntington Beach, California, United States|Influence Study Site, Lomita, California, United States|Influence Study Site, Long Beach, California, United States|Influence Study Site, Modesto, California, United States|Influence Study Site, Norco, California, United States|Influence Study Site, San Ramon, California, United States|Influence Study Site, Stockton, California, United States|Influence Study Site, Centennial, Colorado, United States|Influence Study Site, Colorado Springs, Colorado, United States|Influence Study Site, Colorado Springs, Colorado, United States|Influence Study Site, Littleton, Colorado, United States|Influence Study Site, Longmont, Colorado, United States|Influence Study Site, Thornton, Colorado, United States|Influence Study Site, Boynton Beach, Florida, United States|Influence Study Site, Coral Gables, Florida, United States|Influence Study Site, Edgewater, Florida, United States|Influence Study Site, Kissimmee, Florida, United States|Influence Study Site, Lauderdale Lakes, Florida, United States|Influence Study Site, Miami, Florida, United States|Influence Study Site, Orlando, Florida, United States|Influence Study Site, Pembroke Pines, Florida, United States|Influence Study Site, Saint Cloud, Florida, United States|Influence Study Site, West Palm Beach, Florida, United States|Influence Study Site, Atlanta, Georgia, United States|Influence Study Site, Canton, Georgia, United States|Influence Study Site, Columbus, Georgia, United States|Influence Study Site, Blackfoot, Idaho, United States|Influence Study Site, Skokie, Illinois, United States|Influence Study Site, Evansville, Indiana, United States|Influence Study Site, Franklin, Indiana, United States|Influence Study Site, Muncie, Indiana, United States|Influence Study Site, Augusta, Kansas, United States|Influence Study Site, Kansas City, Kansas, United States|Influence Study Site, Newton, Kansas, United States|Influence Study Site, Wichita, Kansas, United States|Influence Study Site, Wichita, Kansas, United States|Influence Study Site, Hawesville, Kentucky, United States|Influence Study Site, Madisonville, Kentucky, United States|Influence Study Site, Owensboro, Kentucky, United States|Influence Study Site, Eunice, Louisiana, United States|Influence Study Site, Lafayette, Louisiana, United States|Influence Study Site, Lake Charles, Louisiana, United States|Influence Study Site, Fall River, Massachusetts, United States|Influence Study Site, Ann Arbor, Michigan, United States|Influence Study Site, Chelsea, Michigan, United States|Influence Study Site, Essexville, Michigan, United States|Influence Study Site, Niles, Michigan, United States|Influence Study Site, Troy, Michigan, United States|Influence Study Site, Bridgeton, Missouri, United States|Influence Study Site, Fremont, Nebraska, United States|Influence Study Site, Las Vegas, Nevada, United States|Influence Study Site, Las Vegas, Nevada, United States|Influence Study Site, Teaneck, New Jersey, United States|Influence Study Site, Albuquerque, New Mexico, United States|Influence Study Site, Brooklyn, New York, United States|Influence Study Site, Brooklyn, New York, United States|Influence Study Site, Great Neck, New York, United States|Influence Study Site, New York, New York, United States|Influence Study Site, Rochester, New York, United States|Influence Study Site, Westfield, New York, United States|Influence Study Site, Charlotte, North Carolina, United States|Influence Study Site, Charlotte, North Carolina, United States|Influence Study Site, Hickory, North Carolina, United States|Influence Study Site, Mooresville, North Carolina, United States|Influence Study Site, Winston-Salem, North Carolina, United States|Influence Study Site, Columbus, Ohio, United States|Influence Study Site, Dayton, Ohio, United States|Influence Study Site, Groveport, Ohio, United States|Influence Study Site, Lyndhurst, Ohio, United States|Influence Study Site, Middleburg Heights, Ohio, United States|Influence Study Site, Milford, Ohio, United States|Influence Study Site, Willoughby Hills, Ohio, United States|Influence Study Site, Wooster, Ohio, United States|Influence Study Site, Tulsa, Oklahoma, United States|Influence Study Site, Ashland, Oregon, United States|Influence Study Site, Gresham, Oregon, United States|Influence Study Site, Altoona, Pennsylvania, United States|Influence Study Site, Lansdale, Pennsylvania, United States|Influence Study Site, Pittsburgh, Pennsylvania, United States|Influence Study Site, Pittsburgh, Pennsylvania, United States|Influence Study Site, Reading, Pennsylvania, United States|Influence Study Site, Scottdale, Pennsylvania, United States|Influence Study Site, Uniontown, Pennsylvania, United States|Influence Study Site, Warwick, Rhode Island, United States|Influence Study Site, Charleston, South Carolina, United States|Influence Study Site, Rapid City, South Dakota, United States|Influence Study Site, Rapid City, South Dakota, United States|Influence Study Site, Bristol, Tennessee, United States|Influence Study Site, Columbia, Tennessee, United States|Influence Study Site, Elizabethton, Tennessee, United States|Influence Study Site, Franklin, Tennessee, United States|Influence Study Site, Jackson, Tennessee, United States|Influence Study Site, Smyrna, Tennessee, United States|Influence Study Site, Austin, Texas, United States|Influence Study Site, Beaumont, Texas, United States|Influence Study Site, Bryan, Texas, United States|Influence Study Site, Houston, Texas, United States|Influence Study Site, Houston, Texas, United States|Influence Study Site, Irving, Texas, United States|Influence Study Site, Lake Jackson, Texas, United States|Influence Study Site, North Richland Hills, Texas, United States|Influence Study Site, Pharr, Texas, United States|Influence Study Site, Plano, Texas, United States|Influence Study Site, San Antonio, Texas, United States|Influence Study Site, San Antonio, Texas, United States|Influence Study Site, San Antonio, Texas, United States|Influence Study Site, Sugar Land, Texas, United States|Influence Study Site, Waco, Texas, United States|Influence Study Site, Draper, Utah, United States|Influence Study Site, Magna, Utah, United States|Influence Study Site, Orem, Utah, United States|Influence Study Site, Salt Lake City, Utah, United States|Influence Study Site, Alexandria, Virginia, United States|Influence Study Site, Ashburn, Virginia, United States|Influence Study Site, Charlottesville, Virginia, United States|Influence Study Site, Gainesville, Virginia, United States|Influence Study Site, Midlothian, Virginia, United States|Influence Study Site, Norfolk, Virginia, United States|Influence Study Site, Virginia Beach, Virginia, United States|Influence Study Site, Port Orchard, Washington, United States|Influence Study Site, Spokane, Washington, United States|Influence Study Site, Spokane, Washington, United States|Influence Study Site, La Crosse, Wisconsin, United States|Influence Study Site, Cardiff, New South Wales, Australia|Influence Study Site, Castle Hill, New South Wales, Australia|Influence Study Site, Darlinghurst, New South Wales, Australia|Influence Study Site, Westmead, Sydney, New South Wales, Australia|Influence Study Site, Chermside, Queensland, Australia|Influence Study Site, Sherwood, Queensland, Australia|Influence Study Site, Daw Park, South Australia, Australia|Influence Study Site, Clayton, Victoria, Australia|Influence Study Site, Fitzroy North, Victoria, Australia|Influence Study Site, Prahran, Victoria, Australia|Influence Study SIte, Nedlands, Western Australia, Australia|Influence Study Site, Antwerpen, Belgium|Influence Study Site, Coquitlam, British Columbia, Canada|Influence Study Site, Langley, British Columbia, Canada|Influence Study Site, Surrey, British Columbia, Canada|Influence Study Site, Brampton, Ontario, Canada|Influence Study Site, London, Ontario, Canada|Influence Study Site, Niagara Falls, Ontario, Canada|Influence Study Site, Sarnia, Ontario, Canada|Influence Study Site, Toronto, Ontario, Canada|Influence Study Site, Toronto, Ontario, Canada|Influence Study Site, Mirabel, Quebec, Canada|Influence Study Site, Montreal, Quebec, Canada|Influence Study Site, Pointe-Claire, Quebec, Canada|Influence Study Site, Birkenhead, Auckland, New Zealand|Influence Study Site, Grafton, Auckland, New Zealand|Influence Study Site, Remuera, Auckland, New Zealand|Influence Study Site, Rotorua, Bay Of Plenty, New Zealand|Influence Study Site, Tauranga, Bay Of Plenty, New Zealand|Influence Study Site, Beckenham, Christchurch, New Zealand|Influence Study Site, Christchurch Central, Christchurch, New Zealand","https://ClinicalTrials.gov/show/NCT01610245"
263,"A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older","Completed","No Results Available","Influenza","Biological: High-dose quadrivalent influenza virus vaccine|Biological: High-dose influenza virus vaccine|Biological: High-dose trivalent inactivated influenza vaccine","Milford, Connecticut, United States|Coral Gables, Florida, United States|Wichita, Kansas, United States|Saint Louis, Missouri, United States|Rochester, New York, United States|Warwick, Rhode Island, United States|Nashville, Tennessee, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT02553343"
264,"Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza","Completed","Has Results","Influenza","Drug: 40 mg Laninamivir Octanoate|Drug: 80 mg Laninamivir Octanoate|Drug: Placebo","Scottsboro Quick Care Clinic, Scottsboro, Alabama, United States|Clinical Trial Connection, Camp Verde, Arizona, United States|Warner Family Practice, Chandler, Arizona, United States|Clinical Research Connections, LLC, Harrisburg, Arkansas, United States|NEA Baptist Clinic, Jonesboro, Arkansas, United States|eStudySite, Chula Vista, California, United States|Beach Physicians Medical Group, Inc., Huntington Beach, California, United States|eStudySite, La Mesa, California, United States|Novo Research, Inc., Long Beach, California, United States|Lucita M. Cruz, MD, Inc, Norwalk, California, United States|eStudySite, Oceanside, California, United States|Clinical Trials of Orange County, Inc, Orange, California, United States|California Research Foundation, San Diego, California, United States|San Diego Sports Medicine & Family Health Center, San Diego, California, United States|Orange County Research Center, Inc, Tustin, California, United States|SC Clinical Research, Inc., Upland, California, United States|Complete Family Care, Northglenn, Colorado, United States|BRCR Medical Center, Inc DBA Boca Raton Clinical Research, Boca Raton, Florida, United States|Zasa Clinical Research, LLC, Boynton Beach, Florida, United States|Southeast Clinical Research, LLC, Chiefland, Florida, United States|Sanitas Research, Coral Gables, Florida, United States|Southeast Clinical Research, LLC - Parent, Jacksonville, Florida, United States|Crystal Biomedical Research, Miami Lakes, Florida, United States|Columbus Clinical Services, LLC, Miami, Florida, United States|New Horizon Research Center, Inc, Miami, Florida, United States|DCT - FMC, LLC, d/b/a Discovery Clinical Trials, Orlando, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Dr. B. Abraham, PC, Snellville, Georgia, United States|Women's Healthcare Associates P.A., Idaho Falls, Idaho, United States|Baptist Health Clinical Studies, Madisonville, Kentucky, United States|Clinical Trials Management, LLC, Mandeville, Louisiana, United States|Clinical Trials Management, LLC, Metairie, Louisiana, United States|Medipharmics, LLC, Metairie, Louisiana, United States|KAMP Medical Research, Natchitoches, Louisiana, United States|Paul Shapero, MD, Bangor, Maine, United States|Bethesda Allergy, Asthma & Research Center, LLC, Bethesda, Maryland, United States|Neccr Imca, Llc, Fall River, Massachusetts, United States|University of Massachusetts Medical Center, Worcester, Massachusetts, United States|Oakland Medical Research Center, Troy, Michigan, United States|Olive Branch Family Medical Center, Olive Branch, Mississippi, United States|Pioneer Clinical Research, LLC, Bellevue, Nebraska, United States|The Asthma & Allergy Center, P.C. master, Bellevue, Nebraska, United States|Beacom Family Health Connection, Fremont, Nebraska, United States|eStudySite, Las Vegas, Nevada, United States|Comprehensive Clinical Research, Berlin, New Jersey, United States|PMG Research of Hickory, LLC, Hickory, North Carolina, United States|Sentral Clinical Research Services, LLC, Cincinnati, Ohio, United States|Hometown Urgent Care & Occupational Health, Milford, Ohio, United States|ProMedica Health System, Inc, Sylvania, Ohio, United States|Vital Prospects Clinical Research Institute, P.C., Tulsa, Oklahoma, United States|Detweiler Family Medicine & Associates, Lansdale, Pennsylvania, United States|Warminster Medical Associates, PC, Warminster, Pennsylvania, United States|AAPRI Clinical Research Institute, Warwick, Rhode Island, United States|Hillcrest Clinical Research, LLC, Simpsonville, South Carolina, United States|Clinical Research Solutions, PC, Columbia, Tennessee, United States|HCCA Clinical Research Solutions, Franklin, Tennessee, United States|Clinical Research Solutions, PC, Franklin, Tennessee, United States|HCCA Clinical Research Solutions, Jackson, Tennessee, United States|PMG Research of Knoxville, Knoxville, Tennessee, United States|Clinical Research Solutions, PC, Nashville, Tennessee, United States|Clinical Research Solutions, PC, Smyrna, Tennessee, United States|ACRC Trials, Plano, Texas, United States|Sun Research Institute, LLC, San Antonio, Texas, United States|Oakwell Clinical Research, San Antonio, Texas, United States|DBA Southwest Clinic, San Antonio, Texas, United States|DCT-Stone Oak, LLC dba Discovery Clinical Trials, San Antonio, Texas, United States|Westside Medical, Clinton, Utah, United States|Focus Clinical Research, Draper, Utah, United States|J. Lewis Research - FirstMed East, Salt Lake City, Utah, United States|Carilion Infectious Disease, Roanoke, Virginia, United States|Dr Doong's Surgery, Burwood, New South Wales, Australia|Hyde Park Medical, Sydney, New South Wales, Australia|Westmead Hospital, Wentworthville, New South Wales, Australia|Cairns Base Hospital, Cairns, Queensland, Australia|Jimboomba Junction Family Practice & Skin Cancer Clinic, Jimboomba, Queensland, Australia|Mermaid Beach Medical Centre, Mermaid Beach, Queensland, Australia|Morayfield 7 Day Medical Centre, Morayfield, Queensland, Australia|AusTrials Pty Ltd. Sherwood, Sherwood, Queensland, Australia|Pain & Anaesthesia Research Clinic, Adelaide, South Australia, Australia|Hunter Clinical Research, Broadmeadows, Victoria, Australia|Dokter Luc Timmermans, Borgerhout, Belgium|Vereecken Guy, Halen, Belgium|Calozet, Yven, Herbeumont, Belgium|Hutsebaut, Andre, Moerkerke, Belgium|Van Mulders, Norbert, Moorsel, Belgium|Parque, Jean-Luc, Mouscron, Belgium|Mortelmans, Jaak, Oostham, Belgium|Private Practice, Oudenaarde, Belgium|BVBA Dr. Luc Capiau, Wetteren, Belgium|SHATPPD-Ruse EOOD, Ruse, Bulgaria|DCARC ""Hill Clinic"", Sofia, Bulgaria|Diagnostic Consultative Center II - Sofia OOD, Sofia, Bulgaria|Fifth MHAT-Sofia, EAD, Sofia, Bulgaria|MHAT ""Lyulin"", EAD, Sofia, Bulgaria|Military Medical Academy - MHAT - Sofia, Sofia, Bulgaria|NMTH ""Tsar Boris III"", Sofia, Bulgaria|UMHAT "" Alexandrovska"" EAD, Sofia, Bulgaria|UMHAT 'Lozenets"", Sofia, Bulgaria|MDHAT Dr Stefan Cherkezov, AD, Veliko Tarnovo, Bulgaria|Aggarwal and Associates Ltd, Brampton, Ontario, Canada|Dr. Anil K. Gupta Medicine Professional Corporation, Etobicoke, Ontario, Canada|SKDS Research Inc., Newmarket, Ontario, Canada|Omnispec Clinical Research Inc, Mirabel, Quebec, Canada|Clinique Medicale St-Louis (Recherche) Inc, Quebec, Canada|Administradora Country S.A., Bogota, Colombia|Centro de Investigacion Clinica - CAFAM, Bogota, Colombia|Clinica Colsanitas S.A. sede Clinica Universitaria Columbia, Bogota, Colombia|Vee Family Doctor's Center OY, Paide, Estonia|Medicum Perearstikeskus AS, Tallinn, Estonia|Meie Tervis OU, Tallinn, Estonia|Merekivi Perearstid OU, Tallinn, Estonia|Merelahe Family Doctors Centre, Tallinn, Estonia|Mustamae Health Centre, Tallinn, Estonia|Pirita Family Doctors Centre, Tallinn, Estonia|Dr Monika Vask Ltd., Tartu, Estonia|Marje Toom Family Doctors Practice, Voru, Estonia|Cabinet Medical, La Bouexiere, Ille Et Vilaine, France|Cabinet Medical, Tours, Indre Et Loire, France|Cabinet Medical, La Montagne, Loire Atlantique, France|Cabinet Medical - Alain Boye, Nantes, Loire Atlantique, France|Cabinet Medical, Briollay, Maine Et Loire, France|Cabinet Medical Jacques Marty, Murs-Erigne, Maine Et Loire, France|Cabinet Medical Jean Charcot, Segre, Maine Et Loire, France|Cabinet Medical, Vihiers, France|Institut fuer Praeventive Medizin Freiburg, Freiburg, Baden Wuerttemberg, Germany|Gemeinschaftspraxis Dr. med. Reinhold Jerwan-Keim, Renate Metz, Dietzenbach, Hessen, Germany|Gemeinschaftspraxis Dres. Hagemann, Duerfeld und Breiderhoff, Essen, Nordrhein Westfalen, Germany|Hausarztzentrum Bocholder Strasse, Essen, Nordrhein Westfalen, Germany|Medizentrum Essen Borbeck, Essen, Nordrhein Westfalen, Germany|Unterfrintroper Hausarztzentrum, Essen, Nordrhein Westfalen, Germany|medicoKIT, Goch, Nordrhein Westfalen, Germany|Gemeinschaftspraxis Heisters und Sungen, Kamp-Lintfort, Nordrhein Westfalen, Germany|Gemeinschaftspraxis Dres. Kleinecke-Pohl, Kirsch, Benner-Hemsen, Koein, Nordrhein Westfalen, Germany|ABX-CRO advanced pharmaceuticals Forschungsqesellschaft mbH, Dresden, Sachsen, Germany|Praxis Dr. Schiewe, Hamburg, Germany|Clinexpert Egeszsegugyi Szolg. es Ker. Kft., Budapest, Hungary|CSALADGYOGYYASZ Szolgaltato es Oktato Bt., Budapest, Hungary|Haziorvosi Rendelo, Budapest, Hungary|QUALICLINIC Eu-i Szolg. es Kutatasszervezo Kft, Budapest, Hungary|Kenezy Korhaz es Rendelointezet, Debrecen, Hungary|Bekes Megyei Pandy Kalman Korhaz, Gyula, Hungary|Felnott Haziorvosi Rendelo, Kecskemet, Hungary|Haziorvosi Rendelo, Kecskemet, Hungary|Felnott Haziorvosi Rendelo, Miskolc, Hungary|Revamed Kft., Nyiregyhaza, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Hungary|Liga Kozlovska Family Doctor Practice, Balvi, Latvia|Jelgava Outpatient Clinic, Jelgava, Latvia|Dr. R. Eglite's Private Practice, Kuldiga, Latvia|Dr. Dz.Trosk's practice, Lielvarde, Latvia|Regional Hospital of Liepaja, Liepaja, Latvia|Hospital of Reseknes, Rezekne, Latvia|Clinic of GP A.Lasmanis ""ALMA"", Riga, Latvia|Vecverdina Vizma - GP Practice, Riga, Latvia|Centro de Investigacion Clinica Acelerada, S.C., Mexico, Distrito Federal, Mexico|Centro de Investigacion Clinica GRAMEL S.C, Mexico, Distrito Federal, Mexico|Facultad Mexicana de Medicina, Universidad La Salle A.C., Mexico, Distrito Federal, Mexico|Hospital Angeles Lindavista, Mexico, Distrito Federal, Mexico|Mexico Centre for Clinical Research S.A. de C.V, Mexico, Distrito Federal, Mexico|Phylasis Clinicas Research S de RL de CV, Cuautitlan Izcalli, Estado De Mexico, Mexico|Clinical Research Institute S.C., Tlalnepantla, Estado De Mexico, Mexico|Centro de Investigacion Medico Biologica y Terapia Avanzada (CIMBYTA), Guadalajara, Jalisco, Mexico|Hospital de Especialidades Centro Medico Puerta de Hierro, Zapopan, Jalisco, Mexico|Centro de Investigaction y Transferencia en Salud del Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico|Hospital Universitario de Monterrey, Monterrey, Nuevo Leon, Mexico|Nucleo Victoria de Investigacion Clinica S.C., Durango, Mexico|Oaxaca Site Management Organization S.C., Oaxaca, Mexico|Optimal Clinical Trials, Auckland, New Zealand|Primorus Clinical Trials Ltd, Christchurch, New Zealand|Shirley Medical Centre, Christchurch, New Zealand|Clinical Trials New Zealand Ltd, Hamilton, New Zealand|Auckland Family Medical Centre, Remuera, New Zealand|Hospital Nacional Carlos Alberto Seguin Escobedo, Arequipa, Peru|Hospital Nacional Adolfo Guevara Velasco, Cusco, Peru|Clinica Internacional Sede San Borja, Lima, Peru|Clinica San Borja, Lima, Peru|Hospital Maria Auxiliadora, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Global Clinical Trials PE, Port Elizabeth, Eastern Cape, South Africa|Iatros International, Bloemfontein, Free State, South Africa|Josha Research, Bloemfontein, Free State, South Africa|Drs YAK Vahed and Partners, Welkom, Free State, South Africa|Maphutha, MB, Johannesburg, Gauteng, South Africa|Medicross Roodepoort Clinical Research, Johannesburg, Gauteng, South Africa|Clinresco Centres (Pty) Ltd, Kempton Park, Gauteng, South Africa|DJW Research, Krugersdorp, Gauteng, South Africa|Synexus SA, Stanza Bopape Clinical Research Centre, Mamelodi East, Gauteng, South Africa|Emmed Research, Pretoria, Gauteng, South Africa|Engelbrecht, I, Pretoria, Gauteng, South Africa|Global Clinical Trials Pretoria, Pretoria, Gauteng, South Africa|Jongaie Research, Pretoria, Gauteng, South Africa|Synexus SA - Watermeyer Clinical Research Centre, Pretoria, Gauteng, South Africa|Syzygy Clinical Research Services Wilgers, Pretoria, Gauteng, South Africa|University of Pretoria Clinical Research Unit, Pretoria, Gauteng, South Africa|De Villiers Clinical Trials, Durban, KwaZulu-Natal, South Africa|Sebastian, Peter, Durban, KwaZulu-Natal, South Africa|Synapta Clinical Research, Durban, KwaZulu-Natal, South Africa|van Rensburg, CJJ, Durban, KwaZulu-Natal, South Africa|Vawda, ZFA, Durban, KwaZulu-Natal, South Africa|Brookdale Clinical Research Centre, Phoenix, KwaZulu-Natal, South Africa|Richards Bay Trial Centre (Pty) Ltd, Richards Bay, KwaZulu-Natal, South Africa|Aliwal Shoal Medical Centre, Umkomaas, KwaZulu-Natal, South Africa|Limpopo Clinical Research Initiative, Thabazimbi, Limpopo, South Africa|Mzansi Ethical Research Centre, Middelburg, Mpumalanga, South Africa|Africa International Research, Cape Town, Western Cape, South Africa|Allergy Diagnostic & Clinical Research Unit, Cape Town, Western Cape, South Africa|Boyd, WV, Cape Town, Western Cape, South Africa|Helderberg Clinical Trials Centre, Cape Town, Western Cape, South Africa|Langeberg Clinical Trials, Cape Town, Western Cape, South Africa|Tiervlei Trial Centre, Cape Town, Western Cape, South Africa|Western Cape Clinical Trials, Cape Town, Western Cape, South Africa|Excellentis Clinical Trial Consultants, George, Western Cape, South Africa|Somerset West Clinical Trial Unit, Somerset West, Western Cape, South Africa|Clinical Projects Research SA (PTY) LTD, Worcester, Western Cape, South Africa|Staploe Medical Centre, Ely, Cambridgeshire, United Kingdom|Avondale Surgery Research, Chesterfield, Derbyshire, United Kingdom|Knowle House Surgery, Plymouth, Devon, United Kingdom|Sheepcot Medical Centre, Watford, Hertfordshire, United Kingdom|CPS Ltd, Glasgow, Strathclyde, United Kingdom|Holbrook Lane Surgery, Coventry, Warwickshire, United Kingdom|Bradford on Avon Health Centre, Bradford-on-Avon, Wiltshire, United Kingdom","https://ClinicalTrials.gov/show/NCT01793883"
265,"Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)","Completed","No Results Available","Influenza","Biological: Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified)|Biological: VCIV manufactured with the current manufacturing process (VCIV current)|Biological: Fluzone®, licensed trivalent influenza vaccine (TIV)","East Valley Family Physicians, PLC, Chandler, Arizona, United States|Anaheim Clinical Trials, Anaheim, California, United States|Center for Clinical Trials, LLC, Paramount, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research San Francisco, San Francisco, California, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|Avail Clinical Research, LLC, Deland, Florida, United States|Miami Research Associates, South Miami, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Heartland Research Associates, LLC, Wichita, Kansas, United States|The Center for Pharmaceutical Research, P.C., Kansas City, Missouri, United States|Sundance Clinical Research, LLC, St. Louis, Missouri, United States|Rochester Clinical Research Inc., Rochester, New York, United States|PMG Research of Cary, LLC, Cary, North Carolina, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Rapid Medical Research, Inc., Cleveland, Ohio, United States|Spartanburg Medical Research, Spartanburg, South Carolina, United States|Benchmark Research Austin, Austin, Texas, United States|Benchmark Research, Fort Worth, Texas, United States|Jean Brown Research, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01773928"
266,"A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children","Completed","Has Results","Influenza","Biological: Quadrivalent seasonal influenza vaccine GSK2282512A|Biological: Fluarix™ VB|Biological: Fluarix™ YB","GSK Investigational Site, Chandler, Arizona, United States|GSK Investigational Site, Scottsdale, Arizona, United States|GSK Investigational Site, Harrisburg, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Huntington Beach, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Centennial, Colorado, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Thornton, Colorado, United States|GSK Investigational Site, Niles, Michigan, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Hermitage, Pennsylvania, United States|GSK Investigational Site, Barnwell, South Carolina, United States|GSK Investigational Site, Clarksville, Tennessee, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Edmonton, Alberta, Canada|GSK Investigational Site, Surrey, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Mount Pearl, Newfoundland and Labrador, Canada|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Brampton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Saskatoon, Saskatchewan, Canada|GSK Investigational Site, Monterrey, Nuevo León, Mexico|GSK Investigational Site, Mexico city, Mexico|GSK Investigational Site, Alcala de Guadaira, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Pozuelo De Alarcón/Madrid, Spain|GSK Investigational Site, Sevilla, Spain|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT01198756"
267,"Influenza Vaccine in Pregnant Women","Completed","Has Results","Influenza","Biological: Fluzone®|Biological: Fluarix®","Emory University School of Medicine - Gynecology and Obstetrics, Atlanta, Georgia, United States|University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Mayo Clinic, Rochester - Vaccine Research Group, Rochester, Minnesota, United States|Saint Louis University, St. Louis, Missouri, United States|Duke University Medical Center, Durham, North Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Cooperative, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00905125"
268,"Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza","Completed","Has Results","Influenza","Drug: Favipiravir|Drug: Placebo comparator","#065, Birmingham, Alabama, United States|#156, Huntsville, Alabama, United States|#151, Mobile, Alabama, United States|#155, Scottsboro, Alabama, United States|#173, Toney, Alabama, United States|#161, Tuscumbia, Alabama, United States|#089, Chandler, Arizona, United States|#018, Green Valley, Arizona, United States|#110, Mesa, Arizona, United States|#105, Phoenix, Arizona, United States|#188, Tucson, Arizona, United States|#107, Jonesboro, Arkansas, United States|#019, North Little Rock, Arkansas, United States|#140, Searcy, Arkansas, United States|#059, Anaheim, California, United States|#179, Anaheim, California, United States|#032, Chino, California, United States|#154, Cypress, California, United States|#004, Garden Grove, California, United States|#144, Long Beach, California, United States|#043, Los Angeles, California, United States|#139, Los Angeles, California, United States|#096, Oxnard, California, United States|#091, Pacific Palisades, California, United States|#114, Pasadena, California, United States|#111, Pico Rivera, California, United States|#097, Pomona, California, United States|#068, Sacramento, California, United States|#035, San Diego, California, United States|#054, San Diego, California, United States|#042, Torrance, California, United States|#197, Bridgeport, Connecticut, United States|#022, Boca Raton, Florida, United States|#152, Boynton Beach, Florida, United States|#060, Coral Gables, Florida, United States|#007, Delray Beach, Florida, United States|#086, Edgewater, Florida, United States|#016, Ft. Myers, Florida, United States|#038, Gainesville, Florida, United States|#014, Hialeah, Florida, United States|#052, Hialeah, Florida, United States|#088, Hialeah, Florida, United States|#035, Jacksonville, Florida, United States|#094, Kissimmee, Florida, United States|#153, Kissimmee, Florida, United States|#177, Lauderdale Lakes, Florida, United States|#012, Melbourne, Florida, United States|#149, Miami Gardens, Florida, United States|#034, Miami, Florida, United States|#040, Miami, Florida, United States|#047, Miami, Florida, United States|#082, Miami, Florida, United States|#166, Miami, Florida, United States|#134, Pinellas Park, Florida, United States|#050, Port Orange, Florida, United States|#163, Venice, Florida, United States|#020, West Palm Beach, Florida, United States|#814, Snellville, Georgia, United States|#080, Honolulu, Hawaii, United States|#063, Boise, Idaho, United States|#835, Oak Lawn, Illinois, United States|#804, Fishers, Indiana, United States|#803, Franklin, Indiana, United States|#198, Greenfield, Indiana, United States|#195, Munci, Indiana, United States|#168, Council Bluffs, Iowa, United States|#827, West Des Moines, Iowa, United States|#008, Newton, Kansas, United States|#138, Shawnee, Kansas, United States|#106, Wichita, Kansas, United States|#055, Hazard, Kentucky, United States|#823, Alexandria, Louisiana, United States|#801, Baton Rouge, Louisiana, United States|#048, Elkridge, Maryland, United States|#085, Silver Spring, Maryland, United States|#187, Worcester, Massachusetts, United States|#811, Detroit, Michigan, United States|#015, Bellevue, Nebraska, United States|#170, Bellevue, Nebraska, United States|#081, Lincoln, Nebraska, United States|#017, Omaha, Nebraska, United States|#041, Omaha, Nebraska, United States|#169, Omaha, Nebraska, United States|#112, Henderson, Nevada, United States|#146, Henderson, Nevada, United States|#079, Las Vegas, Nevada, United States|#176, Las Vegas, Nevada, United States|#171, Brooklyn, New York, United States|#011, Endwell, New York, United States|#164, New York, New York, United States|#021, Harrisburg, North Carolina, United States|#178, High Point, North Carolina, United States|#189, Morganton, North Carolina, United States|#030, Carlisle, Ohio, United States|#006, Cleveland, Ohio, United States|#182, Grove City, Ohio, United States|#083, Wadsworth, Ohio, United States|#167, Oklahoma City, Oklahoma, United States|#810, Oklahoma City, Oklahoma, United States|#071, Tulsa, Oklahoma, United States|#045, Portland, Oregon, United States|#024, Bridgeville, Pennsylvania, United States|#815, Clairton, Pennsylvania, United States|#192, Harleysville, Pennsylvania, United States|#816, Philladelphia, Pennsylvania, United States|#191, Pittsburgh, Pennsylvania, United States|#828, Scottdale, Pennsylvania, United States|#824, Uniontown, Pennsylvania, United States|#194, Johnston, Rhode Island, United States|#819, Clinton, South Carolina, United States|#805, Easley, South Carolina, United States|#160, Murrells Inlet, South Carolina, United States|#833, Orangeburg, South Carolina, United States|#831, Pawleys Island, South Carolina, United States|#147, Simpsonville, South Carolina, United States|#002, Rapid City, South Dakota, United States|#084, Clarksville, Tennessee, United States|#001, Amarillo, Texas, United States|#812, Arlington, Texas, United States|#137, Austin, Texas, United States|#037, Beaumont, Texas, United States|#113, Bryan, Texas, United States|#058, Carrollton, Texas, United States|#066, Corpus Christi, Texas, United States|#039, Houston, Texas, United States|#053, Houston, Texas, United States|#132, Houston, Texas, United States|#136, Houston, Texas, United States|#157, Houston, Texas, United States|#158, Katy, Texas, United States|#003, San Antonio, Texas, United States|#108, San Antonio, Texas, United States|#180, San Antonio, Texas, United States|#817, San Antonio, Texas, United States|#818, San Antonio, Texas, United States|#830, Sugar Land, Texas, United States|#135, Tomball, Texas, United States|#809, Tomball, Texas, United States|#822, Draper, Utah, United States|#090, Orem, Utah, United States|#117, Salt Lake City, Utah, United States|#832, Salt Lake City, Utah, United States|#825, South Jordan, Utah, United States|#133, West Jordan, Utah, United States|#142, Alexandria, Virginia, United States|#800, Alexandria, Virginia, United States|#009, Richmond, Virginia, United States|#172, Spokane, Washington, United States|#216, Blacktown, New South Wales, Australia|#207, Burwood, New South Wales, Australia|#214, Carlton, New South Wales, Australia|#208, Darlinghurst, New South Wales, Australia|#205, Glebe, New South Wales, Australia|#201, Maroubra, New South Wales, Australia|#218, Neutral Bay, New South Wales, Australia|#202, Sydney, New South Wales, Australia|#204, Sydney, New South Wales, Australia|#219, Biggera Waters, Queensland, Australia|#215, Caboolture, Queensland, Australia|#221, Deception Bay, Queensland, Australia|#217, Jimboomba, Queensland, Australia|#220, Nerang, Queensland, Australia|#206, Sherwood, Queensland, Australia|#223, Mirrabooka, Western Australia, Australia|#222, Morley, Western Australia, Australia|#224, Spearwood, Western Australia, Australia|#613, Antofagasta, Chile|#612, Curico, Chile|#606, Quillota, Chile|#614, Rancagua, Chile|#603, Santiago, Chile|#607, Santiago, Chile|#609, Santiago, Chile|#610, Santiago, Chile|#602, Talca, Chile|#600, Temuco, Chile|#601, Temuco, Chile|#611, Viña del Mar, Chile|#306, Otara, Auckland, New Zealand|#305, Rotorua, Bay of Plenty, New Zealand|#302, Tauranga, Bay of Plenty, New Zealand|#301, Christchurch, Canterbury, New Zealand|#304, Dunedin, Otago, New Zealand|#307, Auckland, New Zealand|#308, Hamilton, New Zealand|#702, Florida, Asuncion, Paraguay|#707, Pai Perez, Asuncion, Paraguay|#703, esquina Pai Perez, Asunción, Paraguay|#704, Campos Cervera, Luque, Paraguay|#505, Arequipa, Peru|#511, Callao, Peru|#506, Cusco, Peru|#513, ICA, Peru|#500, Lima, Peru|#501, Lima, Peru|#502, Lima, Peru|#504, Lima, Peru|#508, Lima, Peru|#509, Lima, Peru|#510, Lima, Peru|#512, Lima, Peru|#515, Lima, Peru|#516, Lima, Peru|#517, Lima, Peru|#514, Piura, Peru|#507, Trujillo, Peru|#421, Benoni, South Africa|#402, Cape Town, South Africa|#405, Durban, South Africa|#406, Durban, South Africa|#408, Durban, South Africa|#412, Durban, South Africa|#414, Durban, South Africa|#404, Johannesburg, South Africa|#422, Kemptonpark, South Africa|#411, Kraaifontein, South Africa|#410, Krugersdorp, South Africa|#407, Port Elizabeth, South Africa|#409, Pretoria, South Africa|#413, Pretoria, South Africa|#415, Pretoria, South Africa|#418, Pretoria, South Africa|#419, Pretoria, South Africa|#420, Pretoria, South Africa|#423, Pretoria, South Africa|#417, Sandton, South Africa|#416, Somerset West, South Africa|#401, Soweto, South Africa","https://ClinicalTrials.gov/show/NCT01068912"
269,"Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children","Completed","Has Results","Influenza","Biological: Influenza vaccine GSK2321138A|Biological: FluarixTM|Biological: Influenza vaccine GSK2604409A","GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Boca Raton, Florida, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Binghamton, New York, United States|GSK Investigational Site, Elmira, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Decin, Czechia|GSK Investigational Site, Humpolec, Czechia|GSK Investigational Site, Jindrichuv Hradec, Czechia|GSK Investigational Site, Kolin, Czechia|GSK Investigational Site, Nachod, Czechia|GSK Investigational Site, Odolena voda, Czechia|GSK Investigational Site, Pardubice, Czechia|GSK Investigational Site, Plzen, Czechia|GSK Investigational Site, Praha 6, Czechia|GSK Investigational Site, Tabor, Czechia|GSK Investigational Site, Aix en Provence, France|GSK Investigational Site, Draguignan, France|GSK Investigational Site, Essey les Nancy, France|GSK Investigational Site, La Bouexiere, France|GSK Investigational Site, Le Havre, France|GSK Investigational Site, Nantes, France|GSK Investigational Site, Nice, France|GSK Investigational Site, Seysses, France|GSK Investigational Site, Tours, France|GSK Investigational Site, Ettenheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Kehl, Baden-Wuerttemberg, Germany|GSK Investigational Site, Schwaebisch-Hall, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Tauberbischofsheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Tuttlingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Gilching, Bayern, Germany|GSK Investigational Site, Kirchheim, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Noerdlingen, Bayern, Germany|GSK Investigational Site, Eschwege, Hessen, Germany|GSK Investigational Site, Wolfenbuettel, Niedersachsen, Germany|GSK Investigational Site, Heiligenhaus, Nordrhein-Westfalen, Germany|GSK Investigational Site, Kleve-Materborn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Solingen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Willich, Nordrhein-Westfalen, Germany|GSK Investigational Site, Trier, Rheinland-Pfalz, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Flensburg, Schleswig-Holstein, Germany|GSK Investigational Site, Weimar, Thueringen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Dasmariñas, Cavite, Philippines|GSK Investigational Site, Quezon City, Philippines","https://ClinicalTrials.gov/show/NCT01196988"
270,"Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)","Completed","Has Results","Influenza","Biological: Influenza vaccine GSK2321138A|Biological: FluarixTM|Biological: Influenza vaccine GSK2604409A","GSK Investigational Site, Chandler, Arizona, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Newton, Kansas, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Columbia, Maryland, United States|GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Salisbury, North Carolina, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Augsburg, Bayern, Germany|GSK Investigational Site, Haag, Bayern, Germany|GSK Investigational Site, Finsterwalde, Brandenburg, Germany|GSK Investigational Site, Frankfurt am Main, Hessen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Freiberg, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Guro Gu, Korea, Republic of|GSK Investigational Site, Gyeonggi, Korea, Republic of|GSK Investigational Site, Incheon, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Braila, Romania|GSK Investigational Site, Brasov, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Galati, Romania|GSK Investigational Site, Galati, Romania|GSK Investigational Site, Pantelimon, Romania|GSK Investigational Site, Ploiesti, Romania|GSK Investigational Site, Balenyà (Barcelona), Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Centelles, Spain|GSK Investigational Site, La Roca Del Valles (Barcelona), Spain|GSK Investigational Site, Vic/ Barcelona, Spain|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Taipei, Taiwan","https://ClinicalTrials.gov/show/NCT01204671"
271,"A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults","Completed","Has Results","Influenza","Biological: Quadrivalent seasonal influenza vaccine GSK2282512A|Biological: FluLavalTM-VB|Biological: FluLavalTM-YB","GSK Investigational Site, Mesa, Arizona, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Elkridge, Maryland, United States|GSK Investigational Site, Endwell, New York, United States|GSK Investigational Site, Jefferson Hills, Pennsylvania, United States|GSK Investigational Site, Wenatchee, Washington, United States|GSK Investigational Site, Coquitlam, British Columbia, Canada|GSK Investigational Site, Surrey, British Columbia, Canada|GSK Investigational Site, Quebec City, Quebec, Canada|GSK Investigational Site, Cuernavaca, Morelos, Mexico|GSK Investigational Site, Durango, Mexico|GSK Investigational Site, Estado de Mexico, Mexico","https://ClinicalTrials.gov/show/NCT01196975"
272,"Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children","Completed","Has Results","Influenza","Biological: GSK investigational vaccine GSK1557482A|Biological: Fluzone®","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Huntington Beach, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Woodstock, Georgia, United States|GSK Investigational Site, DeKalb, Illinois, United States|GSK Investigational Site, Newton, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Woburn, Massachusetts, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Henderson, Nevada, United States|GSK Investigational Site, Cortland, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Cary, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Austintown, Ohio, United States|GSK Investigational Site, Albany, Oregon, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Hermitage, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Provo, Utah, United States|GSK Investigational Site, Burke, Virginia, United States","https://ClinicalTrials.gov/show/NCT00980005"
273,"Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation|Biological: Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone® Intradermal|Biological: Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone Intradermal","Hoover, Alabama, United States|Huntsville, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Chula Vista, California, United States|Sacramento, California, United States|San Diego, California, United States|Milford, Connecticut, United States|Coral Gables, Florida, United States|Melbourne, Florida, United States|Pinellas Park, Florida, United States|South Miami, Florida, United States|Boise, Idaho, United States|Iowa City, Iowa, United States|Overland Park, Kansas, United States|Wichita, Kansas, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|Binghamton, New York, United States|Rochester, New York, United States|Rochester, New York, United States|Allentown, Pennsylvania, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Mt. Pleasant, South Carolina, United States|Dakota Dunes, South Dakota, United States|Austin, Texas, United States|Fort Worth, Texas, United States|Fort Worth, Texas, United States|San Angelo, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01712984"
274,"Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older","Completed","Has Results","Influenza","Biological: QIVc|Biological: TIV1c|Biological: TIV2c","Huntsville, Alabama, United States|Phoenix, Arizona, United States|Anaheim, California, United States|San Diego, California, United States|Coral Gables, Florida, United States|Hollywood, Florida, United States|Melbourne, Florida, United States|South Miami, Florida, United States|West Palm Beach, Florida, United States|Peoria, Illinois, United States|Mishawaka, Indiana, United States|Council Bluffs, Iowa, United States|Newton, Kansas, United States|Wichita, Kansas, United States|Wichita, Kansas, United States|Metairie, Louisiana, United States|Rockville, Maryland, United States|Edina, Minnesota, United States|Bellevue, Nebraska, United States|Omaha, Nebraska, United States|Endwell, New York, United States|Rochester, New York, United States|Cary, North Carolina, United States|Charlotte, North Carolina, United States|Raleigh, North Carolina, United States|Wilmington, North Carolina, United States|Oklahoma City, Oklahoma, United States|Warwick, Rhode Island, United States|Anderson, South Carolina, United States|Mt. Pleasant, South Carolina, United States|Dakota Dunes, South Dakota, United States|Austin, Texas, United States|Austin, Texas, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|San Angelo, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT01992094"
275,"Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A","University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Children's Mercy Hospital and Clinics - Infectious Diseases, Kansas City, Missouri, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Duke Translational Medicine Institute - Clinical Vaccine Unit, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Seattle Children's Hospital - Infectious Diseases, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00944073"
276,"Study of Quadrivalent Influenza Vaccine Among Adults","Completed","Has Results","Influenza","Biological: Investigational Quadrivalent Inactivated Influenza Vaccine, No Preservative|Biological: Investigational Trivalent Inactivated Influenza Vaccine, No Preservative|Biological: Fluzone®: 2010-2011 Trivalent Inactivated Influenza Vaccine, No Preservative","Hoover, Alabama, United States|South Miami, Florida, United States|Springfield, Missouri, United States|New York, New York, United States|Rochester, New York, United States|Cincinnati, Ohio, United States|Allentown, Pennsylvania, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Mt. Pleasant, South Carolina, United States|Nashville, Tennessee, United States|San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT01218646"
277,"Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old","Completed","Has Results","Influenza","Biological: QIVc|Biological: TIV1c|Biological: TIV2c","Huntsville, Alabama, United States|Mobile, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Mesa, Arizona, United States|Harrisburg, Arkansas, United States|Jonesboro, Arkansas, United States|Anaheim, California, United States|Anaheim, California, United States|Downey, California, United States|Garden Grove, California, United States|Modesto, California, United States|Paramount, California, United States|Sacramento, California, United States|San Diego, California, United States|San Francisco, California, United States|Santa Rosa, California, United States|West Covina, California, United States|Colorado Springs, Colorado, United States|Denver, Colorado, United States|Denver, Colorado, United States|Thornton, Colorado, United States|Boca Raton, Florida, United States|Lake Mary, Florida, United States|Melbourne, Florida, United States|Miami Beach, Florida, United States|Opa Locka, Florida, United States|Pinellas Park, Florida, United States|Atlanta, Georgia, United States|Marietta, Georgia, United States|Woodstock, Georgia, United States|Boise, Idaho, United States|Peoria, Illinois, United States|Mishawaka, Indiana, United States|Council Bluffs, Iowa, United States|Newton, Kansas, United States|Wichita, Kansas, United States|Wichita, Kansas, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Metairie, Louisiana, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Bellevue, Nebraska, United States|Fremont, Nebraska, United States|Omaha, Nebraska, United States|Omaha, Nebraska, United States|Las Vegas, Nevada, United States|Binghamton, New York, United States|Wilmington, North Carolina, United States|Akron, Ohio, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Cleveland, Ohio, United States|Dayton, Ohio, United States|Dayton, Ohio, United States|Kettering, Ohio, United States|Oklahoma City, Oklahoma, United States|Oklahoma City, Oklahoma, United States|Tulsa, Oklahoma, United States|Erie, Pennsylvania, United States|Erie, Pennsylvania, United States|Hermitage, Pennsylvania, United States|Sellersville, Pennsylvania, United States|Upper St. Clair, Pennsylvania, United States|Anderson, South Carolina, United States|Charleston, South Carolina, United States|Mt. Pleasant, South Carolina, United States|Bristol, Tennessee, United States|Jefferson City, Tennessee, United States|Lebanon, Tennessee, United States|Nashville, Tennessee, United States|Austin, Texas, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Fort Worth, Texas, United States|Round Rock, Texas, United States|San Angelo, Texas, United States|San Antonio, Texas, United States|Draper, Utah, United States|Layton, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States|West Jordan, Utah, United States|Burke, Virginia, United States|Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT01992107"
278,"H5N1 (Clade 2) Vaccination of Adults and Elderly","Completed","No Results Available","Influenza","Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005","Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|University of Iowa - Vaccine Research and Education Unit, Iowa City, Iowa, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Duke Translational Medicine Institute - Clinical Vaccine Unit, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00680069"
279,"Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations","Completed","Has Results","Influenza","Drug: AS03|Biological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A","Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|University of Iowa - Vaccine Research & Education Unit, Iowa City, Iowa, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Group Health Research Institute - Seattle, Seattle, Washington, United States|The University of Washington - Virology Research Clinic, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00963157"
280,"Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.","Completed","Has Results","Influenza","Drug: Peramivir 150 mg|Drug: Peramivir 300 mg|Drug: Placebo","Radiant Research, Birmingham, Alabama, United States|Clopton Clinic, Jonesboro, Arkansas, United States|Advanced Clinical Research Institute, Anaheim, California, United States|Orange County Clinical Trials, Anaheim, California, United States|Medical Center, Carmichael, California, United States|Pacific Sleep Medicines Service, El Centro, California, United States|Advanced Clinical Research Institute, Orange, California, United States|Benchmark Research, Sacramento, California, United States|Pacific Sleep Medicine Services, San Diego, California, United States|Pacific Sleep Medicine Services, San Francisco, California, United States|Alpine Clinical Research Center, Boulder, Colorado, United States|George Washington Unviersity, Washington, District of Columbia, United States|Clinical Research of Southern Florida, Coral Gables, Florida, United States|University Clinical Research-Deland, LLC, DeLand, Florida, United States|Florida Medical Research Institute, Gainesville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Clinical Research Center, Sarasota, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Georgia Clinical Research, Atlanta, Georgia, United States|Wishard Hospital, Indianapolis, Indiana, United States|Radiant Research, Overland Park, Kansas, United States|Kentucky Pediatric / Adult Research, Bardstown, Kentucky, United States|Central Kentucky Research Assoc, Inc, Lexington, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Radiant Research, Minneapolis, Edina, Minnesota, United States|Barnes-Jewish Hospital Emergency Department, St Louis, Missouri, United States|Medex Healthcare Research, Inc., St. Louis, Missouri, United States|Radiant Research, St. Louis, Missouri, United States|Bozeman Urgent Care Center, Bozeman, Montana, United States|Alliance Medical Center, Alliance, Nebraska, United States|Midwest Family Physicians, Omaha, Nebraska, United States|UMDNJ, Cherry Hill, New Jersey, United States|Pulmonary & Critical Care Associates, East Brunswick, New Jersey, United States|Brooklyn Hospital Center, Brooklyn, New York, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Summa Health, Akron, Ohio, United States|Sterling Research Group, LTD., Cincinnati, Ohio, United States|Integrated Medical Research, PC, Ashland, Oregon, United States|Research Across America at Oyster Point Family Health Center, Lancaster, Pennsylvania, United States|Radiant Research, Philadelphia, Pennsylvania, United States|Primary Physicians Research, Inc, Pittsburgh, Pennsylvania, United States|New England Center for Clinical Research, Inc, Cranston, Rhode Island, United States|Paragon Clinical Research, Inc., Cranston, Rhode Island, United States|Omega Medical Research, Warwick, Rhode Island, United States|Hillcrest Family Practice, Simpsonville, South Carolina, United States|Research Across America, Dallas, Texas, United States|Radiant Research, Dallas, Texas, United States|Towngate Plaza Medical Center, Garland, Texas, United States|Baylor Clinic-Baylor College of Medicine, Houston, Texas, United States|GSA Research, San Antonio, Texas, United States|Radiant Research-San Antonio Northeast, San Antonio, Texas, United States|Radiant Research San Antonio, San Antonio, Texas, United States|Balbir Chahal M.D. ,P.A, Tomball, Texas, United States|Dynamed Clinical Research, Tomball, Texas, United States|J. Lewis Research, Inc. Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. Foothill Family Clinic South, Salt Lake City, Utah, United States|J. Lewis Research, Inc./Southwest Family Medicine, West Jordan, Utah, United States|Calgary West Medical Cnetre Clinical Studies, Calgary, Alberta, Canada|Belvedere Medicentre, Edmonton, Alberta, Canada|Hermitage Medicentres, Edmonton, Alberta, Canada|RJA Medicentres, Edmonton, Alberta, Canada|Castledowns Medicentre, Edmonton, Alberta, Canada|Gain Medical Centre, Coquitlam, British Columbia, Canada|Source Unique Clinic, Hawkesbury, Ontario, Canada|Manna Research, Toronto, Ontario, Canada|Omnispec Clinical Reasearch Inc, Mirabel, Quebec, Canada|Clinique Medicale des Campus, Ste-Foy, Quebec, Canada|Prairie Clinical, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00419263"
281,"Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™","Completed","Has Results","Influenza","Biological: Fluarix™","GSK Investigational Site, Mobile, Alabama, United States|GSK Investigational Site, Delray Beach, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Camillus, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Norfolk, Virginia, United States|GSK Investigational Site, Gueglingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Rudersberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Weinheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Potsdam, Brandenburg, Germany|GSK Investigational Site, Frankfurt/Main, Hessen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Witten, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Rhaunen, Rheinland-Pfalz, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Leipzg, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Utrecht, Netherlands|GSK Investigational Site, Debica, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Mielec, Poland|GSK Investigational Site, Porabka, Poland|GSK Investigational Site, Siemianowice Slaskie, Poland|GSK Investigational Site, Wroclaw, Poland","https://ClinicalTrials.gov/show/NCT00377611"
282,"Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza","Completed","Has Results","Influenza","Drug: Peramivir 200 mg|Drug: Peramivir 400 mg|Drug: Oseltamivir","Pulmonary Associates of Mobile, P.C., Mobile, Alabama, United States|St. Bernards Research Center/Clopton Clinic, Jonesboro, Arkansas, United States|Pulmonary Consultants & Primary Care Physicians Medical Group, Inc., Orange, California, United States|University of California Irvine Medical Center, Orange, California, United States|University of California Davis Medical Center, Department of Emergency Medicine, Sacramento, California, United States|Good Samaritan Hospital, San Jose, California, United States|National Jewish Medical and Research Center, Clinical Research Unit, Denver, Colorado, United States|Orlando Regional Healthcare, Orlando, Florida, United States|James A. Haley Veterans Hospital, Department of Infectious Disease, Tampa, Florida, United States|Medical College of Georgia, Augusta, Georgia, United States|Infectious Disease Specialists of Atlanta, P.C., Decatur, Georgia, United States|St. Joseph's/Candler Health System, Inc., Savannah, Georgia, United States|Idaho Falls Infectious Diseases, PLLC, Idaho Falls, Idaho, United States|Northwestern University, Chicago, Illinois, United States|Springfield Clinic, LLP, Springfield, Illinois, United States|Wishard Hospital/Indiana University, Indianapolis, Indiana, United States|Infectious Disease of Indiana, PSC, Indianapolis, Indiana, United States|Natchitoches Internal Medicine, Natchitoches, Louisiana, United States|Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States|VA Maryland Health Care System, Baltimore, Maryland, United States|Franklin Square Hospital, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Wayne State University School of Medicine, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|William Beaumont Hospital Troy, Troy, Michigan, United States|Washington University School of Medicine, St. Louis, Missouri, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Hackensack University Medical Center, Department of Infectious Disease, Hackensack, New Jersey, United States|Jersey Shore University Medical Center, Neptune, New Jersey, United States|University of New Mexico, Albuquerque, New Mexico, United States|Rochester General Hospital/University of Rochester, Rochester, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Lowcountry Infectious Diseases, P.A., Charleston, South Carolina, United States|Baylor College of Medicine, Houston, Texas, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|Veterans Affairs Medical Center, Salem, Virginia, United States|Franciscan Health System, Tacoma, Washington, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Prince Of Wales Hospital, Randwick, New South Wales, Australia|Westmead Hospital, Wentworthville, New South Wales, Australia|Cairns Base Hospital, Cairns, Queensland, Australia|Mater Adult Hospital, South Brisbane, Queensland, Australia|Gold Coast Hospital, Southport, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Repatriation General Hospital, Daw Park, South Australia, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Kelowna General Hospital, Kelowna, British Columbia, Canada|Hamilton Health Sciences-McMaster University Medical Centre, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton-L424, Hamilton, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Mount Sinai Hospital / Toronto Medical Laboratories, Toronto, Ontario, Canada|Center de Sante et des Services Sociaux de Chicoutimi, Chicoutimi, Quebec, Canada|Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada|Centre de sante et de services sociaux Rimouski-Neigette (CSSSRN), Rimouski, Quebec, Canada|Division of Infectious Diseases, Saskatoon, Saskatchewan, Canada|Centre Hospitalier Universitaire de Quebec-Pavillon CHUL, Quebec, Canada|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|United Christian Hospital, Hong Kong, Hong Kong|The Prince of Wales Hospital, Shatin - New Territories, Hong Kong|Christchurch Hospital, Christchurch, New Zealand|Waikato Hospital, Hamilton, New Zealand|Tauranga Hospital, Tauranga, New Zealand|National University Hospital, Singapore, Singapore|Tan Tock Seng Hospital, Singapore, Singapore|Global Clinical Trial Center, Port Elizabeth, E. Cape, South Africa|Genclin Corporation, Bloemfontein, Free State, South Africa|Benmed / Pentagon Hospital, Benoni, Gauteng, South Africa|Private Practice, Cape Town, Gauteng, South Africa|Newgate Centre, Johannesburg,, Gauteng, South Africa|DJW Navorsing, Krugersdorp, Gauteng, South Africa|Medforum Hospital, Pretoria, Gauteng, South Africa|Eugene Marais Hospital, Pretoria, Gauteng, South Africa|Global Clinical Trials (GCT), Pretoria, Gauteng, South Africa|Dr Bhorat, Soweto, Gauteng, South Africa|Sebastian, P, Durban, KZ-Natal, South Africa|Eksteen, MC, Nelspruit, Mpumalanga, South Africa|Dr. L.J. van Zyl, Worcester, W Cape, South Africa|N1 City Hospital, Cape town, WC, South Africa","https://ClinicalTrials.gov/show/NCT00453999"
283,"H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00294099"
284,"Study of Quadrivalent Influenza Vaccine Among Children","Completed","Has Results","Influenza","Biological: Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative|Biological: Investigational Trivalent Influenza Vaccine with alternate B strain, No Preservative|Biological: Quadrivalent Influenza Vaccine, No Preservative","Dothan, Alabama, United States|Chandler, Arizona, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Mesa, Arizona, United States|Scottsdale, Arizona, United States|Little Rock, Arkansas, United States|Los Angeles, California, United States|San Diego, California, United States|San Diego, California, United States|Colorado Spring, Colorado, United States|Denver, Colorado, United States|Ridgefield, Connecticut, United States|Boca Raton, Florida, United States|Jacksonville, Florida, United States|Melbourne, Florida, United States|Miami Beach, Florida, United States|Ponte Vedra, Florida, United States|Sarasota, Florida, United States|Sarasota, Florida, United States|South Miami, Florida, United States|Marietta, Georgia, United States|Arkansas City, Kansas, United States|Newton, Kansas, United States|Overland Park, Kansas, United States|Wichita, Kansas, United States|Wichita, Kansas, United States|Bardstown, Kentucky, United States|Crestview Hills, Kentucky, United States|Lexington, Kentucky, United States|Metairie, Louisiana, United States|Columbia, Maryland, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Las Vegas, Nevada, United States|Binghamton, New York, United States|Cary, North Carolina, United States|Akron, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Portland, Oregon, United States|Pittsburgh, Pennsylvania, United States|Pittsburg, Pennsylvania, United States|Scranton, Pennsylvania, United States|Warwick, Rhode Island, United States|Barnwell, South Carolina, United States|Mount Pleasant, South Carolina, United States|Clarksville, Tennessee, United States|Kingsport, Tennessee, United States|Austin, Texas, United States|Fort Worth, Texas, United States|Ft. Worth, Texas, United States|Houston, Texas, United States|Katy, Texas, United States|Layton, Utah, United States|Murray, Utah, United States|Orem, Utah, United States|Provo, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States|West Jordan, Utah, United States|Charlottesville, Virginia, United States|Midlothian, Virginia, United States|Williamsburg, Virginia, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01240746"
285,"Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults","Completed","No Results Available","Influenza","Biological: CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free|Biological: CSL Trivalent Inactivated Influenza Vaccine with Thimerosal|Biological: Placebo with Thimerosal","Stanford University, Stanford, California, United States|University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|Clinical Alliance for Research & Education - Infectious Diseases, Annandale, Virginia, United States","https://ClinicalTrials.gov/show/NCT00333398"
286,"Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults","Completed","Has Results","Influenza","Biological: Pumarix™|Biological: Pandemrix ™","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00510874"
287,"Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly","Completed","Has Results","Influenza","Biological: Influenza vaccine GSK2186877A|Biological: GSK Biologicals' Fluarix™","GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Coral Gables, Florida, United States|GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Chaska, Minnesota, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Messkirch, Baden-Wuerttemberg, Germany|GSK Investigational Site, Augsburg, Bayern, Germany|GSK Investigational Site, Haag, Bayern, Germany|GSK Investigational Site, Hoehenkirchen-Siegertsbrunn, Bayern, Germany|GSK Investigational Site, Langquaid, Bayern, Germany|GSK Investigational Site, Ruedersdorf, Brandenburg, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Bekkestua, Norway|GSK Investigational Site, Bergen, Norway|GSK Investigational Site, Elverum, Norway|GSK Investigational Site, Fredrikstad, Norway|GSK Investigational Site, Hamar, Norway|GSK Investigational Site, Haugesund, Norway|GSK Investigational Site, Skien, Norway","https://ClinicalTrials.gov/show/NCT00772889"
288,"Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine USP Trivalent Types A and B","Hoover, Alabama, United States|Huntsville, Alabama, United States|Mobile, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Tempe, Arizona, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|San Diego, California, United States|Milford, Connecticut, United States|Melbourne, Florida, United States|Pembroke Pines, Florida, United States|Pinellas Park, Florida, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Iowa City, Iowa, United States|Wichita, Kansas, United States|Lexington, Kentucky, United States|Madisonville, Kentucky, United States|Rockville, Maryland, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|St. Louis, Missouri, United States|Albuquerque, New Mexico, United States|Binghamton, New York, United States|Endwell, New York, United States|Rochester, New York, United States|Rochester, New York, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Allentown, Pennsylvania, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Mt. Pleasant, South Carolina, United States|Nashville, Tennessee, United States|Austin, Texas, United States|Fort Worth, Texas, United States|Fort Worth, Texas, United States|San Angelo, Texas, United States|Salt Lake City, Utah, United States|Salt Lake, Utah, United States|West Jordan, Utah, United States|Marshfield, Wisconsin, United States|San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT01011049"
289,"Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults","Completed","Has Results","Influenza","Biological: Fluarix|Biological: GSK Biologicals Influenza Vaccine GSK576389A","GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Coral Gables, Florida, United States|GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Chaska, Minnesota, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Messkirch, Baden-Wuerttemberg, Germany|GSK Investigational Site, Augsburg, Bayern, Germany|GSK Investigational Site, Haag, Bayern, Germany|GSK Investigational Site, Hoehenkirchen-Siegertsbrunn, Bayern, Germany|GSK Investigational Site, Langquaid, Bayern, Germany|GSK Investigational Site, Ruedersdorf, Brandenburg, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Bekkestua, Norway|GSK Investigational Site, Bergen, Norway|GSK Investigational Site, Elverum, Norway|GSK Investigational Site, Fredrikstad, Norway|GSK Investigational Site, Hamar, Norway|GSK Investigational Site, Haugesund, Norway|GSK Investigational Site, Skien, Norway","https://ClinicalTrials.gov/show/NCT00529516"
290,"Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age","Completed","Has Results","Influenza","Biological: FluLaval™ Quadrivalent|Biological: Fluzone® Quadrivalent","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Dothan, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Chino, California, United States|GSK Investigational Site, Daly City, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Hayward, California, United States|GSK Investigational Site, Oakland, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Pleasanton, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Walnut Creek, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Colorado Springs, Colorado, United States|GSK Investigational Site, Colorado Springs, Colorado, United States|GSK Investigational Site, Lake Mary, Florida, United States|GSK Investigational Site, Miami Lakes, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Augusta, Kansas, United States|GSK Investigational Site, Newton, Kansas, United States|GSK Investigational Site, Topeka, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Columbia, Maryland, United States|GSK Investigational Site, Woburn, Massachusetts, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Lincoln, Nebraska, United States|GSK Investigational Site, Lincoln, Nebraska, United States|GSK Investigational Site, Lincoln, Nebraska, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Binghamton, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Beavercreek, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Dayton, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Hermitage, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Sellersville, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Cheraw, South Carolina, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, Tomball, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Payson, Utah, United States|GSK Investigational Site, Provo, Utah, United States|GSK Investigational Site, Roy, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Ellensburg, Washington, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, San Nicolas de los Garza, Nuevo León, Mexico|GSK Investigational Site, Mexico city, Mexico","https://ClinicalTrials.gov/show/NCT02242643"
291,"Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults","Completed","No Results Available","Influenza","Drug: favipiravir|Drug: placebo","Birmingham, Alabama, United States|Birmingham, Alabama, United States|Huntsville, Alabama, United States|Camp Verde, Arizona, United States|Mesa, Arizona, United States|Little Rock, Arkansas, United States|Anaheim, California, United States|Carmichael, California, United States|Chula Vista, California, United States|Fountain Valley, California, United States|Fresno, California, United States|Garden Grove, California, United States|Gold River, California, United States|Harbor City, California, United States|La Mesa, California, United States|Lomita, California, United States|Los Angeles, California, United States|Modesto, California, United States|North Hollywood, California, United States|Northridge, California, United States|Oceanside, California, United States|Paramount, California, United States|Roseville, California, United States|San Diego, California, United States|San Diego, California, United States|San Gabriel, California, United States|Stockton, California, United States|Upland, California, United States|Centennial, Colorado, United States|Colorado Springs, Colorado, United States|Colorado Springs, Colorado, United States|Colorado Springs, Colorado, United States|Denver, Colorado, United States|Glenwood Springs, Colorado, United States|Waterbury, Connecticut, United States|Celebration, Florida, United States|Clearwater, Florida, United States|Delray Beach, Florida, United States|Edgewater, Florida, United States|Hialeah, Florida, United States|Hialeah, Florida, United States|Hialeah, Florida, United States|Jacksonville, Florida, United States|Kissimmee, Florida, United States|Lauderdale Lakes, Florida, United States|Lynn Haven, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|New Port Richey, Florida, United States|New Smyrna Beach, Florida, United States|Ormond Beach, Florida, United States|Pembroke Pines, Florida, United States|Plantation, Florida, United States|Port Orange, Florida, United States|Saint Cloud, Florida, United States|South Miami, Florida, United States|Summerfield, Florida, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Dunwoody, Georgia, United States|Norcross, Georgia, United States|Oakwood, Georgia, United States|Riverdale, Georgia, United States|Snellville, Georgia, United States|Idaho Falls, Idaho, United States|Twin Falls, Idaho, United States|Brownsburg, Indiana, United States|Evansville, Indiana, United States|Wichita, Kansas, United States|Bardstown, Kentucky, United States|Monroe, Louisiana, United States|New Orleans, Louisiana, United States|Opelousas, Louisiana, United States|Columbia, Maryland, United States|Towson, Maryland, United States|Watertown, Massachusetts, United States|Worcester, Massachusetts, United States|Madison Heights, Michigan, United States|Troy, Michigan, United States|Saint Louis, Missouri, United States|Billings, Montana, United States|Butte, Montana, United States|Missoula, Montana, United States|Bellevue, Nebraska, United States|Las Vegas, Nevada, United States|Las Vegas, Nevada, United States|Las Vegas, Nevada, United States|Las Vegas, Nevada, United States|Lodi, New Jersey, United States|New York, New York, United States|Calabash, North Carolina, United States|Charlotte, North Carolina, United States|Charlotte, North Carolina, United States|Greensboro, North Carolina, United States|Hickory, North Carolina, United States|Huntersville, North Carolina, United States|Lexington, North Carolina, United States|Morganton, North Carolina, United States|Winston Salem, North Carolina, United States|Kettering, Ohio, United States|Toledo, Ohio, United States|Wadsworth, Ohio, United States|Ashland, Oregon, United States|Belle Vernon, Pennsylvania, United States|Clairton, Pennsylvania, United States|Indiana, Pennsylvania, United States|Scottdale, Pennsylvania, United States|Smithfield, Pennsylvania, United States|Tyrone, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Cumberland, Rhode Island, United States|Greenville, South Carolina, United States|Greenville, South Carolina, United States|Greer, South Carolina, United States|Murrells Inlet, South Carolina, United States|North Myrtle Beach, South Carolina, United States|Rock Hill, South Carolina, United States|Rapid City, South Dakota, United States|Bristol, Tennessee, United States|Franklin, Tennessee, United States|Jackson, Tennessee, United States|Smyrna, Tennessee, United States|Allen, Texas, United States|Carrollton, Texas, United States|Corpus Christi, Texas, United States|Dallas, Texas, United States|Houston, Texas, United States|Houston, Texas, United States|Houston, Texas, United States|Houston, Texas, United States|Houston, Texas, United States|McKinney, Texas, United States|Plano, Texas, United States|Plano, Texas, United States|San Antonio, Texas, United States|Sealy, Texas, United States|Sugar Land, Texas, United States|Victoria, Texas, United States|Draper, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States|Newport News, Virginia, United States|Spokane, Washington, United States|La Palta, Buenos Aires, Argentina|Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina|Rosario, Santa Fe, Argentina|Buenos Aires, Argentina|Buenos Aires, Argentina|Cordoba, Argentina|Córdoba, Argentina|Mar del Plata, Argentina|Ramos Mejia, Argentina|San Miguel De Tucuman, Argentina|Santa Fe, Argentina|Vicente Lopez, Argentina|Belo Horizonte, Minas Gerais, Brazil|Juiz De Fora, Minas Gerais, Brazil|Curitiba, Paraná, Brazil|Passo Fundo, Rio Grande do Sul, Brazil|Porto Alegre, Rio Grande do Sul, Brazil|Porto Alegre, Rio Grande do Sul, Brazil|Campinas, São Paulo, Brazil|Santo André, São Paulo, Brazil|Santo André, São Paulo, Brazil|Brasília, Brazil|São Paulo, Brazil|São Paulo, Brazil|São Paulo, Brazil|Calgary, Alberta, Canada|Edmonton, Alberta, Canada|Vancouver, British Columbia, Canada|Vancouver, British Columbia, Canada|Vancouver, British Columbia, Canada|Mount Pearl, Newfoundland and Labrador, Canada|Saint John's, Newfoundland and Labrador, Canada|Burlington, Ontario, Canada|Cambridge, Ontario, Canada|Corunna, Ontario, Canada|Hamilton, Ontario, Canada|London, Ontario, Canada|Newmarket, Ontario, Canada|Oshawa, Ontario, Canada|Sarnia, Ontario, Canada|Scarborough, Ontario, Canada|Toronto, Ontario, Canada|Toronto, Ontario, Canada|Drummondville, Quebec, Canada|Montreal, Quebec, Canada|Sainte Foy, Quebec, Canada|Sherbrooke, Quebec, Canada|Victoriaville, Quebec, Canada|Saskatoon, Saskatchewan, Canada|Quebec, Canada|Medellín, Antioquia, Colombia|Bogotá, Cundinamarca, Colombia|Cali, Valle de Cauca, Colombia|Cali, Valle del Cauca, Colombia|Medellin, Colombia|Santo Domingo, National District, Dominican Republic|Santo Domingo, National District, Dominican Republic|Santo Domingo, National District, Dominican Republic|Santa Tecla, La Libertad, El Salvador|San Salvador, El Salvador|Guatemala City, Guatemala|Guatemala City, Guatemala|Leon, Guanajanto, Mexico|Leon de los Aldamas, Guanajuato, Mexico|Acapulco, Guerrero, Mexico|El Salto, Jalisco, Mexico|Guadalajara, Jalisco, Mexico|Guadalajara, Jalisco, Mexico|Guadalajara, Jalisco, Mexico|Guadalajara, Jalisco, Mexico|Zapopan, Jalisco, Mexico|Cuernavaca, Morelos, Mexico|Cuernavaca, Morelos, Mexico|Monterrey, Nuevo Leon, Mexico|Culiacán, Sinaloa, Mexico|Jalapa Enriquez, Veracruz, Mexico|Chihuahua, Mexico|Cuautitlan Izcalli, Mexico|Distrito Federal, Mexico|Distrito Federal, Mexico|Guanajanto, Mexico|Mexico City, Mexico|Mexico City, Mexico|Mexico City, Mexico|Tlalnepantla De Baz, Mexico|Trujillo, La Libertad, Peru|Miraflores, Lima, Peru|Arequipa, Peru|Cusco, Peru|Ica, Peru|Lima, Peru|Lima, Peru|Lima, Peru|Lima, Peru|Lima, Peru|Loreto, Peru|Piura, Peru|Manati, Puerto Rico|San Juan, Puerto Rico|San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT02008344"
292,"Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination","Completed","No Results Available","Influenza","Biological: Cell-Derived Trivalent Subunit Influenza Vaccine|Biological: Placebo","Site Reference ID/Investigator# 45690, Jacksonville, Florida, United States|Site Reference ID/Investigator# 45687, Pembroke Pines, Florida, United States|Site Reference ID/Investigator# 45697, South Miami, Florida, United States|Site Reference ID/Investigator# 45691, Lenexa, Kansas, United States|Site Reference ID/Investigator# 45689, Overland Park, Kansas, United States|Site Reference ID/Investigator# 45694, Wichita, Kansas, United States|Site Reference ID/Investigator# 45682, Lexington, Kentucky, United States|Site Reference ID/Investigator# 45684, Kansas City, Missouri, United States|Site Reference ID/Investigator# 45685, Omaha, Nebraska, United States|Site Reference ID/Investigator# 45686, Las Vegas, Nevada, United States|Site Reference ID/Investigator# 45688, Raleigh, North Carolina, United States|Site Reference ID/Investigator# 45696, Nashville, Tennessee, United States|Site Reference ID/Investigator# 45683, Austin, Texas, United States|Site Reference ID/Investigator# 45695, Fort Worth, Texas, United States|Site Reference ID/Investigator# 45692, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00889889"
293,"Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316","Completed","No Results Available","Influenza","Drug: favipiravir|Drug: Placebo","Birmingham, Alabama, United States|Birmingham, Alabama, United States|Hunstville, Alabama, United States|Hot Springs, Arkansas, United States|Los Angeles, California, United States|Los Angeles, California, United States|Orange, California, United States|Sacramento, California, United States|San Diego, California, United States|San Diego, California, United States|Tustin, California, United States|Upland, California, United States|Colorado Springs, Colorado, United States|Hamden, Connecticut, United States|Bradenton, Florida, United States|Brooksville, Florida, United States|Gainesville, Florida, United States|Gainesville, Florida, United States|Hialeah, Florida, United States|Hialeah, Florida, United States|Lakeland Hills, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|Miami, Florida, United States|Saint Cloud, Florida, United States|Saint Petersburg, Florida, United States|South Miami, Florida, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Snellville, Georgia, United States|Bardstown, Kentucky, United States|Monroe, Louisiana, United States|Opelousas, Louisiana, United States|Flint, Michigan, United States|Omaha, Nebraska, United States|Las Vegas, Nevada, United States|Hickory, North Carolina, United States|Morganton, North Carolina, United States|Winston Salem, North Carolina, United States|Lansdale, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Smithfield, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Gaffney, South Carolina, United States|Greenville, South Carolina, United States|Greer, South Carolina, United States|Simpsonville, South Carolina, United States|Arlington, Texas, United States|Austin, Texas, United States|Carrollton, Texas, United States|Forth Worth, Texas, United States|Houston, Texas, United States|Plano, Texas, United States|San Antonio, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States|Arlington, Virginia, United States|La Crosse, Wisconsin, United States|Bedford Park, South Australia, Australia|Deurne, Antwerpen, Belgium|Bruxelles, Brussels, Belgium|Gozee, Hainaut, Belgium|Mont-sur-Marchienne, Hainaut, Belgium|Halen, Limburg, Belgium|Ham, Limburg, Belgium|Chenée, Liège, Belgium|Deurne, Belgium|Gribomont, Belgium|Linkebeek, Belgium|Sofia, Sofia-Grad, Bulgaria|Burgas, Bulgaria|Burgas, Bulgaria|Gabrovo, Bulgaria|Haskovo, Bulgaria|Plovdiv, Bulgaria|Plovdiv, Bulgaria|Ruse, Bulgaria|Ruse, Bulgaria|Samokov, Bulgaria|Sevlievo, Bulgaria|Sliven, Bulgaria|Smolyan, Bulgaria|Sofia, Bulgaria|Sofia, Bulgaria|Sofia, Bulgaria|Sofia, Bulgaria|Sofia, Bulgaria|Sofia, Bulgaria|Varna, Bulgaria|Varna, Bulgaria|Veliko Tarnovo, Bulgaria|Balassagyarmat, Hungary|Budapest, Hungary|Csongrad, Hungary|Debrecen, Hungary|Gyula, Hungary|Gödöllő, Hungary|Nyiregyhaza, Hungary|Zalaegerszeg, Hungary|Nijverdal, Overijssel, Netherlands|Nijverdal, Overissel, Netherlands|Hoogvliet, Zuid-Holland, Netherlands|Den Haag, Netherlands|Lieshout, Netherlands|Nijverdal, Netherlands|Rotterdam, Netherlands|Zwijndrecht, Netherlands|Auckland, North Island, New Zealand|Christchurch, South Island, New Zealand|Hamilton, Waikato, New Zealand|Tauranga, New Zealand|Olesnica, Dolnoslaskie, Poland|Wroclaw, Dolnoslaskie, Poland|Wroclaw, Dolnoslaskie, Poland|Torun, Kujawsko-pomorskie, Poland|Swidnik, Lubelskie, Poland|Lodz, Lódzkie, Poland|Zgierz, Lódzkie, Poland|Tarnów, Malopolskie, Poland|Losice, Mazowieckie, Poland|Debica, Podkarpackie, Poland|Rzeszow, Podkarpackie, Poland|Katowice, Slaskie, Poland|Katowice, Slaskie, Poland|Katowice, Poland|Katowice, Poland|Krakow, Poland|Kraków, Poland|Lódz, Poland|Ostroda, Poland|Oswiecim, Poland|Arkangelsk, Russian Federation|Kazan, Russian Federation|Moscow, Russian Federation|Novosibirsk, Russian Federation|Novosibirsk, Russian Federation|Ryazan, Russian Federation|Saratov, Russian Federation|St. Petersburg, Russian Federation|St. Petersburg, Russian Federation|St. Petersburg, Russian Federation|St. Petersburg, Russian Federation|Tomsk, Russian Federation|Vladimir, Russian Federation|Yaroslavl, Russian Federation|Bloemfontein, Free State, South Africa|Bryanston, Gauteng, South Africa|Johannesburg, Gauteng, South Africa|Johannesburg, Gauteng, South Africa|Johannesburg, Gauteng, South Africa|Pretoria, Gauteng, South Africa|Pretoria, Gauteng, South Africa|Pretoria, Gauteng, South Africa|Pretoria, Gauteng, South Africa|Sophiatown, Johannesburg, Gauteng, South Africa|Soweto, Gauteng, South Africa|Amanzimtoti, Kwazulu - Natal, South Africa|Dundee, Kwazulu - Natal, South Africa|Middelburg, Mpumalanga, South Africa|Witbank, Mpumalanga, South Africa|Cape Town, Western Cape, South Africa|Cape Town, Western Cape, South Africa|Cape Town, Western Cape, South Africa|Paarl, Western Cape, South Africa|Worcester, Western Cape, South Africa|Cape Town, South Africa|Durban, South Africa|Johannesburg, South Africa|Krugersdorp, South Africa|Potchefstroom, South Africa|Pretoria, South Africa|Sophiatown, Johannesburg, South Africa|Umkomaas, South Africa|Welkom, South Africa|Benidorm, Alicante, Spain|Orihuela, Alicante, Spain|Badalona, Barcelona, Spain|Castellon de la Plana, Castellón, Spain|Barcelona, Cataluña, Spain|Llanca, Girona, Spain|Alicante, Spain|Barcelona, Spain|Barcelona, Spain|Barcelona, Spain|Tarragona, Spain|Malmö, Skane lan, Sweden|Stockholm, Sodermanlands lan, Sweden|Stockholm, Sodermanlands lan, Sweden|Uppsala, Uppsala Ian, Sweden|Göteborg, Vastra Gotalands lan, Sweden|Karlskrona, Sweden|Linköping, Sweden|Malmö, Sweden|Uppsala, Sweden|Ankara, Turkey|Diyarbakir, Turkey|Duzce, Turkey|Erzurum, Turkey|Eskisehir, Turkey|Izmir, Turkey|Izmir, Turkey|Konya, Turkey|Samsun, Turkey|Trabzon, Turkey|Chernivtsi, Chernivets'ka Oblast, Ukraine|Ivano-Frankivsk, Ivano-Frankivs'ka Oblast, Ukraine|Kharkiv, Kharkivs'ka Oblast, Ukraine|Kyiv, Kyïvs'ka Oblast, Ukraine|Kyiv, Kyïv, Ukraine|Odesa, Odes'ka Oblast, Ukraine|Odesa, Odes'ka Oblast, Ukraine|Ternopil, Ternopil's'ka Oblast, Ukraine|Vinnytsya, Vinnyts'ka Oblast, Ukraine|Kharkiv, Ukraine|Kherson, Ukraine|Kyiv, Ukraine|Kyiv, Ukraine|Kyiv, Ukraine|Poltava, Ukraine|Sumy, Ukraine","https://ClinicalTrials.gov/show/NCT02026349"
294,"Comparison of Flu Vaccine Doses in Children","Completed","No Results Available","Influenza","Biological: Trivalent Inactivated Influenza Vaccine","Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Infectious Diseases, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT01164553"
295,"Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age","Completed","Has Results","Influenza","Biological: FluLaval® Quadrivalent|Biological: Fluzone®","GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Altamonte Springs, Florida, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Woburn, Massachusetts, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Hermitage, Pennsylvania, United States|GSK Investigational Site, Barnwell, South Carolina, United States|GSK Investigational Site, Cheraw, South Carolina, United States|GSK Investigational Site, Fort Worth, Texas, United States","https://ClinicalTrials.gov/show/NCT01974895"
296,"Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)","Completed","No Results Available","Influenza","Biological: Intravenous hyperimmune immunoglobulin (Flu-IVIG)|Biological: Placebo","University of California at San Diego, San Diego, California, United States|Denver Public Health, Denver, Colorado, United States|George Washington University, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Henry Ford Hospital, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Cooper University Hospital, Camden, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States","https://ClinicalTrials.gov/show/NCT02008578"
297,"Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations","Completed","No Results Available","Influenza","Biological: Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203","Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Children's Mercy Hospital and Clinics - Infectious Diseases, Kansas City, Missouri, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Duke Health Center at Roxboro, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT02100436"
298,"Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects","Completed","No Results Available","Influenza","Drug: Oseltamivir Phosphate|Drug: ADS-8902","Adamas Investigational Site, San Francisco, California, United States|Adamas Investigational Site, San Francisco, California, United States|Adamas Investigational Site, San Francisco, California, United States|Adamas Investigational Site, Hollywood, Florida, United States|Adamas Investigational Site, Miramar, Florida, United States|Adamas Investigational Site, Pinellas Park, Florida, United States|Adamas Investigational Site, Honolulu, Hawaii, United States|Adamas Investigational Site, Owensboro, Kentucky, United States|Adamas Investigational Site, New Orleans, Louisiana, United States|Adamas Investigational Site, Las Vegas, Nevada, United States|Adamas Investigational Site, New York, New York, United States|Adamas Investigational Site, Rapid City, South Dakota, United States|Adamas Investigational Site, Memphis, Tennessee, United States|Adamas Investigational Site, Amarillo, Texas, United States|Adamas Investigational Site, Seattle, Washington, United States|Adamas Investigational Site, Tacoma, Washington, United States|Adamas Investigational Site, Darlinghurst, New South Wales, Australia|Adamas Investigational Site, Herston, New South Wales, Australia|Adamas Investigational Site, Sydney, New South Wales, Australia|Adamas Investigative Site, Parkville, Victoria, Australia|Adamas Investigational Site, Melbourne, Australia|Adamas Investigational Site, Edmonton, Alberta, Canada|Adamas Investigational Site, Toronto, Ontario, Canada|Adamas Investigational Site, Leiden, Netherlands|Adamas Investigational Site, Singapore, Singapore","https://ClinicalTrials.gov/show/NCT00979251"
299,"Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age","Completed","No Results Available","Influenza","Biological: Investigational H7N1 vaccine GSK2789869A|Biological: Investigational H7N1 vaccine GSK2789868A|Biological: Placebo","GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01934127"
300,"Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older","Completed","Has Results","Influenza","Biological: GSK Bio's influenza vaccine GSK2186877A|Biological: Fluarix TM","GSK Investigational Site, Alabaster, Alabama, United States|GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Mobile, Alabama, United States|GSK Investigational Site, Chandler, Arizona, United States|GSK Investigational Site, Mesa, Arizona, United States|GSK Investigational Site, Mesa, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Tempe, Arizona, United States|GSK Investigational Site, Hot Springs, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Santa Ana, California, United States|GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Coral Gables, Florida, United States|GSK Investigational Site, Crystal River, Florida, United States|GSK Investigational Site, Delray Beach, Florida, United States|GSK Investigational Site, Inverness, Florida, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Boise, Idaho, United States|GSK Investigational Site, Peoria, Illinois, United States|GSK Investigational Site, Overland Park, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Kansas City, Missouri, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Hackensack, New Jersey, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Camillus, New York, United States|GSK Investigational Site, Endwell, New York, United States|GSK Investigational Site, Johnson City, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Cary, North Carolina, United States|GSK Investigational Site, Charlotte, North Carolina, United States|GSK Investigational Site, Hickory, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Salisbury, North Carolina, United States|GSK Investigational Site, Tabor City, North Carolina, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Grove City, Pennsylvania, United States|GSK Investigational Site, Jefferson Hills, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Uniontown, Pennsylvania, United States|GSK Investigational Site, Upper Saint Clair, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, North Myrtle Beach, South Carolina, United States|GSK Investigational Site, Spartanburg, South Carolina, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Anthée, Belgium|GSK Investigational Site, Deinze, Belgium|GSK Investigational Site, Dour, Belgium|GSK Investigational Site, Drongen, Belgium|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Gozée, Belgium|GSK Investigational Site, Hamois (Natoye), Belgium|GSK Investigational Site, Kerksken, Belgium|GSK Investigational Site, Libramont, Belgium|GSK Investigational Site, Linkebeek, Belgium|GSK Investigational Site, Maldegem, Belgium|GSK Investigational Site, Melsbroek, Belgium|GSK Investigational Site, Merelbeke, Belgium|GSK Investigational Site, Mettet, Belgium|GSK Investigational Site, Oostakker, Belgium|GSK Investigational Site, Waarschoot, Belgium|GSK Investigational Site, Coquitlam, British Columbia, Canada|GSK Investigational Site, Vancouver, British Columbia, Canada|GSK Investigational Site, Bay Roberts, Newfoundland and Labrador, Canada|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Brampton, Ontario, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Gatineau, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada|GSK Investigational Site, St-Romulad, Quebec, Canada|GSK Investigational Site, Quebec, Canada|GSK Investigational Site, Hradec Kralove, Czechia|GSK Investigational Site, Jaroměř, Czechia|GSK Investigational Site, Jaroměř, Czechia|GSK Investigational Site, Pardubice, Czechia|GSK Investigational Site, Pardubice, Czechia|GSK Investigational Site, Pardubice, Czechia|GSK Investigational Site, Saku, Estonia|GSK Investigational Site, Tallinn, Estonia|GSK Investigational Site, Tallinn, Estonia|GSK Investigational Site, Tallinn, Estonia|GSK Investigational Site, Tallinn, Estonia|GSK Investigational Site, Tartu, Estonia|GSK Investigational Site, Tartu, Estonia|GSK Investigational Site, Angers, France|GSK Investigational Site, Angers, France|GSK Investigational Site, Anzin, France|GSK Investigational Site, Arras, France|GSK Investigational Site, Bordeaux, France|GSK Investigational Site, Bécon les Granits, France|GSK Investigational Site, Cannes, France|GSK Investigational Site, Chambery, France|GSK Investigational Site, Château Gontier, France|GSK Investigational Site, Clermont-Ferrand, France|GSK Investigational Site, Ecouflant, France|GSK Investigational Site, Gresy sur Aix, France|GSK Investigational Site, La Rochelle, France|GSK Investigational Site, Laval, France|GSK Investigational Site, Le Fousseret, France|GSK Investigational Site, Montpellier Cedex 5, France|GSK Investigational Site, Montreuil Juigne, France|GSK Investigational Site, Muret, France|GSK Investigational Site, Nieul sur Mer, France|GSK Investigational Site, Oignies, France|GSK Investigational Site, Orthez, France|GSK Investigational Site, Paris Cedex 18, France|GSK Investigational Site, Paris, France|GSK Investigational Site, Rosiers d'Egletons, France|GSK Investigational Site, Saint Etienne, France|GSK Investigational Site, Segré, France|GSK Investigational Site, Seysses, France|GSK Investigational Site, Tierce, France|GSK Investigational Site, Tours, France|GSK Investigational Site, Vourey, France|GSK Investigational Site, Gueglingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Messkirch, Baden-Wuerttemberg, Germany|GSK Investigational Site, Rudersberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Schwetzingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Sinsheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Weinheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Augsburg, Bayern, Germany|GSK Investigational Site, Haag, Bayern, Germany|GSK Investigational Site, Hoehenkirchen-Siegertsbrunn, Bayern, Germany|GSK Investigational Site, Kuenzing, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Rednitzhembach, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Cottbus, Brandenburg, Germany|GSK Investigational Site, Ketzin, Brandenburg, Germany|GSK Investigational Site, Ruedersdorf, Brandenburg, Germany|GSK Investigational Site, Bad Kreuznach, Hessen, Germany|GSK Investigational Site, Floersheim, Hessen, Germany|GSK Investigational Site, Rostock, Mecklenburg-Vorpommern, Germany|GSK Investigational Site, Schwerin, Mecklenburg-Vorpommern, Germany|GSK Investigational Site, Brinkum/Stuhr, Niedersachsen, Germany|GSK Investigational Site, Duelmen, Niedersachsen, Germany|GSK Investigational Site, Koenigslutter, Niedersachsen, Germany|GSK Investigational Site, Rotenburg (Wuemme), Niedersachsen, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Goch, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Witten, Nordrhein-Westfalen, Germany|GSK Investigational Site, Ingelheim, Rheinland-Pfalz, Germany|GSK Investigational Site, Kallstadt, Rheinland-Pfalz, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Rhaunen, Rheinland-Pfalz, Germany|GSK Investigational Site, Koethen, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Wolmirstedt, Sachsen-Anhalt, Germany|GSK Investigational Site, Borna, Sachsen, Germany|GSK Investigational Site, Delitzsch, Sachsen, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Freiberg, Sachsen, Germany|GSK Investigational Site, Freital, Sachsen, Germany|GSK Investigational Site, Geringswalde, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Schmiedeberg, Sachsen, Germany|GSK Investigational Site, Weissenberg, Sachsen, Germany|GSK Investigational Site, Bad Bramstedt, Schleswig-Holstein, Germany|GSK Investigational Site, Bad Segeberg, Schleswig-Holstein, Germany|GSK Investigational Site, Luebeck, Schleswig-Holstein, Germany|GSK Investigational Site, Erfurt, Thueringen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Ecatepec de Morelos, Estado De México, Mexico|GSK Investigational Site, Cuernavaca, Morelos, Mexico|GSK Investigational Site, Monterrey, Nuevo León, Mexico|GSK Investigational Site, Mexico, Mexico|GSK Investigational Site, Rotterdam, Netherlands|GSK Investigational Site, Rotterdam, Netherlands|GSK Investigational Site, Soest, Netherlands|GSK Investigational Site, Utrecht, Netherlands|GSK Investigational Site, Alesund, Norway|GSK Investigational Site, Bekkestua, Norway|GSK Investigational Site, Bergen, Norway|GSK Investigational Site, Elverum, Norway|GSK Investigational Site, Hamar, Norway|GSK Investigational Site, Oslo, Norway|GSK Investigational Site, Oslo, Norway|GSK Investigational Site, Skien, Norway|GSK Investigational Site, Stavanger, Norway|GSK Investigational Site, Bydgoszcz, Poland|GSK Investigational Site, Debica, Poland|GSK Investigational Site, Grodzisk Mazowiecki, Poland|GSK Investigational Site, Ilawa, Poland|GSK Investigational Site, Inowrocław, Poland|GSK Investigational Site, Katowice, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Lubartow, Poland|GSK Investigational Site, Olesnica, Poland|GSK Investigational Site, Plock, Poland|GSK Investigational Site, Porabka, Poland|GSK Investigational Site, Siemianowice Slaskie, Poland|GSK Investigational Site, Sopot, Poland|GSK Investigational Site, Torun, Poland|GSK Investigational Site, Trzebnica, Poland|GSK Investigational Site, Tychy, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Braila, Romania|GSK Investigational Site, Braila, Romania|GSK Investigational Site, Brasov, Romania|GSK Investigational Site, Brasov, Romania|GSK Investigational Site, Brasov, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Craiova, Romania|GSK Investigational Site, Galati, Romania|GSK Investigational Site, Galati, Romania|GSK Investigational Site, Pantelimon, Romania|GSK Investigational Site, Ploiesti, Romania|GSK Investigational Site, Barnaul, Russian Federation|GSK Investigational Site, Ekaterinburg, Russian Federation|GSK Investigational Site, Ekaterinburg, Russian Federation|GSK Investigational Site, Perm, Russian Federation|GSK Investigational Site, Perm, Russian Federation|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Reading, Berkshire, United Kingdom|GSK Investigational Site, Buckshaw Village, Chorley, Lancashire, United Kingdom|GSK Investigational Site, Liverpool, Merseyside, United Kingdom|GSK Investigational Site, Waterloo, Liverpool, United Kingdom","https://ClinicalTrials.gov/show/NCT00753272"
301,"Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.","Completed","No Results Available","Influenza Virus","Biological: Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)|Biological: Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)","222, Novartis Investigational Site, Chandler, Arizona, United States|267, Novartis Investigational Site, Harrisburg, Arkansas, United States|259, Novartis Investigational Site, Anaheim, California, United States|280, Novartis Investigational Site, Anaheim, California, United States|213, Novartis Investigational Site, Baldwin Park, California, United States|407, Novartis Investigational Site, Downey, California, United States|238, Novartis Investigational Site, La Puente, California, United States|411, Novartis Investigational Site, Ontario, California, United States|202, Novartis Investigational Site, Paramount, California, United States|250, Novartis Investigational Site, San Diego, California, United States|293, Novartis Investigational Site, San Francisco, California, United States|243, Novartis Investigational Site, Colorado Springs, Colorado, United States|249, Novartis Investigational Site, Denver, Colorado, United States|229, Novartis Investigational Site, Boca Raton, Florida, United States|416, Novartis Investigational Site, Hialeah, Florida, United States|287, Novartis Investigational Site, Hialeah, Florida, United States|412, Novartis Investigational Site, Homestead, Florida, United States|224, Novartis Investigational Site, Melbourne, Florida, United States|417, Novartis Investigational Site, Miami, Florida, United States|404, Novartis Investigational Site, Miami, Florida, United States|285, Novartis Investigational Site, Miami, Florida, United States|277,Novartis Investigational Site, Miami, Florida, United States|234, Novartis Investigational Site, Opa-locka, Florida, United States|297, Novartis Investigational Site, Orlando, Florida, United States|297, Novartis Investigational vaccine, Orlando, Florida, United States|410, Novartis Investigational Site, Sarasota, Florida, United States|401, Novartis iNvestiagtional Site, Atlanta, Georgia, United States|299, Novartis Investigational Site, DeKalb, Illinois, United States|268, Novartis Investigational Site, Peoria, Illinois, United States|209, Novartis Investigational Site, Augusta, Kansas, United States|210, Novartis Investigational Site, Newton, Kansas, United States|274 Novartis Investigational Site, Park City, Kansas, United States|211, Novartis Investigational Site, Wichita, Kansas, United States|269, Novartis Investigational Site, Bardstown, Kentucky, United States|226, Novartis Investigational Site, Louisville, Kentucky, United States|248, Novartis Investigational Site, Louisville, Kentucky, United States|207, Novartis Investigational Site, Louisville, Kentucky, United States|290, Novartis Investigational Site, Louisville, Kentucky, United States|265, Novartis Investigational Site, Haughton, Louisiana, United States|408, Novartis Investigational Site, Mangham, Louisiana, United States|225, Novartis Investigational Site, Metairie, Louisiana, United States|233, Novartis Investigational Site, Metairie, Louisiana, United States|418, Novartis Investigational SIte, Monroe, Louisiana, United States|262, Novartis Investigational site, Annapolis, Maryland, United States|263, Novartis Investigational Site, Frederick, Maryland, United States|405, Novartis Investigational Site, Silver Spring, Maryland, United States|278, Novartis Investigational Site, Saint Paul, Minnesota, United States|221, Novartis Investigational Site, Bellevue, Nebraska, United States|219, Novartis Investigational Site, Fremont, Nebraska, United States|402, Novartis Investigational Site, Omaha, Nebraska, United States|288, Novartis Investigational Site, Omaha, Nebraska, United States|228, Novartis Investigational Site, Omaha, Nebraska, United States|244, Novartis Investigational Site, Henderson, Nevada, United States|286, Novartis Investigational site, Las Vegas, Nevada, United States|255, Novartis Investigational Site, Binghamton, New York, United States|414, Novartis Investigational Site, Brooklyn, New York, United States|264, Novartis Investigational Site, Syracuse, New York, United States|409, Novartis Investigational Site, Boone, North Carolina, United States|266, Novartis Investigational Site, Cary, North Carolina, United States|403, Novartis Investigational Site, Clyde, North Carolina, United States|240, Novartis Investigational Site, Akron, Ohio, United States|254, Novartis iNvestigational Site, Cleveland, Ohio, United States|245, Novartis Investigational Site, Dayton, Ohio, United States|281, Novartis Investigational Site, Dayton, Ohio, United States|281, Novartis Investigational vaccines, Dayton, Ohio, United States|256, Novartis Investigational Site, Tulsa, Oklahoma, United States|292, Novartis Investigational Site, Erie, Pennsylvania, United States|270, Novartis Investigational Site, Scottdale, Pennsylvania, United States|220, Novartis Investigational Site, Anderson, South Carolina, United States|406, novartis Investigational Site, Barnwell, South Carolina, United States|272, Novartis Investigational Site, Charleston, South Carolina, United States|232, Novartis Investigational Site, Moncks Corner, South Carolina, United States|291, Novartis Investigational vaccine, Spartanburg, South Carolina, United States|283, Novartis Investigational Site, Nashville, Tennessee, United States|208, Novartis Investigational Site, Austin, Texas, United States|247, Novartis Investigational Site, Fort Worth, Texas, United States|217, Novartis Investigational Site, Fort Worth, Texas, United States|214, Novartis Investigational Site, San Angelo, Texas, United States|400, Novartis investigational Site, San Antonio, Texas, United States|260, Novartis Investigational Site, Tomball, Texas, United States|295, Novartis Investigational Site, Layton, Utah, United States|236, Novartis Investigational Site, Salt Lake City, Utah, United States|212, Novartis Investigational Site, Salt Lake City, Utah, United States|246, Novartis Investigational Site, Salt Lake City, Utah, United States|279, Novartis Investigational Site, Spanish Fork, Utah, United States|282, Novartis Investigational Site, Syracuse, Utah, United States|294, Novartis Investigational Site, West Haven, Utah, United States|201, Novartis Investigational Site, West Jordan, Utah, United States|271, Novartis Investigational Site, West Jordan, Utah, United States|251, Novartis Investigational Site, Burke, Virginia, United States|296, Novartis Investigational Site, Vienna, Virginia, United States|180, Novartis Investigational Site, Newmarket, Ontario, Canada|184, Novartis Investigational Site, Sudbury, Ontario, Canada|182,Novartis Investigational Site, Toronto, Ontario, Canada|186, Novartis Investigational Site, Quebec, Canada|183, Novartis Investigational Site, Québec, Canada|001, Novartis Investigational Site, Espoo, Finland|003, Novartis Investigational Site, Helsinki, Finland|002, Novartis Investigational Site, Helsinki, Finland|004, Novartis Investigational Site, Järvenpää, Finland|005, Novartis Investigational Site, Kokkola, Finland|006, Novartis Investigational Site, Oulu, Finland|007, Novartis Investigational Site, Pori, Finland|008, Novartis Investigational Site, Seinäjoki, Finland|009, Novartis Investigational Site, Tampere, Finland|010, Novartis Investigational Site, Turku, Finland|011, Novartis Investigational Site, Vantaa, Finland|030, Novartis Investigational Site, Florence, Italy|023, Novartis Investigational Site, Genova, Italy|020, Novartis Investigational Site, Milano, Italy|026, Novartis Investigational Site, Milano, Italy|025, Novartis Investigational Site, Napoli, Italy|021, Novartis Investigational Site, Novara, Italy|022, Novartis Investigational Site, Padova, Italy|024, Novartis Investigational Site, Pisa, Italy|028, Novartis Investigational Site, Sassari, Italy|173, Novartis Investigational Site, Morelia, Michoacan, Mexico|176, Novartis Investigational Site, Durango, Mexico|170, Novartis Investigational Site, Mexico, Mexico|177, Novartis Investigational Site, Mexico, Mexico|178, Novartis Investigational Site, Mexico, Mexico|175, Novartis Investigational Site, Mexico, Mexico|300, Novartis Investigational Site, Dasmariñas, Cavite, Philippines|306, Novartis Investigational Site, Alabang, Muntilupa, Philippines|302, Novartis Investigational Site, Manila, Philippines|301, Novartis Investigational Site, Manila, Philippines|303, Novartis Investigational Site, Muntinlupa, Philippines|304, Novartis Investigational Site, Muntinlupa, Philippines|305, Novartis Investigational Site, Muntinlupa, Philippines|040, Novartis Investigational Site, Debica, Poland|042, Novartis Investigational Site, Katowice, Poland|052, Novartis Investigational Site, Leczna, Poland|048, Novartis Investigational Site, Lodz, Poland|049, Novartis Investigational Site, Lubartow, Poland|051, Novartis Investigational Site, Oborniki Slaskie, Poland|046, Novartis Investigational Site, Osielsko, Poland|043, Novartis Investigational Site, Siemianowice Slaskie, Poland|047, Novartis Investigational Site, Tarnow, Poland|041, Novartis Investigational Site, Warszawa, Poland|050, Novartis Investigational Site, Warszawa, Poland|045, Novartis Investigational Site, Wola, Poland|044, Novartis Investigational Site, Wroclaw, Poland|257, Novartis Investigational Site, Ponce, Puerto Rico|415, Novartis Investigational vaccine, San Juan, Puerto Rico|415, Novartis Investigational Site, San Juan, Puerto Rico|80, Novartis Investigational Site, Sabadell, Barcelona, Spain|075, Novartis Investigational Site, Santiago, Galicia, Spain|074, Novartis Investigational Site, Granada, Spain|076, Novartis Investigational Site, Madrid, Spain|077, Novartis Investigational Site, Madrid, Spain|79, Novartis Investigational Site, Malaga, Spain|078, Novartis Investigational Site, Valencia, Spain|343, Novartis Investigational Site, Banciao, New Taipei City, Taiwan|346, Novartis Investigational Site, Datong, Taipei City, Taiwan|344, Novartis Investigational Site, Taichung, Taiwan|345, Novartis Investigational Site, Taichung, Taiwan|340, Novartis Investigational Site, Taipei City, Taiwan|341, Novartis Investigational Site, Taipei City, Taiwan|342, Novartis Investigational Site, Taoyuan, Taiwan|321, Novartis Investigational Site, Bangkoknoi, Bangkok, Thailand|322, Novartis Investigational Site, Bangkoknoi, Bangkok, Thailand|323, Novartis Investigational Site, Pathum Wan, Bangkok, Thailand|327, Novartis Investigational Site, Ratchathewi, Bangkok, Thailand|325, Novartis Investigational Site, Pathum Thani, Prathumthani, Thailand|326, Novartis Investigational Site, Hat Yai, Songkhia, Thailand|320, Novartis Investigational Site, Bangkok, Thailand|324, Novartis Investigational Site, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT01964989"
302,"Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children","Completed","Has Results","Influenza","Biological: Fluarix™|Biological: Fluzone","GSK Investigational Site, Antioch, California, United States|GSK Investigational Site, Fairfield, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Pleasanton, California, United States|GSK Investigational Site, Redwood City, California, United States|GSK Investigational Site, Richmond, California, United States|GSK Investigational Site, Rolling Hills Estates, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Santa Rosa, California, United States|GSK Investigational Site, Vacaville, California, United States|GSK Investigational Site, Vallejo, California, United States|GSK Investigational Site, Walnut Creek, California, United States|GSK Investigational Site, Englewood, Colorado, United States|GSK Investigational Site, Lakewood, Colorado, United States|GSK Investigational Site, Tifton, Georgia, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Whitehouse Station, New Jersey, United States|GSK Investigational Site, Fishkill, New York, United States|GSK Investigational Site, Hopewell Junction, New York, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Cary, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Uniontown, Pennsylvania, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00383123"
303,"Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.","Completed","Has Results","Prophylaxis of A/H3N2v Influenza","Biological: Swine Influenza","51, Northern California Clinical Research Center, Redding, California, United States|47, Benchmark Research, Sacramento, California, United States|46, Johnson County Clinical Trials, Lenexa, Kansas, United States|49, Heartland Research Associates, LLC, Wichita, Kansas, United States|43, Central Kentucky Research Associates, Lexington, Kentucky, United States|41, Benchmark Research, Metairie, Louisiana, United States|44, Rochester Clinical Research Inc., Rochester, New York, United States|50, PMG Research of Raleigh, Raleight, North Carolina, United States|45, Omega Medical Research, Warwick, Rhode Island, United States|42, Research Acros, Dallas, Texas, United States|48, ""J. Lewis Research, Inc., Salt lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT01855945"
304,"Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children","Completed","Has Results","Pandemic H5N1 Influenza","Biological: Adjuvanted H5N1 pandemic influenza vaccine","3 Meridian Clinical Research, Miami, Florida, United States|7 Heartland Research Associates, Newton, Kansas, United States|5 Heartland Research Associates, Wichita, Kansas, United States|9 Heartland Research Associates, Wichita, Kansas, United States|1 Saint Louis University, Saint Louis, Missouri, United States|6 Meridian Clinical Research, Omaha, Nebraska, United States|10 Tekton Research, Georgetown, Texas, United States|8 Foothill Family Clinic, Salt Lake City, Utah, United States|4 Foothill Family Clinic, South Cottonwood Heights, Utah, United States|2 Rockwood Clinic P S, Spokane, Washington, United States|75 Phramongkutklao Hospital, Bangkok, Thailand|76 Faculty of Tropical Medicine Mahidol University, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT01776554"
305,"Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects","Completed","Has Results","Pandemic H5N1 Influenza","Biological: Adjuvanted H5N1 pandemic influenza vaccine","1 Tatum Highlands Med Ass PLLC, Phoenix, Arizona, United States|5 Broward Research Group Pembroke Pines, Hollywood, Florida, United States|7 Heartland Rsrch Ass LLC, Wichita, Kansas, United States|9 Heartland Research Associates, Wichita, Kansas, United States|2 Mercy Health Research, Saint Louis, Missouri, United States|3 Saint Louis University, Saint Louis, Missouri, United States|6 Regional Clinical Research Endwell,, Endwell, New York, United States|4 Benchmark Medical Research, Austin, Texas, United States|12 Tekton Research, Georgetown, Texas, United States|8 J. Lewis Research Inc., Salt Lake City, Utah, United States|10 Foothill Family Clinic, South Cottonwood Heights, Utah, United States|11 Jordan River Family Medicine, South Jordan, Utah, United States|42 Hunter Clinical Research, Newcastle, New South Wales, Australia|44 Wesley Research Institute Clinical Trials Center, Auchenflower, Queensland, Australia|40 CMAX, Adelaide, South Australia, Australia|41 Linear Clinical Research, Nedlands, Western Australia, Australia|45 Childrens Clin Rsrch Facility, Perth, Western Australia, Australia|50 Southern Clinical Trials, Beckenham, Christchurch, New Zealand|51 Riccarton Clinic, Riccarton, Christchurch, New Zealand|72 Faculty of Medicine, Chulalongkorn University - Queen Saovabha Memorial Institute, Bangkok, Thailand|71 Phramongkutklao Hospital, Bangkok, Thailand|73 Siriraj Clinical Research Ctr, Bangkok, Thailand|74 Chiang Mai Uni Hospital Clinical Trial Center, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT01766921"
306,"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age","Completed","No Results Available","Influenza","Biological: Investigational H7N9 vaccine GSK3206641A|Biological: Investigational H7N9 vaccine GSK3206640A|Biological: Placebo","GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Boise, Idaho, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Seattle, Washington, United States|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Woodstock, Ontario, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT01999842"
307,"Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza","Completed","Has Results","Influenza A|Influenza B","Biological: Anti-Influenza Immune Plasma|Drug: Standard Care","David Geffen School of Medicine at UCLA, Los Angeles, California, United States|Naval Medical Center San Diego, San Diego, California, United States|Los Angeles Biomedical Research Institute, CA, Torrance, California, United States|Children's National Medical Center, Washington, D.C., District of Columbia, United States|Washington, DC VA Med Center, Washington, D.C., District of Columbia, United States|University of Florida, Gainesville, Florida, United States|Emory University Hospital, Atlanta, Georgia, United States|Northwestern University (NU), Chicago, Illinois, United States|The Rush University Medical Center, Chicago, Illinois, United States|University of Maryland School of Medicine Center for Vaccine Development, Baltimore, Maryland, United States|John Hopkins University (JHU), Baltimore, Maryland, United States|Walter Reed National Military Medical Center (WRNMMC), Bethesda, Maryland, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Boston Med Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Bronson Healthcare Group, Kalamazoo, Michigan, United States|Saint Mary's Hospital (Mayo Clinic), Rochester, Minnesota, United States|Mount Sinai Medical Center, New York, New York, United States|Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, United States|Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|University of Cincinnati College of Medicine, Cincinnati, Ohio, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States|Texas Tech University Health Science Center (HSC)- Amarillo, Amarillo, Texas, United States|Texas Children's Hospital, Houston, Texas, United States|Texas Tech HSC-Lubbock, TX, Lubbock, Texas, United States|Naval Medical Center Portsmouth, Portsmouth, Virginia, United States|Madigan Army Medical Center (MAMC), Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT01052480"
308,"Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines","Completed","No Results Available","Influenza","Biological: Influenza","GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Evansville, Indiana, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Buffalo, New York, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Cincinnati, Ohio, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Katy, Texas, United States|GSK Investigational Site, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00197288"
309,"Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects","Completed","Has Results","Influenza","Biological: MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)|Biological: Non-adjuvanted trivalent subunit influenza vaccine (TIV)","301, Tatum Highlands Medical Associates PLLC, 26224 N Tatum Blvd 15A, Phoenix, Arizona, United States|318 Avail Clinical Research, 860 Peachwood Drive, Deland, Florida, United States|306 Westside Center for Clinical Research, 810 Lane Avenue South, Jacksonville, Florida, United States|328 Miami Research Associates, 6141 Sunset Drive, Miami, Florida, United States|320 Johnson County Clin-Trials, 15602 College Blvd, Lenexa, Kansas, United States|316 Heartland Research Associates LLC - Axtell Clinic - PA, 700 Medical Center Dr, Newton, Kansas, United States|310 Heartland Research Associates LLC, 3730 N Ridge Road Suite 600, Wichita, Kansas, United States|322 Heartland Research Associates Wichita, 1709 S. Rock Road, Wichita, Kansas, United States|314 Saint Louis Univ Med Div of Infectious Diseases Immunology, 1100 S Grand Blvd DRC- Rm 827, Saint Louis, Missouri, United States|330 Mercy Health Research, 12680 Olive Blvd Suite 200, Saint Louis, Missouri, United States|313 Clinical Research Center of Nevada, 7425 W Azure Suite 150, Las Vegas, Nevada, United States|311 Regional Clinical Research INC, 415 Hooper Road, Endwell, New York, United States|326 Triangle Medical Research, 5816 Creedmoor Rd. Suite 104, Raleigh, North Carolina, United States|332 Piedmont Medical Research, 1901 S. Hawthorne Rd. Suite 306, Winston-Salem, North Carolina, United States|303 Prestige Clinical Research, 333 Conover Drive, Franklin, Ohio, United States|325 Omega Medical Research, 400 Bald Hill Road, Warwick, Rhode Island, United States|312 Spartanburg Regional Medical Center, 485 Simuel Road, Spartanburg, South Carolina, United States|321 Jordan River Family Medicine, 1868 West 9800 South Ste 100, Jordan, Utah, United States|317 J. Lewis Research Inc., 2295 Foothill Drive, Salt Lake City, Utah, United States|305 Foothill Family Clinic South, 6360 South 3000 East, Salt Lake City, Utah, United States|323 PI Coor Clinical Research LCC, 10721 Main St Suite 1500, Fairfax, Virginia, United States|209, Centro de Investigacion CAFAM, Avenida Carrera 68, Bogota, Colombia|206, Centro de Atencion e Investigacion Medica CAIMED, Carrera 42A, Bogota, Colombia|213, Centro de Atencion e Investigacion Medica CAIMED, Carrera 42A, Bogota, Colombia|207, Centro de Investigacion Cafesalud Medicina Prepagada, Cra 14 No Piso Sexto, Bogota, Colombia|203, Health Research International HRI, Clayton ciudad del Saber Edificio 118, Panama|205, Medical and Research Center Calle 53 Urbanizacion Marbella, Consultorios Royal Center 108, Panama|103, De La Salle Health Sciences Institute, DBB B Dasmarinas, Cavite, Philippines|102, De La Salle Health Sciences Institute, Dbbb Dasmarinas, Cavite, Philippines|105, Manila Doctors Hospital, 667 United Nations Avenue, Ermita, Manila, Philippines|106, Our Lady of Lourdes Hospital, 46 P. Sanchez Street Sta., Mesa, Manila, Philippines|104 Jose Reyes Memorial Medical Center, Rizal Avenue Avenida Cruz, Manila, Philippines|107 Philippine General Hospital, Taft Avenue, Manila, Philippines|101, Asian Hospital and Medical Center 2205 Civic Drive Filinvest, Corporate City Alabang, Muntinlupa, Philippines|109, Research Institute for Tropical Medicine Department of Health Compound FILINVEST, Corporate City Alabang, Muntinlupa, Philippines|108, City Health Office 1 Rosa City, City Health Office 1, Rosa City, Philippines|110, San Juan de Dios Hospital, 2772 Roxas Blvd, Pasay City, Philippines|111, St Lukes Medical Center, 279 E Rodriguez Sr Boulevard, Quezon City, Philippines","https://ClinicalTrials.gov/show/NCT01162122"
310,"Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults","Completed","Has Results","Influenza","Biological: GSK2340274A|Biological: GSK2340273A|Biological: Seasonal trivalent influenza vaccine (TIV)|Biological: Saline placebo","GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00985673"
311,"Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older","Completed","Has Results","Influenza","Biological: Investigational H7N1 vaccine GSK2789869A|Biological: Placebo","GSK Investigational Site, Hollywood, Florida, United States|GSK Investigational Site, Meridian, Idaho, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada","https://ClinicalTrials.gov/show/NCT01949090"
312,"Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects","Completed","Has Results","Influenza","Biological: Cell culture-derived influenza vaccine|Biological: Egg-derived influenza virus vaccine|Biological: Placebo","Site 14, Denver, Colorado, United States|Site 15, Pembroke Pines, Florida, United States|Site 17, South Miami, Florida, United States|Site 13, Lenexa, Kansas, United States|Site 2, Bardstown, Kentucky, United States|Site 1, Saint Louis, Missouri, United States|Site 4, Edison, New Jersey, United States|Site 10, Binghamton, New York, United States|Site 5, Endwell, New York, United States|Site 16, Winston-Salem, North Carolina, United States|Site 11, Warwick, Rhode Island, United States|Site 12, Anderson, South Carolina, United States|Site 9, Austin, Texas, United States|Site 8, Dallas, Texas, United States|Site 7, Salt Lake City, Utah, United States|Site 3, Salt Lake City, Utah, United States|Site 6, Burke, Virginia, United States|Site 25, Espoo, Finland|Site 26, Helsinki, Finland|Site 27, Helsinki, Finland|Site 33, Järvenpää, Finland|Site 35, Kokkola, Finland|Site 34, Kotka, Finland|Site 30, Kuopio, Finland|Site 22, Lahti, Finland|Site 31, Oulu, Finland|Site 23, Pori, Finland|Site 32, Seinäjoki, Finland|Site 21, Tampere, Finland|Site 24, Turku, Finland|Site 28, Vantaa, Finland|Site 29, Vantaa, Finland|Site 49, Bydgoszcz, Poland|Site 53, Gniewkowo, Poland|Site 59, Katowice, Poland|Site 63, Kielce, Poland|Site 62, Końskie, Poland|Site 57, Krakow, Poland|Site 41, Kraków, Poland|Site 43, Kraków, Poland|Site 42, Kraków, Poland|Site 50, Kraków, Poland|Site 44, Lubartów, Poland|Site 45, Lublin, Poland|Site 65, Oleśnica, Poland|Site 47, Olsztyn, Poland|Site 48, Olsztyn, Poland|Site 46, Olsztyn, Poland|Site 58, Radziszów, Poland|Site 61, Ruda Śląska, Poland|Site 60, Rzeszów, Poland|Site 52, Warszawa, Poland|Site 55, Wilkowice, Poland|Site 64, Wrocław, Poland|Site 54, Wąbrzeźno, Poland|Site 51, Łodź, Poland","https://ClinicalTrials.gov/show/NCT00630331"
313,"Comparison of Delivery Routes of Flu Vaccine in Adults","Completed","No Results Available","Influenza","Biological: Trivalent inactivated influenza vaccine","Stanford University School of Medicine, Stanford, California, United States|UCLA Center For Vaccine Research, Torrance, California, United States|University of Iowa - Vaccine Research & Education Unit, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States|Duke Health Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00170547"
314,"A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children","Completed","Has Results","Influenza","Biological: Influsplit Tetra™ vaccine produced by investigational process (IP)|Biological: Influsplit Tetra™ vaccine produced by licensed process (LP)","GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Warwick, Rhode Island, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Dhaka, Bangladesh|GSK Investigational Site, Brno, Czechia|GSK Investigational Site, Chlumec nad Cidlinou, Czechia|GSK Investigational Site, Decin, Czechia|GSK Investigational Site, Jindrichuv Hradec, Czechia|GSK Investigational Site, Liberec, Czechia|GSK Investigational Site, Lipnik nad Becvou, Czechia|GSK Investigational Site, Nachod, Czechia|GSK Investigational Site, Odolena voda, Czechia|GSK Investigational Site, Ostrava - Poruba, Czechia|GSK Investigational Site, Pardubice, Czechia|GSK Investigational Site, Praha 6, Czechia|GSK Investigational Site, Aix en Provence, France|GSK Investigational Site, Dax, France|GSK Investigational Site, Draguignan, France|GSK Investigational Site, Essey les Nancy, France|GSK Investigational Site, Le Havre, France|GSK Investigational Site, Nantes cedex 2, France|GSK Investigational Site, Nice, France|GSK Investigational Site, Kehl, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Kirchheim, Bayern, Germany|GSK Investigational Site, Schoenau Am Koenigssee, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Detmold, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Goch, Nordrhein-Westfalen, Germany|GSK Investigational Site, Kleve-Materborn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Loehne, Nordrhein-Westfalen, Germany|GSK Investigational Site, Trier, Rheinland-Pfalz, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Radebeul, Sachsen, Germany|GSK Investigational Site, Wurzen, Sachsen, Germany|GSK Investigational Site, Flensburg, Schleswig-Holstein, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Neumuenster, Germany|GSK Investigational Site, Bydgoszcz, Poland|GSK Investigational Site, Debica, Poland|GSK Investigational Site, Katowice, Poland|GSK Investigational Site, Poznan, Poland|GSK Investigational Site, Siemianowice Slaskie, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Antequera/Málaga, Spain|GSK Investigational Site, Badalona, Spain|GSK Investigational Site, Burgos, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Santiago de Compostela, Spain|GSK Investigational Site, Sevilla, Spain","https://ClinicalTrials.gov/show/NCT02207413"
315,"A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza","Completed","Has Results","Influenza","Drug: oseltamivir [Tamiflu]","Los Angeles, California, United States|Oakland, California, United States|Aurora, Colorado, United States|Wilmington, Delaware, United States|Jacksonville, Florida, United States|Chicago, Illinois, United States|South Bend, Indiana, United States|Wichita, Kansas, United States|Louisville, Kentucky, United States|Boston, Massachusetts, United States|Boston, Massachusetts, United States|Boston, Massachusetts, United States|Springfield, Massachusetts, United States|Detroit, Michigan, United States|Duluth, Minnesota, United States|Omaha, Nebraska, United States|Morristown, New Jersey, United States|Bronx, New York, United States|Brooklyn, New York, United States|New York, New York, United States|Stony Brook, New York, United States|Syracuse, New York, United States|Durham, North Carolina, United States|Raleigh, North Carolina, United States|Akron, Ohio, United States|Cleveland, Ohio, United States|Dayton, Ohio, United States|Toledo, Ohio, United States|Toledo, Ohio, United States|Oklahoma City, Oklahoma, United States|Tyrone, Pennsylvania, United States|Providence, Rhode Island, United States|Charleston, South Carolina, United States|Houston, Texas, United States|Richmond, Virginia, United States|Madison, Wisconsin, United States|Petach Tikva, Israel|Beirut, Lebanon","https://ClinicalTrials.gov/show/NCT01033734"
316,"A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza","Completed","Has Results","Influenza","Drug: Oseltamivir IV|Drug: Oseltamivir Oral","Birmingham, Alabama, United States|Montgomery, Alabama, United States|Phoenix, Arizona, United States|Little Rock, Arkansas, United States|Duarte, California, United States|Los Angeles, California, United States|San Diego, California, United States|Wilmington, Delaware, United States|Melbourne, Florida, United States|Miami, Florida, United States|Pensacola, Florida, United States|South Miami, Florida, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Chicago, Illinois, United States|Maywood, Illinois, United States|Des Moines, Iowa, United States|Kansas City, Kansas, United States|Overland Park, Kansas, United States|Wichita, Kansas, United States|Madisonville, Kentucky, United States|New Orleans, Louisiana, United States|Worcester, Massachusetts, United States|Detroit, Michigan, United States|Kalamazoo, Michigan, United States|Duluth, Minnesota, United States|Minneapolis, Minnesota, United States|Jackson, Mississippi, United States|St. Joseph, Missouri, United States|Butte, Montana, United States|Grand Island, Nebraska, United States|Holmdel, New Jersey, United States|Bronx, New York, United States|New York, New York, United States|New York, New York, United States|New York, New York, United States|South Bronx, New York, United States|Stony Brook, New York, United States|Charlotte, North Carolina, United States|Winston-Salem, North Carolina, United States|Akron, Ohio, United States|Cincinnati, Ohio, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Dayton, Ohio, United States|Youngstown, Ohio, United States|Oklahoma City, Oklahoma, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Dallas, Texas, United States|Dallas, Texas, United States|San Antonio, Texas, United States|San Antonio, Texas, United States|Norfolk, Virginia, United States|Charleston, West Virginia, United States|Odense C, Denmark|Bron, France|Garches, France|La Tronche, France|Paris, France|Paris, France|Paris, France|Tours, France|Budapest, Hungary|Budapest, Hungary|Debrecen, Hungary|Eger, Hungary|Gyor, Hungary|Gyula, Hungary|Kaposvar, Hungary|Miskolc, Hungary|Nyiregyhaza, Hungary|Pecs, Hungary|Szeged, Hungary|Szolnok, Hungary|Szombathely, Hungary|Veszprem, Hungary|Genova, Italy|Milano, Italy|Monza, Italy|Pavia, Italy|Roma, Italy|Kaunas, Lithuania|Vilnius, Lithuania|Bialystok, Poland|Chorzow, Poland|Radom, Poland|Warszawa, Poland|Bucharest, Romania|Constanta, Romania|Craiova, Romania|Timisoara, Romania|Elche, Alicante, Spain|Almeria, Spain|Madrid, Spain","https://ClinicalTrials.gov/show/NCT01050257"
317,"A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza","Completed","Has Results","Influenza, Human","Drug: Zanamivir|Drug: Placebo to match zanamivir|Drug: Oseltamivir|Drug: Placebo to match oseltamivir","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Chula Vista, California, United States|GSK Investigational Site, Escondido, California, United States|GSK Investigational Site, Fullerton, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, La Mesa, California, United States|GSK Investigational Site, Oceanside, California, United States|GSK Investigational Site, Aurora, Colorado, United States|GSK Investigational Site, Stamford, Connecticut, United States|GSK Investigational Site, Orlando, Florida, United States|GSK Investigational Site, Sarasota, Florida, United States|GSK Investigational Site, Sunrise, Florida, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Augusta, Georgia, United States|GSK Investigational Site, Idaho Falls, Idaho, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Oak Park, Illinois, United States|GSK Investigational Site, Peoria, Illinois, United States|GSK Investigational Site, Council Bluffs, Iowa, United States|GSK Investigational Site, Topeka, Kansas, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Royal Oak, Michigan, United States|GSK Investigational Site, Troy, Michigan, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Valhalla, New York, United States|GSK Investigational Site, Asheville, North Carolina, United States|GSK Investigational Site, Chapel Hill, North Carolina, United States|GSK Investigational Site, Bismarck, North Dakota, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Columbus, Ohio, United States|GSK Investigational Site, Toledo, Ohio, United States|GSK Investigational Site, Bethlehem, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Roanoke, Virginia, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Westmead, New South Wales, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, Adelaide, South Australia, Australia|GSK Investigational Site, Bedford Park, South Australia, Australia|GSK Investigational Site, Clayton, Victoria, Australia|GSK Investigational Site, Heidelberg, Victoria, Australia|GSK Investigational Site, Melbourne, Victoria, Australia|GSK Investigational Site, Melbourne, Victoria, Australia|GSK Investigational Site, Perth, Western Australia, Australia|GSK Investigational Site, Brussel, Belgium|GSK Investigational Site, Bruxelles, Belgium|GSK Investigational Site, Leuven, Belgium|GSK Investigational Site, Liege, Belgium|GSK Investigational Site, Rio de Janeiro, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Calgary, Alberta, Canada|GSK Investigational Site, Calgary, Alberta, Canada|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Chicoutimi, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Trois-Rivières, Quebec, Canada|GSK Investigational Site, Haikou, Hainan, China|GSK Investigational Site, Changsha, Hunan, China|GSK Investigational Site, Nanchang, Jiangxi, China|GSK Investigational Site, Changchun, Jilin, China|GSK Investigational Site, Xian, Shaanxi, China|GSK Investigational Site, Hangzhou, Zhejiang, China|GSK Investigational Site, Beijing, China|GSK Investigational Site, Beijing, China|GSK Investigational Site, Chengdu, China|GSK Investigational Site, Chongqing, China|GSK Investigational Site, Guangzhou, China|GSK Investigational Site, Hangzhou, China|GSK Investigational Site, Shanghai, China|GSK Investigational Site, Tianjin, China|GSK Investigational Site, Bogotá, Colombia|GSK Investigational Site, Brno - Bohunice, Czechia|GSK Investigational Site, Brno, Czechia|GSK Investigational Site, Hradec Kralove, Czechia|GSK Investigational Site, Praha 8, Czechia|GSK Investigational Site, Aarhus N, Denmark|GSK Investigational Site, Hvidovre, Denmark|GSK Investigational Site, Odense C, Denmark|GSK Investigational Site, Dijon Cedex, France|GSK Investigational Site, Limoges cedex, France|GSK Investigational Site, Nîmes cedex 9, France|GSK Investigational Site, Orléans cedex 2, France|GSK Investigational Site, Poitiers Cedex, France|GSK Investigational Site, Tours cedex 9, France|GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany|GSK Investigational Site, Erlangen, Bayern, Germany|GSK Investigational Site, Regensburg, Bayern, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Homburg, Saarland, Germany|GSK Investigational Site, Chaidari, Greece|GSK Investigational Site, Goudi, Athens, Greece|GSK Investigational Site, Kwun Tong, Hong Kong|GSK Investigational Site, Shatin, Hong Kong|GSK Investigational Site, Tuen Mun, Hong Kong|GSK Investigational Site, Debrecen, Hungary|GSK Investigational Site, Kaposvár, Hungary|GSK Investigational Site, Miskolc, Hungary|GSK Investigational Site, Szombathely, Hungary|GSK Investigational Site, Székesfehérvár, Hungary|GSK Investigational Site, Bangalore, India|GSK Investigational Site, Civil Lines, India|GSK Investigational Site, Lucknow, India|GSK Investigational Site, Lucknow, India|GSK Investigational Site, Pune, India|GSK Investigational Site, Pune, India|GSK Investigational Site, Trivandrum, India|GSK Investigational Site, Guro Gu, Korea, Republic of|GSK Investigational Site, Gyeonggi, Korea, Republic of|GSK Investigational Site, Kangwon-do, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Cuautitlán, Estado De México, Estado De México, Mexico|GSK Investigational Site, Guadalajara, Jalisco, Mexico|GSK Investigational Site, San Nicolas de los Garza, Nuevo León, Mexico|GSK Investigational Site, Aguascalientes, Mexico|GSK Investigational Site, Chihuahua, Mexico|GSK Investigational Site, Nijmegen, Netherlands|GSK Investigational Site, Auckland, New Zealand|GSK Investigational Site, Auckland, New Zealand|GSK Investigational Site, Auckland, New Zealand|GSK Investigational Site, Christchurch, New Zealand|GSK Investigational Site, Hamilton, New Zealand|GSK Investigational Site, Hastings, New Zealand|GSK Investigational Site, Newtown, New Zealand|GSK Investigational Site, Bergen, Norway|GSK Investigational Site, Trondheim, Norway|GSK Investigational Site, Chorzow, Poland|GSK Investigational Site, Debica, Poland|GSK Investigational Site, Trzebnica, Poland|GSK Investigational Site, Warszawa, Poland|GSK Investigational Site, Barnaul, Russian Federation|GSK Investigational Site, Barnaul, Russian Federation|GSK Investigational Site, Saint-Petersburg, Russian Federation|GSK Investigational Site, Sankt-Peterburg, Russian Federation|GSK Investigational Site, Smolensk, Russian Federation|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Martin, Slovakia|GSK Investigational Site, Middelburg, Mpumalanga, South Africa|GSK Investigational Site, Bellville, South Africa|GSK Investigational Site, Die Wilgers, South Africa|GSK Investigational Site, Les Marais, South Africa|GSK Investigational Site, Panorama, South Africa|GSK Investigational Site, Worcester, South Africa|GSK Investigational Site, Alicante, Spain|GSK Investigational Site, Badalona, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Granada, Spain|GSK Investigational Site, Granada, Spain|GSK Investigational Site, L'Hospitalet de Llobregat, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Murcia, Spain|GSK Investigational Site, Oviedo, Spain|GSK Investigational Site, Pama de Mallorca, Spain|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Bristol, United Kingdom|GSK Investigational Site, Cardiff, United Kingdom|GSK Investigational Site, Liverpool, United Kingdom|GSK Investigational Site, Manchester, United Kingdom","https://ClinicalTrials.gov/show/NCT01231620"
318,"Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma","Completed","Has Results","H1N1 Influenza Virus","Biological: H1N1 vaccine high dose|Biological: H1N1 vaccine low dose","Emory University, Atlanta, Georgia, United States|Washington University School of Medicine, St. Louis, Missouri, United States|Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Pittsburgh Asthma Institute, Pittsburgh, Pennsylvania, United States|University of Virginia, Charlottesville, Virginia, United States|University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00978120"
319,"Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications","Completed","Has Results","Influenza","Drug: Amantadine, Ribavirin, Oseltamivir|Drug: Oseltamivir","Simon Williamson Clinic, Birmingham, Alabama, United States|East Valley Family Physicians, Chandler, Arizona, United States|Thomas Lenzmeier Family Practice, Glendale, Arizona, United States|Central Phoenix Medical Center, Phoenix, Arizona, United States|WCCT Global LLC, Costa Mesa, California, United States|Advanced Rx Clinical Research, Garden Grove, California, United States|Torrance Clinical Research Institute, Inc., Lomita, California, United States|University of Southern California, Los Angeles, California, United States|University of California at San Diego, San Diego, California, United States|Westlake Medical Research (CA), Thousand Oaks, California, United States|Los Angeles BioMedical Research Institute, Torrance, California, United States|Empire Clinical Research, Upland, California, United States|University of Colorado, Aurora, Colorado, United States|Centennial - IMMUNOe International Research, Centennial, Colorado, United States|University of Florida, Gainesville, Florida, United States|Best Quality Research Inc., Hialeah, Florida, United States|San Marcus Research Clinic, Inc., Miami, Florida, United States|Medical Consulting Center, Miami, Florida, United States|Suncoast Research Group, LLC, Miami, Florida, United States|University of Miami, Miami, Florida, United States|DMI Research, Inc., Pinellas Park, Florida, United States|Northwestern University, Chicago, Illinois, United States|Sneeze, Wheeze & Itch Associates, LLC, Normal, Illinois, United States|Ridge Family Practice, Council Bluffs, Iowa, United States|University of Iowa, Iowa City, Iowa, United States|Research Integrity, LLC, Owensboro, Kentucky, United States|Horizon Research Group, of Opelousas, LLC, Eunice, Louisiana, United States|Centex Studies Inc. - Dr. Seep, Lake Charles, Louisiana, United States|NIH Clinical Center, Bethesda, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|UMass Medical School, Worcester, Massachusetts, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Florissant Internists, Bridgeton, Missouri, United States|Clinical Research Advantage/ Skyline Medical Center, Elkhorn, Nebraska, United States|Prairie Fields Family Medicine, Fremont, Nebraska, United States|Southwest Family Physicians, Omaha, Nebraska, United States|New Jersey Medical School, Newark, New Jersey, United States|James J. Peters, VA Medical Center, Bronx, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States|Duke University, Durham, North Carolina, United States|Clinical Research Solutions - Dr. Panuto, Middleburg Heights, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Montgomery Medical, Smithfield, Pennsylvania, United States|Health Concepts, Rapid City, South Dakota, United States|Clinical Research Solutions - Dr. Bart, Columbia, Tennessee, United States|Clinical Research Solutions - Dr. Slandzicki, Franklin, Tennessee, United States|Clinical Research Solutions - Dr. Hoppers, Jackson, Tennessee, United States|Holston Medical Group, Kingsport, Tennessee, United States|Clinical Research Solutions - Dr. Rowe, Nashville, Tennessee, United States|Clinical Research Solutions - Dr. Dar, Smyrna, Tennessee, United States|University of Texas Tech Amarillo, Amarillo, Texas, United States|Family Medicine Associates of Texas, Carrollton, Texas, United States|3rd Coast Research Associates, Corpus Christi, Texas, United States|University of Texas at Houston, Houston, Texas, United States|Centex Studies Inc. - Dr. Pouzar, Houston, Texas, United States|Pioneer Research Solutions, Inc., Houston, Texas, United States|Texas Tech HSC, Lubbock, Texas, United States|Centex Studies Inc. - Dr. Garcia, Pharr, Texas, United States|Village Health Partners, Plano, Texas, United States|Endeavor Clinical Trials, San Antonio, Texas, United States|Bandera Family Healthcare Research, San Antonio, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Instituto Medico Platense, La Plata, Buenos Aires, Argentina|Hospital Houssay, Vicente Lopez, Provincia De Buenos Aires, Argentina|Centro de Educación Médica e Investigaciónes Clínicas (CEMIC), Buenos Aires, Argentina|Fundación del Centro de Estudios Infectológicos (FUNCEI), Buenos Aires, Argentina|Hospital General de Agudos J. M. Ramos Mejía, Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Buenos Aires, Argentina|Hospital Rawson, Cordoba, Argentina|Instituto Centralizado de Asistencia e Investigación Clínica Integral (CAICI), Santa Fe, Argentina|Holdsworth House Med Practice, Darlinghurst, New South Wales, Australia|Taylor Square Private Clinic, Darlinghurst, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Royal Brisbane, Herston, Queensland, Australia|Northside Clinic, Fitzroy North, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Instituto Nacional de Ciencias Médicas y Nutrición (INCMN) Salvador Zubirán, México City, Mexico|Hospital General y de Alta Especialidad ""Dr. Manuel GEA Gonzalez"", Tlalpan, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER), Tlalpan, Mexico|Siriraj Hospital, Mahidol University, Bangkoknoi, Bangkok, Thailand|HIV-NAT, The Thai Red Cross AIDS, Patumwan, Bangkok, Thailand|Srinagarind Hospital, Khon Kaen University, Muang, Khon Kaen, Thailand|Bamrasnaradura Infectious Diseases Institute, Muang, Nonthaburi, Thailand","https://ClinicalTrials.gov/show/NCT01227967"
320,"A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA","Completed","Has Results","Influenza","Biological: CSL425|Biological: Placebo","Study Site, Huntsville, Alabama, United States|Study Site, San Diego, California, United States|Study Site, Melbourne, Florida, United States|Study Site, Peoria, Illinois, United States|Study Site, South Bend, Indiana, United States|Study Site, Metairie, Louisiana, United States|Study Site, Baltimore, Maryland, United States|Study Site, Rockville, Maryland, United States|Study Site, Austin, Texas, United States|Study Site, Fort Worth, Texas, United States|Study Site, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00958126"
321,"A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA","Completed","Has Results","Influenza","Biological: CSL's 2009 H1N1 Influenza Vaccine (CSL425)|Biological: Placebo","Chandler, Arizona, United States|Melbourne, Florida, United States|Bardstown, Kentucky, United States|Metairie, Louisiana, United States|Omaha, Nebraska, United States|Austintown, Ohio, United States|Cincinnati, Ohio, United States|Latrobe, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Austin, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Murray, Utah, United States","https://ClinicalTrials.gov/show/NCT00958243"
322,"Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital","Completed","Has Results","Influenza, Human","Drug: zanamivir aqueous solution","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, San Diego, California, United States|GSK Investigational Site, Stamford, Connecticut, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Gainesville, Florida, United States|GSK Investigational Site, Tampa, Florida, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Decatur, Georgia, United States|GSK Investigational Site, Indianapolis, Indiana, United States|GSK Investigational Site, Topeka, Kansas, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, New Orleans, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, St. Paul, Minnesota, United States|GSK Investigational Site, Kansas City, Missouri, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Butte, Montana, United States|GSK Investigational Site, Camden, New Jersey, United States|GSK Investigational Site, New Hyde Park, New York, United States|GSK Investigational Site, Chapel Hill, North Carolina, United States|GSK Investigational Site, Charlotte, North Carolina, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Columbus, Ohio, United States|GSK Investigational Site, Toledo, Ohio, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Memphis, Tennessee, United States|GSK Investigational Site, Memphis, Tennessee, United States|GSK Investigational Site, Dallas, Texas, United States|GSK Investigational Site, Dallas, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Milwaukee, Wisconsin, United States|GSK Investigational Site, Garran, Australian Capital Territory, Australia|GSK Investigational Site, Chermside, Queensland, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, Adelaide, South Australia, Australia|GSK Investigational Site, Bedford Park, South Australia, Australia|GSK Investigational Site, Heidelberg, Victoria, Australia|GSK Investigational Site, Perth, Western Australia, Australia|GSK Investigational Site, Subiaco, Western Australia, Australia|GSK Investigational Site, Sao Paulo, São Paulo, Brazil|GSK Investigational Site, Rio de Janeiro, Brazil|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Chicoutimi, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Quebec, Canada|GSK Investigational Site, Bron cedex, France|GSK Investigational Site, Grenoble cedex 9, France|GSK Investigational Site, Limoges cedex, France|GSK Investigational Site, Nancy cedex, France|GSK Investigational Site, Nice, France|GSK Investigational Site, Nîmes cedex 9, France|GSK Investigational Site, Orléans cedex 2, France|GSK Investigational Site, Paris cedex 14, France|GSK Investigational Site, Paris, France|GSK Investigational Site, Tours cedex 9, France|GSK Investigational Site, Shatin, Hong Kong|GSK Investigational Site, Fukuoka, Japan|GSK Investigational Site, Hokkaido, Japan|GSK Investigational Site, Kanagawa, Japan|GSK Investigational Site, Osaka, Japan|GSK Investigational Site, Osaka, Japan|GSK Investigational Site, Yamanashi, Japan|GSK Investigational Site, Bergen, Norway|GSK Investigational Site, Trondheim, Norway|GSK Investigational Site, Ekaterinburg, Russian Federation|GSK Investigational Site, Smolensk, Russian Federation|GSK Investigational Site, Middelburg, Mpumalanga, South Africa|GSK Investigational Site, Bellville, South Africa|GSK Investigational Site, Observatory, South Africa|GSK Investigational Site, Panorama, South Africa|GSK Investigational Site, Rondebosch, South Africa|GSK Investigational Site, Tygerberg, South Africa|GSK Investigational Site, Worcester, South Africa|GSK Investigational Site, (Móstoles) Madrid, Spain|GSK Investigational Site, Badalona, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Getafe/Madrid, Spain|GSK Investigational Site, L'Hospitalet de Llobregat, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom|GSK Investigational Site, Liverpool, Merseyside, United Kingdom|GSK Investigational Site, Livingston, West Lothian, United Kingdom|GSK Investigational Site, Bristol, United Kingdom|GSK Investigational Site, Bristol, United Kingdom|GSK Investigational Site, Cardiff, United Kingdom|GSK Investigational Site, Leeds, United Kingdom|GSK Investigational Site, Leicester, United Kingdom|GSK Investigational Site, Leicester, United Kingdom|GSK Investigational Site, London, United Kingdom|GSK Investigational Site, Oxford, United Kingdom|GSK Investigational Site, Southampton, United Kingdom","https://ClinicalTrials.gov/show/NCT01014988"
323,"A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age","Completed","Has Results","Influenza, Human","Biological: Seqirus QIV|Biological: Comparator QIV","Site 296, Huntsville, Alabama, United States|Site 401, Madera, California, United States|Site 397, Ontario, California, United States|Site 392, Redding, California, United States|Site 402, Sacramento, California, United States|Site 398, San Jose, California, United States|Site 388, Hialeah, Florida, United States|Site 293, Melbourne, Florida, United States|Site 289, Boise, Idaho, United States|Site 294, Peoria, Illinois, United States|Site 390, Augusta, Kansas, United States|Site 396, Newton, Kansas, United States|Site 400, Park City, Kansas, United States|Site 317, Wichita, Kansas, United States|Site 386, Bardstown, Kentucky, United States|Site 393, Metairie, Louisiana, United States|Site 287, Saint Louis, Missouri, United States|Site 316, Bellevue, Nebraska, United States|Site 382, Omaha, Nebraska, United States|Site 285, Binghamton, New York, United States|Site 387, Cary, North Carolina, United States|Site 385, Cincinnati, Ohio, United States|Site 383, Cleveland, Ohio, United States|Site 399, Dayton, Ohio, United States|Site 384, Grove City, Ohio, United States|Site 389, Gresham, Oregon, United States|Site 283, Austin, Texas, United States|Site 282, Fort Worth, Texas, United States|Site 288, San Angelo, Texas, United States|Site 394, San Antonio, Texas, United States|Site 395, Layton, Utah, United States|Site 300, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02545543"
324,"A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years","Completed","Has Results","Influenza, Human","Biological: bioCSL Trivalent Influenza Virus Vaccine (CSL TIV)|Biological: Comparator Quadrivalent Influenza Virus Vaccine","Site 286, Los Angeles, California, United States|Site 289, Boise, Idaho, United States|Site 287, Saint Louis, Missouri, United States|Site 285, Binghamton, New York, United States|Site 290, Durham, North Carolina, United States|Site 281, Raleigh, North Carolina, United States|Site 280, Winston-Salem, North Carolina, United States|Site 284, Charleston, South Carolina, United States|Site 283, Austin, Texas, United States|Site 282, Fort Worth, Texas, United States|Site 288, San Angelo, Texas, United States","https://ClinicalTrials.gov/show/NCT02212106"
325,"Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection","Completed","No Results Available","Influenza","Biological: Vero cell-derived, trivalent, seasonal influenza vaccine|Biological: Placebo: Phosphate-buffered saline","Quality of Life Medical & Research Center, LLC, Tucson, Arizona, United States|Benchmark Research, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research San Francisco, San Francisco, California, United States|Radiant Research, Inc, Denver, Colorado, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Pharmax Research Clinic, Miami, Florida, United States|University Clinical Research, Inc, Pembroke Pines, Florida, United States|Miami Research Associates, South Miami, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Radiant Research, Inc - Chicago, Chicago, Illinois, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Vince and Associates Clinical Research, Overland Park, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|Radiant Research, Inc., St. Louis, Missouri, United States|Sundance Clinical Research, St. Louis, Missouri, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|Triangle Medical Research Associates, Raleigh, North Carolina, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Radiant Research - Cincinnati, Cincinnati, Ohio, United States|Omega Medical Research, Warwick, Rhode Island, United States|Spartanburg Medical Research, Spartanburg, South Carolina, United States|Health Concepts, Rapid City, South Dakota, United States|Clinical Research Associates, Inc. - Nashville, Nashville, Tennessee, United States|Benchmark Research Austin, Austin, Texas, United States|Benchmark Research Ft. Worth, Ft. Worth, Texas, United States|Benchmark Research San Angeolo, San Angelo, Texas, United States|Jean Brown Research / Westside Medical, Salt Lake City, Utah, United States|Advanced Clinical Research, West Jordan, Utah, United States|PI-COOR Clinical Research, Burke, Virginia, United States|Clinical Research Associates of Tidewater, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00800605"
326,"Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older","Completed","No Results Available","Influenza","Biological: Vero cell derived, trivalent, seasonal influenza vaccine|Biological: Licensed egg-derived, trivalent seasonal influenza vaccine","Coastal Clinical Research, Inc., Mobile, Alabama, United States|Quality of Life Medical & Research Center, LLC, Tucson, Arizona, United States|Benchmark Research, San Francisco, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research San Francisco, San Francisco, California, United States|Clinical Research of South Florida, Coral Cables, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|University Clinical Research, Inc., Pembrook Pines, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Vince and Associates Clinical Research, Overland Park, Kansas, United States|Heartland Research Associates, LLC, Wichita, Kansas, United States|Heartland Research Associates LLC, Wichita, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|Radiant Research, Inc., St. Louis, Missouri, United States|Sundance Clinical Research, St. Louis, Missouri, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rochester Clinical Research Inc., Rochester, New York, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Omega Medical Research, Warwick, Rhode Island, United States|Palmetto Medical Research, Mt. Pleasant, South Carolina, United States|Clinical Research Associates, Inc. - Nashville, Nashville, Tennessee, United States|Benchmark Research Austin, Austin, Texas, United States|Benchmark Research Ft. Worth, Fort Worth, Texas, United States|Research Across America, Plano, Texas, United States|Benchmark Research San Angelo, San Angelo, Texas, United States|Pi-Coor Clinical Research, Fairfax, Virginia, United States|Clinical Research Associates of Tidewater, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00782431"
327,"A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population","Completed","Has Results","Influenza","Biological: CSL's Influenza Virus Vaccine (Afluria)|Biological: Influenza Virus Vaccine (Fluzone)","Chandler, Arizona, United States|Harrisburg, Arkansas, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Mountain Home, Arkansas, United States|Melbourne, Florida, United States|Bardstown, Kentucky, United States|Omaha, Nebraska, United States|Binghamton, New York, United States|Elmira, New York, United States|Cincinnati Children's Hospital Medical Center- Division of Infectious Disease, Cincinnati, Ohio, United States|Warr Acres, Oklahoma, United States|UPMC / Community Medicine Inc, Greenville, Pennsylvania, United States|Pediatric Associates of Latrobe, Latrobe, Pennsylvania, United States|Pediatric Alliance Greentree Division, Pittsburgh, Pennsylvania, United States|South Hills Pediatrics, Pittsburgh, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States|Burke, Virginia, United States|Vienna, Virginia, United States","https://ClinicalTrials.gov/show/NCT00959049"
328,"A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.","Completed","Has Results","Influenza, Human","Biological: Quadrivalent Influenza Vaccine (QIV)|Biological: Trivalent Influenza Vaccine (TIV-1)|Biological: Trivalent Influenza Vaccine (TIV-2)","Site 296, Huntsville, Alabama, United States|Site 286, Los Angeles, California, United States|Site 315, San Diego, California, United States|Site 301, Milford, Connecticut, United States|Site 297, Jacksonville, Florida, United States|Site 293, Melbourne, Florida, United States|Site 292, Savannah, Georgia, United States|Site 289, Meridian, Idaho, United States|Site 294, Peoria, Illinois, United States|Site 295, Mishawaka, Indiana, United States|Site 317, Witchita, Kansas, United States|Site 291, Rockville, Maryland, United States|Site 310, Methuen, Massachusetts, United States|Site 287, Saint Louis, Missouri, United States|Site 316, Bellevue, Nebraska, United States|Site 298, Las Vegas, Nevada, United States|Site 285, Binghamton, New York, United States|Site 313, Rochester, New York, United States|Site 302, Charlotte, North Carolina, United States|Site 306, Raleigh, North Carolina, United States|Site 309, Wilmington, North Carolina, United States|Site 305, Winston-Salem, North Carolina, United States|Site 299, Oklahoma City, Oklahoma, United States|Site 307, Mount Pleasant, South Carolina, United States|Site 308, Bristol, Tennessee, United States|Site 311, Jefferson City, Tennessee, United States|Site 312, Knoxville, Tennessee, United States|Site 304, Knoxville, Tennessee, United States|Site 283, Austin, Texas, United States|Site 282, Forth Worth, Texas, United States|Site 288, San Angelo, Texas, United States|Site 300, Salt Lake City, Utah, United States|Site 303, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT02214225"
329,"Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)","Completed","No Results Available","Influenza","Biological: Inactivated seasonal influenza vaccine (split virus, Vero cell-derived)|Biological: Phosphate buffered saline","Radiant Research Tucson, Tuscon, Arizona, United States|Advanced Clinical Research Institute, Anaheim, California, United States|Orange County Clinical Research, Inc., Cypress, California, United States|Benchmark Research, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research San Francisco, San Francisco, California, United States|Tampa Bay Medical Research, Clearwater, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Miami Research Associates, Miami, Florida, United States|University Clinical Research, Inc., Pembroke, Florida, United States|Radiant Research Inc. - Chicago, Chicago, Illinois, United States|PRA International Clinical Pharmacology Center, Lenexa, Kansas, United States|Vince and Associates Clinical Research, Overland Park, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Columbia Medical Practice, Columbia, Maryland, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|Sundance Clinical Research, St. Louis, Missouri, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, United States|Rochester Clinical Research, Rochester, New York, United States|Metrolina Medical Research, Charlotte, North Carolina, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Piedmont Medical Research Associates, Winston-Salem, North Carolina, United States|Coastal Carolina Research Center, Goose Creek, South Carolina, United States|Spartanburg Medical Research, Spartanburg, South Carolina, United States|Clinical Research Associates, Inc. - Nashville, Nashville, Tennessee, United States|Benchmark Research Austin, Austin, Texas, United States|Research Across America - CNS Research Group, Dallas, Texas, United States|Benchmark Research Ft. Worth, Ft. Worth, Texas, United States|Research Across America - CNS Research Group, Plano, Texas, United States|Benchmark Research San Angelo, San Angelo, Texas, United States|Radiant Research - San Antonio Northeast, San Antonio, Texas, United States|Jean Brown Associates, Inc., Salt Lake City, Utah, United States|Clinical Research Associates of Tidewater, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00566345"
330,"A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine","Completed","Has Results","Influenza","Biological: CSL Limited Influenza Virus Vaccine (Afluria®)|Biological: US Licensed Influenza Virus Vaccine (Fluzone®)","North Central Arkansas Medical Association, Mountain Home, Arkansas, United States|Covance CRU, Inc, Boise, Idaho, United States|The University of Iowa, Iowa City, Iowa, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|Saint Louis University Medical Center, Saint Louis, Missouri, United States|University of Rochester School of Medicine and Dentistry, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Covance CRU, Inc., Portland, Oregon, United States|Primary Physicians Research, Inc., Pittsburgh, Pennsylvania, United States|Clinical Partners, LLC, Johnston, Rhode Island, United States|Vanderbilt Medical Center, Nashville, Tennessee, United States|Covance CRU Inc., Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT00735475"
331,"A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants","Completed","Has Results","Influenza","Drug: Oseltamivir|Drug: Placebo","Birmingham, Alabama, United States|Little Rock, Arkansas, United States|Stanford, California, United States|Denver, Colorado, United States|Hartford, Connecticut, United States|Newark, Delaware, United States|St Petersburg, Florida, United States|Atlanta, Georgia, United States|Augusta, Georgia, United States|Chicago, Illinois, United States|Chicago, Illinois, United States|New Orleans, Louisiana, United States|Detroit, Michigan, United States|Detroit, Michigan, United States|Brooklyn Center, Minnesota, United States|Missoula, Montana, United States|Camden, New Jersey, United States|Hackensack, New Jersey, United States|Livingston, New Jersey, United States|Newark, New Jersey, United States|Buffalo, New York, United States|New York, New York, United States|New York, New York, United States|Chapel Hill, North Carolina, United States|Charlotte, North Carolina, United States|Durham, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Oklahoma City, Oklahoma, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Dallas, Texas, United States|Houston, Texas, United States|Aalst, Belgium|Bruxelles, Belgium|Bruxelles, Belgium|Edegem, Belgium|Leuven, Belgium|Edmonton, Alberta, Canada|Coquitlam, British Columbia, Canada|Winnipeg, Manitoba, Canada|London, Ontario, Canada|Saskatoon, Saskatchewan, Canada|Brno, Czech Republic|Tallinn, Estonia|Tartu, Estonia|Paris, France|Paris, France|Paris, France|Toulouse, France|Tours, France|Aachen, Germany|Berlin, Germany|Hamburg, Germany|Heidelberg, Germany|München, Germany|München, Germany|Budapest, Hungary|Pecs, Hungary|Szeged, Hungary|Jerusalem, Israel|Petach Tikva, Israel|Ramat Gan, Israel|Padova, Italy|Pavia, Italy|Roma, Italy|Kaunas, Lithuania|Vilnius, Lithuania|Bialystok, Poland|Lodz, Poland|Szczecin, Poland|Warszawa, Poland|Warszawa, Poland|Madrid, Spain|Madrid, Spain|Birmingham, United Kingdom|Edinburgh, United Kingdom","https://ClinicalTrials.gov/show/NCT00412737"
332,"Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults","Completed","Has Results","Pandemic H5N1 Influenza","Biological: Adjuvanted H5N1 pandemic influenza vaccine","1 Miami Research Associates, Miami, Florida, United States|2 Mercy Health Research, St. Louis, Missouri, United States|3 Saint Louis University, St. Louis, Missouri, United States|4 Benchmark Medical Research, Austin, Texas, United States|48 Hunter Clinical Research, Newcastle, New South Wales, Australia|46 CMAX, Adelaide, South Australia, Australia|47 Linear Clinical Research, Nedlands, Western Australia, Australia|80 Faculty of Tropical Medicine, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT01776541"
333,"Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects","Completed","Has Results","Prophylaxis: Influenza","Biological: TIVc_LOT A|Biological: TIVc_LOT B|Biological: TIVc_LOT C|Biological: TIVf","Anaheim Clincial Trials, Anaheim, California, United States|Northern California Clinical Research Center, Redding, California, United States|Southern California CRC, San Diego, California, United States|Broward Research Group, Hollywood, Florida, United States|Comprehensive Clinical Trials, LLC, West Palm Beach, Florida, United States|Palm Bech Research, West Palm Beach, Florida, United States|Meridian Clinical Research, Savannah, Georgia, United States|Johnson County Clin-Trials, LLC, Lenexa, Kansas, United States|Heartland Research Associates, LLC, Wichita, Kansas, United States|Milford Emergency Associate,Inc, Milford, Massachusetts, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Rochester Clinical Research, Inc, Rochester, New York, United States|PMG Research of Charlotte, Charlotte, North Carolina, United States|PMG Research of Hickory, Hickory, North Carolina, United States|PMG Research of Raleigh, Raleigh, North Carolina, United States|New Horizons Clinical Research, Cincinnati, Ohio, United States|Columbia Research Group, Inc, Portland, Oregon, United States|Omega Medical Research, Warwick, Rhode Island, United States|Clinical Research Solutions, LLC, Franklin, Tennessee, United States|Clinical Research Associates, Inc, Nashville, Tennessee, United States|Foothill Family Clinc South, J. Lewis Research Inc., Salt Lake City, Utah, United States|Foothill Family Clinic, J. Lewis Research Inc., Salt Lake City, Utah, United States|Jordan River Family Medicine, J. Lewis Research, Inc., South Jordan, Utah, United States|Clinical Research Associates, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT02256488"
334,"Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine","Completed","Has Results","Influenza","Biological: 13 valent pneumococcal conjugate vaccine","Clinical Research Advantage, Inc., Chandler, Arizona, United States|Peninsula Research Associates, Rolling Hills Estates, California, United States|Clinical Trials Center Pediatric Infectious Diseases and Clinical Trials, Aurora, Colorado, United States|Tampa Bay Medical Research, Inc., Clearwater, Florida, United States|A. G. A. Clinical Trials, Hialeah, Florida, United States|Advanced Clinical Research, Meridian, Idaho, United States|Accelovance, Peoria, Illinois, United States|Suite 100, Riverdale, Maryland, United States|Mayo Clinic, Rochester, Minnesota, United States|Radiant Research, Inc, St. Louis, Missouri, United States|Big Sky Clinical Research, Butte, Montana, United States|FFM Clinical Research, Camillus, New York, United States|Rochester Clinical Research, Rochester, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|PMG Research of Raleigh, LLC, Cary, North Carolina, United States|Hickory Family Practice Associates, Hickory, North Carolina, United States|PMG Research of Hickory, LLC, Hickory, North Carolina, United States|Unifour Medical Research Associates, LLC, Hickory, North Carolina, United States|Unifour Medical Research Associates, Hickory, North Carolina, United States|Fairbrook Medical Clinic, Hickory, North Carolina, United States|PMG Research of Hickory, LLC, Hickory, North Carolina, United States|Unifour Medical Research Associates, LLC, Hickory, North Carolina, United States|PMG Research of Raleigh, LLC, Raleigh, North Carolina, United States|PMG Research of Salisbury, Salisbury, North Carolina, United States|PMG Research of Winston-Salem, Winston-Salem, North Carolina, United States|Cincinnati Children's Hospital Medical Center Gamble Program for Clinical Studies, Cincinnati, Ohio, United States|Rapid Medical Research, Inc., Cleveland, Ohio, United States|Prestige Clinical Research, Franklin, Ohio, United States|Preferred Primary Care Physicians, Inc, Carnegie, Pennsylvania, United States|Family Healthcare Partners, Grove City, Pennsylvania, United States|Family Practice Medical Associates South, Jefferson Office, Jefferson Hills, Pennsylvania, United States|Kid's Plus Pediatrics, Pittsburgh, Pennsylvania, United States|Primary Physicians Research Inc., Pittsburgh, Pennsylvania, United States|Family Practice Medical Associates South, Upper St. Clair, Pennsylvania, United States|The Washington Hospital Family Medicine, Washington, Pennsylvania, United States|Internal Medicine & Pediatric Associates of Bristol, PC, Bristol, Tennessee, United States|PMG Research of Bristol, LLC, Bristol, Tennessee, United States|Volunteer Research Group, Knoxville, Tennessee, United States|Clark D. McKeever, M.D. Research for Health, Houston, Texas, United States|Diagnostics Research Group, San Antonio, Texas, United States|Advanced Clinical Research, West Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00521586"
335,"A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults","Completed","Has Results","Influenza","Biological: High Dose Trivalent Inactivated Influenza Vaccine|Biological: Trivalent Inactivated Influenza Vaccine","Mobile, Alabama, United States|Chandler, Arizona, United States|Glendale, Arizona, United States|Glendale, Arizona, United States|Mesa, Arizona, United States|Mesa, Arizona, United States|Phoenix, Arizona, United States|Phoenix, Arizona, United States|Phoenix, Arizona, United States|Scottsdale, Arizona, United States|Tempe, Arizona, United States|Harrisburg, Arkansas, United States|Anaheim, California, United States|La Mesa, California, United States|Oceanside, California, United States|Redding, California, United States|San Diego, California, United States|Santa Rosa, California, United States|Aurora, Colorado, United States|Colorado Springs, Colorado, United States|Colorado Springs, Colorado, United States|Milford, Connecticut, United States|Milford, Connecticut, United States|Brooksville, Florida, United States|Clearwater, Florida, United States|Clearwater, Florida, United States|Coral Gables, Florida, United States|Crystal River, Florida, United States|DeLand, Florida, United States|Jacksonville, Florida, United States|Melbourne, Florida, United States|Pembroke Pine, Florida, United States|Pinellas Park, Florida, United States|Sarasota, Florida, United States|Stockbridge, Georgia, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Peoria, Illinois, United States|Mishawaka, Indiana, United States|Lenexa, Kansas, United States|Newton, Kansas, United States|Overland Park, Kansas, United States|Prairie Village, Kansas, United States|Wichita, Kansas, United States|Wichita, Kansas, United States|Bardstown, Kentucky, United States|Lexington, Kentucky, United States|Columbia, Maryland, United States|Elkridge, Maryland, United States|Rockville, Maryland, United States|Brockton, Massachusetts, United States|Haverhill, Massachusetts, United States|Edina, Minnesota, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Missoula, Montana, United States|Bellevue, Nebraska, United States|Omaha, Nebraska, United States|Las Vega, Nevada, United States|Newington, New Hampshire, United States|Edison, New Jersey, United States|Albuquerque, New Mexico, United States|Binghamton, New York, United States|Endwell, New York, United States|Rochester, New York, United States|Rochester, New York, United States|Cary, North Carolina, United States|Charlotte, North Carolina, United States|Hickory, North Carolina, United States|Raleigh, North Carolina, United States|Raleigh, North Carolina, United States|Salisbury, North Carolina, United States|Wilmington, North Carolina, United States|Winston Salem, North Carolina, United States|Fargo, North Dakota, United States|Idaho Falls, North Dakota, United States|Akron, Ohio, United States|Cincinnati, Ohio, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Norman, Oklahoma, United States|Erie, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Scranton, Pennsylvania, United States|Warwick, Rhode Island, United States|Anderson, South Carolina, United States|Clinton, South Carolina, United States|Greer, South Carolina, United States|Mt. Pleasant, South Carolina, United States|Spartanburg, South Carolina, United States|Bristol, Tennessee, United States|Nashville, Tennessee, United States|Nashville, Tennessee, United States|Fort Worth, Texas, United States|San Antonio, Texas, United States|Tomball, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States|West Jordan, Utah, United States|Norfolk, Virginia, United States|Williamsburg, Virginia, United States|Winchester, Virginia, United States|Coquitlam, British Columbia, Canada|Mount Pearl, Newfoundland and Labrador, Canada|Truro, Nova Scotia, Canada|Sudbury, Ontario, Canada|Toronto, Ontario, Canada|Sherbrooke, Quebec, Canada|Bayamon, Puerto Rico|San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT01427309"
336,"Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05","Completed","No Results Available","Influenza","Biological: Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)|Biological: non-adjuvanted Quadrivalent Influenza Vaccine (QIV)","San Diego, California, United States|San Gabriel, California, United States|Colorado Springs, Colorado, United States|Melbourne, Florida, United States|Augusta, Kansas, United States|Newton, Kansas, United States|Louisville, Kentucky, United States|Metairie, Louisiana, United States|Bellevue, Nebraska, United States|Binghamton, New York, United States|Dayton, Ohio, United States|Austin, Texas, United States|Fort Worth, Texas, United States|San Angelo, Texas, United States|Tomball, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Espoo, Finland|Helsinki, Finland|Helsinki, Finland|Järvenpää, Finland|Kokkola, Finland|Pori, Finland|Tampere, Finland|Turku, Finland|Vantaa, Finland","https://ClinicalTrials.gov/show/NCT02255409"
337,"Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years","Completed","Has Results","Influenza","Biological: GSK A/turkey H5N1 Influenza vaccine","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00771615"
338,"Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children","Completed","Has Results","Influenza","Biological: Fluarix|Biological: Fluzone","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Dothan, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Conway, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Huntington Beach, California, United States|GSK Investigational Site, Long Beach, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, DeKalb, Illinois, United States|GSK Investigational Site, New Albany, Indiana, United States|GSK Investigational Site, Arkansas City, Kansas, United States|GSK Investigational Site, Newton, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Henderson, Nevada, United States|GSK Investigational Site, Cortland, New York, United States|GSK Investigational Site, Boone, North Carolina, United States|GSK Investigational Site, Cary, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Fargo, North Dakota, United States|GSK Investigational Site, Austintown, Ohio, United States|GSK Investigational Site, Cincinnati, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Dayton, Ohio, United States|GSK Investigational Site, Gresham, Oregon, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Latrobe, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Uniontown, Pennsylvania, United States|GSK Investigational Site, Wexford, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Clarksville, Tennessee, United States|GSK Investigational Site, Jackson, Tennessee, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Bountiful, Utah, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Murray, Utah, United States|GSK Investigational Site, Provo, Utah, United States|GSK Investigational Site, Roy, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, Burke, Virginia, United States|GSK Investigational Site, Pokfulam, Hong Kong|GSK Investigational Site, Shatin, Hong Kong|GSK Investigational Site, Mexico city, Mexico|GSK Investigational Site, Mexico, Mexico|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Bangkok, Thailand","https://ClinicalTrials.gov/show/NCT00764790"
339,"Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age","Completed","Has Results","Influenza","Biological: Flublok|Biological: Afluria","Genova Clinical Research, Tucson, Arizona, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|Meridian Clinical Research, Savannah, Georgia, United States|Heartland Research Associates, LLC, Wichita, Kansas, United States|Benchmark Research, Metairie, Louisiana, United States|Maine Research Associates, LLC, Auburn, Maine, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Regional Clinical Research, Binghamton, New York, United States|Wake Research, Raleigh, North Carolina, United States|Rapid Medical Research, Inc., Cleveland, Ohio, United States|Research Across America, Dallas, Texas, United States|Benchmark Research, Fort Worth, Texas, United States|Benchmark Research, San Angelo, Texas, United States","https://ClinicalTrials.gov/show/NCT01825200"
340,"A Phase 2 Study to Evaluate Immune Responses of FluMist®","Completed","Has Results","Influenza Vaccine","Biological: TIV, Trivalent Inactivated Influenza Virus Vaccine|Biological: FluMist, Influenza Virus Vaccine Live","Harvey Pediatrics, Jonesboro, Arkansas, United States|Arkansas Pediatric Clinic, Little Rock, Arkansas, United States|NuLife Clinical Research, Anaheim, California, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Central Kentucky Research Associates, Lexington, Kentucky, United States|Peak Medical Research, LLC, Owensboro, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Henderson Pediatrics, Henderson, Nevada, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Dayton Clinical Research, Dayton, Ohio, United States|Northeast Cincinnati Pediatric Asso., Inc., Mason, Ohio, United States|Celia Reyes-Acuna, M.D., Corpus Christi, Texas, United States|Allergy Immunology Research Center of North Texas, Dallas, Texas, United States|Healthcare Discoveries, Inc., San Antonio, Texas, United States|Wee Care Pediatrics, Layton, Utah, United States|Bear Care Pediatrics, Ogden, Utah, United States|Advanced Pediatrics, Vienna, Virginia, United States|Pediatrics at the Beach, Virginia Beach, Virginia, United States","https://ClinicalTrials.gov/show/NCT00461981"
341,"Trial to Evaluate the Immunogenicity and Safety of Panblok® (H7 rHA) in Healthy Adults Aged 18 and Older","Completed","Has Results","Influenza","Biological: Panblok|Biological: rHA adjuvant","Coastal Clinical Research, Mobile, Alabama, United States|Avail Clinical Research, DeLand, Florida, United States|Meridian Clinical Research, Savannah, Georgia, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rapid Medical Research, Inc., Cleveland, Ohio, United States|Benchmark Reseach, Austin, Texas, United States|Benchmark Research - Fort Worth, Fort Worth, Texas, United States|Jean Brown Research, Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT02464163"
342,"Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age","Completed","Has Results","Influenza|Fever","Biological: Mammalian cell based flu vaccine|Biological: Egg based flu vaccine","320, Novartis Investigational Site, Mobile, Alabama, United States|312, Novartis Investigational Site, Ponte Vedra, Florida, United States|313, Novartis Investigational Site, Augusta, Kansas, United States|305, Novartis Investigational Site, Newton, Kansas, United States|302, Novartis Investigational Site, Wichita, Kansas, United States|301, Novartis Investigational Site, Wichita, Kansas, United States|311, Novartis Investigational Site, Fremont, Nebraska, United States|308, Novartis Investigational Site, Winston-salem, North Carolina, United States|317, Novartis Investigational Site, Cleveland, Ohio, United States|309, Novartis Investigational Site, Tulsa, Oklahoma, United States|314, Novartis Investigational Site, Warwick, Rhode Island, United States|319, Novartis Investigational Site, Mount Pleasant, South Carolina, United States|310, Novartis Investigational Site, Bristol, Tennessee, United States|318, Novartis Investigational Site, Nashville, Tennessee, United States|304, Novartis Investigational Site, Salt Lake City, Utah, United States|306, Novartis Investigational Site, Salt Lake City, Utah, United States|315, Novartis Investigational Site, Salt Lake, Utah, United States|303, Novartis Investigational Site, South Jordan, Utah, United States|100, Novartis Investigational Site, Westmead, New South Wales, Australia|108, Novartis Investigational Site, Auchenflower, Queensland, Australia|107, Novartis Investigational Site, Sherwood, Queensland, Australia|104, Novartis Investigational Site, North Adelaide, South Australia, Australia|103, Novartis Investigational Site, Carlton, Victoria, Australia|105, Novartis Investigational Site, Subiaco, Western Australia, Australia|151, Novartis Investigational Site, Takapuna, Auckland, New Zealand|150, Novartis Investigational Site, Beckenham, Christchurch, New Zealand|250, Novartis Investigational Site, Muntinlupa City, Alabang, Philippines|251, Novartis Investigational Site, Muntinlupa City, Alabang, Philippines|254, Novartis Investigational Site, Muntinlupa City, Alabang, Philippines|253, Novartis Investigational Site, Manila, Ermita, Philippines|252, Novartis Investigation Site, Manila, Sampaloc, Philippines|201, Novartis Investigational Site, Khon Kaen, Muang, Thailand|200, Novartis Investigational Site, Bangkok, Rajathevi, Thailand|202, Novartis Investigational Site, Bangkoknoi, Siriraj, Thailand","https://ClinicalTrials.gov/show/NCT01857206"
343,"Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok","Completed","No Results Available","Influenza","Biological: Influenza Vaccine, recombinant hemagglutinin, FluBlok","Impact Clinical Trials, Beverly Hills, California, United States|Benchmark Research - Sacramento, Sacramento, California, United States|Benchmark Research - San Francisco, San Francisco, California, United States|University Clinical Research, Inc, Pembroke Pines, Florida, United States|Vince and Associates, Overland Park, Kansas, United States|Kentucky pediatric /Adult Research, Bardstown, Kentucky, United States|Benchmarch Research - New Orleans, Metairie, Louisiana, United States|University of Maryland - Baltimore, Baltimore, Maryland, United States|Saint Louis University, Saint Louis, Missouri, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rochester Medical Center, Rochester, New York, United States|Carolina Medical Trials, Winston-Salem, North Carolina, United States|Sterling Research, Cincinnati, Ohio, United States|Primary Physicians Research - Pediatric Alliance St. Clair, Pittsburgh, Pennsylvania, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Benchmarch Research - Austin, Austin, Texas, United States|Benchmark Research - Fort Worth, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Benchmark Research - San Angelo, San Angelo, Texas, United States|Jean Brown Research, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Marshfield Clinic, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00539981"
344,"Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects","Completed","Has Results","Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)|Biological: Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 2)|Biological: Split, Inactivated, Trivalent Influenza Vaccine (Standard dose)|Biological: Split, Inactivated, Trivalent Influenza Vaccine (High-dose)","Alabaster, Alabama, United States|Mobile, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|San Diego, California, United States|Stanford, Connecticut, United States|Pembroke Pines, Florida, United States|Pinellas Park, Florida, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Wichita, Kansas, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|St. Louis, Missouri, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Allentown, Pennsylvania, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Goose Creek, South Carolina, United States|Fort Worth, Texas, United States|Galveston, Texas, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00551031"
345,"Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59","Completed","No Results Available","Influenza","Biological: MF-59|Biological: A/Anhui/05|Drug: Placebo","Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Mayo Clinic, Rochester - Vaccine Research Group, Rochester, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Duke Translational Medicine Institute - Clinical Vaccine Unit, Durham, North Carolina, United States|Vanderbilt University - Pediatric - Infectious Diseases, Nashville, Tennessee, United States|University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston, Galveston, Texas, United States|Group Health Research Institute - Seattle, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00912496"
346,"Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults","Completed","No Results Available","Influenza","Biological: Influenza Vaccination","Center of Vaccine Development, Univ. of Maryland, Baltimore, Maryland, United States|Passport Health Maryland, Baltimore, Maryland, United States|Mayo Clinic College of Medicine, Rochester, Minnesota, United States|Passport Health New Jersey, Shrewsbury, New Jersey, United States|Rochester Medical Center, Rochester, New York, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00395174"
347,"A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza","Completed","Has Results","Acute, Uncomplicated Human Influenza","Drug: Peramivir|Drug: Placebo","West Alabama Research, Inc., Birmingham, Alabama, United States|Greystone Medical Research, LLC, Birmingham, Alabama, United States|NextCare Institute for Clinical Research, Phoenix, Arizona, United States|Clopton Clinic, Jonesboro, Arkansas, United States|NEA Clinic, Jonesboro, Arkansas, United States|North Central Arkansas Medical Associates, Mountain Home, Arkansas, United States|Impact Clinical Trials, Beverly Hills, California, United States|Medcenter, Carmichael, California, United States|Center for Clinical Trials, LLC, Paramount, California, United States|Coastal Medical Research Group, Inc., San Luis Obispo, California, United States|Alpine Research Center, Boulder, Colorado, United States|1st Allergy and Clinical Research Center, Centennial, Colorado, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|Westside Center for Clinical Research, Jacksonville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|University Clinical Research, Inc., Pembroke Pines, Florida, United States|DMI Research, Inc., Pinellas Park, Florida, United States|Wilker/Powers Center for Clinical Studies, d/b/a ProHealth Clinical Studies, St. Cloud, Florida, United States|Southeast Regional Research Group, Columbus, Georgia, United States|Southeast Regional Research Group, Savannah, Georgia, United States|The Kaufmann Clinic, Inc., Woodstock, Georgia, United States|Idaho Falls Infectious Diseases, Idaho Falls, Idaho, United States|Dr. Arthur Davida, Bloomingdale, Illinois, United States|Investigators Research Group, LLC, Indianapolis, Indiana, United States|Medical Associates Clinic, Dubuque, Iowa, United States|Heart of America Research, Shawnee, Kansas, United States|Kentucky Lung Clinic, Hazard, Kentucky, United States|Gulf Coast Research, LLC, Baton Rouge, Louisiana, United States|Acadia Clinical Research, Bangor, Maine, United States|Clarksburg Medical Center, Clarksburg, Maryland, United States|Miray Medical Center, Brockton, Massachusetts, United States|Detroit Receiving Hospital, UHC 6G, Detroit, Michigan, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|KMED Research, St. Claire Shores, Michigan, United States|Olive Branch Family Medical Center, Olive Branch, Mississippi, United States|Bozeman Urgent Care Center, Bozeman, Montana, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Prairie Fields Family Medicine, P.C., Fremont, Nebraska, United States|Impact Clinical Trials, Las Vegas, Las Vegas, Nevada, United States|United Medical Associates, Johnson City, New York, United States|Twelve Corners Internal Medicine, Rochester, New York, United States|Bland Clinic, Greensboro, North Carolina, United States|Community Medical Associates, LLC, Canfield, Ohio, United States|Advanced Health Care Services, Inc, Thornville, Ohio, United States|Urgent Care of Green County, PLLC, Owasso, Oklahoma, United States|Integrated Medical Research, PC, Ashland, Oregon, United States|Pivotal Clinical Research, LLC, Souderton, Pennsylvania, United States|New England Center for Clinical Research, Inc., Cranston, Rhode Island, United States|Notheast Clinical Research, Cumberland, Rhode Island, United States|Clinical Partners, LLC, Johnston, Rhode Island, United States|Omega Medical Research, Warwick, Rhode Island, United States|Hillcrest Clinical Research, LLC, Simpsonville, South Carolina, United States|Health Concepts, Rapid City, South Dakota, United States|Holston Medical Group, Bristol, Tennessee, United States|DiscoveResearch, Inc., Bryan, Texas, United States|Corpus Christi Family Wellness Center, Research Division, Corpus Christi, Texas, United States|Allergy/Immunology Research Center of North Texas, Dallas, Texas, United States|Towngate Plaza Medical Center, Garland, Texas, United States|West Houston Clinical Research, Houston, Texas, United States|Texas Medical Research Associates, LLC, San Antonio, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc., FirstMed, Salt Lake City, Utah, United States|J. Lewis Research, Inc./Foothill Family Clinic South, Salt Lake City, Utah, United States|J. Lewis Research, Inc./FirstMed East, Salt Lake City, Utah, United States|J. Lewis Research, Inc./Foothill Family Clinic South, Salt Lake City, Utah, United States|Northwest Clinical Research Center, Bellevue, Washington, United States|Dean Medical Center, Oregon, Wisconsin, United States|Pacific Medical Centre Blacktown, Blacktown, New South Wales, Australia|East Sydney Doctors, Darlinghurst, New South Wales, Australia|Symbion Pathology, Hurtsville, New South Wales, Australia|Peninsula Medical Centre, Umina, New South Wales, Australia|Rivercity Private Hospital Specialist, Auchenflower, Queensland, Australia|Caboolture Clinical Research Centre, Caboolture, Queensland, Australia|Peninsula Specialist Centre, Kpparing, Queensland, Australia|Health Services -University of Melbourne, Carlton, Victoria, Australia|Athelstone Medical Clinic, Adelaide, Australia|Trialworks Clinical Research Services, Brisbane, Australia|Dr Doongs Surgery, Burwood, Australia|Holdsworth House Medical Practice, Darlinghurst, Australia|Doctors of Ivanhoe,, Melbourne, Australia|Lung Institute of Western Australia,, Nedlands, Australia|Pitt Street Merrylands Medical Centre, Sydney, Australia|Greenhithe Medical Centre, Auckland, New Zealand|St George's Hospital, Christchurch, New Zealand|Southern Clinical Trials Ltd, Christchurch, New Zealand|Caversham Medical Centre, Dunedin, New Zealand|Bairds Road Family Health Care, Rotorua, New Zealand|Dr. Gillies, Rotorua, New Zealand|Hinemoa House Family Health Centre, Rotorua, New Zealand|Nortje, MD, Goodwood, Capetown, South Africa|Greenbury Medical Centre, Greenbury, Durban, South Africa|Sebastian, MD, Silverglen, Durban, South Africa|Quinta-Research, Bloemfontein, Free State, South Africa|Wilhase, AC, Reigerpark, Gauteg, South Africa|NHC Medical Centre, Bryanston, Gauteng, South Africa|R. Dulabh, MD, Klipspruit West, Gauteng, South Africa|DJW Navorsing, Noordheuwel, Krugersdorp, South Africa|Pillay, MD, Verulam, Kwa Zulu Natal, South Africa|Vawda, Z.FA, Durban, KZ-Natal, South Africa|le Clus, MD, Kempton Park, Pretoria, South Africa|Sunnyside Medi-Clinic, Sunnyside Pretoria, Pretoria, South Africa|Kaapzicht Centre, Cape Town, W. Cape, South Africa|Syzygy SMO Intercare Medical and Dental Centre, Cape Town, W. Cape, South Africa|Clinical Project Research SA (Pty) Ltd., Worcester, W. Cape, South Africa|Dr. van Rensburg, Amanzimtoti, South Africa|Benmed Park Clinic, Benoni, South Africa|Jsha Research, Bloemfontein, South Africa|Armansis Medical Centre, Brits, South Africa|Cape Clinical Trial, Bishop Lavis Day Hospital, Cape town, South Africa|First House, Cape Town, South Africa|Synapta Clinical Research Centre, Durban, South Africa|Dr. Janari, Durban, South Africa|Dr. Makan, Johannesburg, South Africa|Newgate Centre, Johannesburg, South Africa|GCT Trials, Mercantile Hospital no 9, Port Elizabeth, South Africa|Dr. Nel, Pretoria, South Africa|Emmed Research, Pretoria, South Africa|Dr. de Bruin, Pretoria, South Africa|Westmed Clinical Trial Centre, Pretoria West Medicross Building, Pretoria, South Africa|Dr. Fouche, Roodepoort, South Africa|Dr. de Villiers, Scottburgh, South Africa|Dr. Bhorat, Soweto, South Africa|Clinical Projects Research SA Ltd, Worcester, South Africa","https://ClinicalTrials.gov/show/NCT00705406"
348,"H7N9 Mix and Match With MF59 in Healthy Elderly Persons","Completed","No Results Available","Avian Influenza","Drug: MF59|Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013","Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|University of Iowa - Vaccine Research and Education Unit, Iowa City, Iowa, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|Duke Human Vaccine Institute - Duke Clinical Vaccine Unit, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC), Nashville, Tennessee, United States|University of Texas Medical Branch - Sealy Center for Vaccine Development - Clinical Trials Group, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Group Health Research Institute - Seattle - Vaccines and Infectious Diseases, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT02213354"
349,"Sanofi Pasteur, TIV + H1N1, Pediatric Population","Completed","Has Results","Influenza","Biological: Inactivated H1N1 Vaccine|Biological: Trivalent Inactivated Influenza Vaccine","Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases, Atlanta, Georgia, United States|University of Iowa, Iowa City, Iowa, United States|Saint Louis University Hospital - Internal Medicine - Infectious Diseases, Allergy & Immunology, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|The University of Texas Medical Branch, Galveston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00943202"
350,"Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine","Completed","No Results Available","Healthy Volunteers","Biological: BMB72 (actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein)","Massachusetts General Hospital, Boston, Massachusetts, United States","https://ClinicalTrials.gov/show/NCT01311817"
351,"Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years","Completed","Has Results","Influenza","Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted|Biological: Placebo","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Peoria, Illinois, United States|GSK Investigational Site, South Bend, Indiana, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Rockville, Maryland, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Edison, New Jersey, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Spartanburg, South Carolina, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, London, Ontario, Canada|GSK Investigational Site, Sarnia, Ontario, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Woodstock, Ontario, Canada|GSK Investigational Site, Pointe-Claire, Quebec, Canada|GSK Investigational Site, Quebec City, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada|GSK Investigational Site, St-Romuald, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00616928"
352,"DBRCT on the Effect of Grip Strength in Brachial Plexus vs Distal Forearm Nerve Blocks","Completed","No Results Available","Postoperative Mobility","Procedure: Proximal Brachial Plexus vs Distal Forearm Block","University of New Mexico, Albuquerque, New Mexico, United States","https://ClinicalTrials.gov/show/NCT01927289"
353,"Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza","Completed","No Results Available","Influenza","Drug: DAS181 dry powder, formulation F02|Drug: Respitose ML006 (DMV-Fonterra)","Carmichael, California, United States|Chula Vista, California, United States|La Mesa, California, United States|Lincoln, California, United States|Los Angeles, California, United States|Orange, California, United States|Colorado Springs, Colorado, United States|Denver, Colorado, United States|Hialeah, Florida, United States|Miami, Florida, United States|Orlando, Florida, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Boise, Idaho, United States|Covington, Louisiana, United States|Silver Spring, Maryland, United States|North Dartmouth, Massachusetts, United States|Bellevue, Nebraska, United States|Henderson, Nevada, United States|Las Vegas, Nevada, United States|Stony Brook, New York, United States|Canton, Ohio, United States|Dayton, Ohio, United States|Franklin, Ohio, United States|Groveport, Ohio, United States|Miamisburg, Ohio, United States|Oklahoma City, Oklahoma, United States|Tulsa, Oklahoma, United States|Ashland, Oregon, United States|Lansdale, Pennsylvania, United States|Pittsburg, Pennsylvania, United States|Myrtle Beach, South Carolina, United States|Simpsonville, South Carolina, United States|Rapid City, South Dakota, United States|Johnson City, Tennessee, United States|Austin, Texas, United States|Georgetown, Texas, United States|San Antonio, Texas, United States|Salt Lake City, Utah, United States|West Point, Utah, United States|West Valley City, Utah, United States|Richmond, Virginia, United States","https://ClinicalTrials.gov/show/NCT01037205"
354,"Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women","Completed","Has Results","HIV Infections|H1N1 Influenza Virus","Biological: Influenza A (H1N1) monovalent vaccine","Usc La Nichd Crs, Alhambra, California, United States|University of California, UC San Diego CRS, La Jolla, California, United States|Miller Children's Hosp. Long Beach CA NICHD CRS, Long Beach, California, United States|UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States|Univ. of California San Francisco NICHD CRS, San Francisco, California, United States|Univ. of Colorado Denver NICHD CRS, Aurora, Colorado, United States|Washington Hosp. Ctr. NICHD CRS, Washington, District of Columbia, United States|South Florida CDTC Ft Lauderdale NICHD CRS, Fort Lauderdale, Florida, United States|Univ. of Florida Jacksonville NICHD CRS, Jacksonville, Florida, United States|Pediatric Perinatal HIV Clinical Trials Unit CRS, Miami, Florida, United States|USF - Tampa NICHD CRS, Tampa, Florida, United States|Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago, Illinois, United States|Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS, Chicago, Illinois, United States|Tulane Univ. New Orleans NICHD CRS, New Orleans, Louisiana, United States|Johns Hopkins Univ. Baltimore NICHD CRS, Baltimore, Maryland, United States|Children's Hosp. of Boston NICHD CRS, Boston, Massachusetts, United States|Boston Medical Center Ped. HIV Program NICHD CRS, Boston, Massachusetts, United States|WNE Maternal Pediatric Adolescent AIDS CRS, Worcester, Massachusetts, United States|Rutgers - New Jersey Medical School CRS, Newark, New Jersey, United States|Bronx-Lebanon CRS, Bronx, New York, United States|Jacobi Med. Ctr. Bronx NICHD CRS, Bronx, New York, United States|Metropolitan Hosp. NICHD CRS, New York, New York, United States|Columbia IMPAACT CRS, New York, New York, United States|SUNY Stony Brook NICHD CRS, Stony Brook, New York, United States|DUMC Ped. CRS, Durham, North Carolina, United States|The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States|St. Jude Children's Research Hospital CRS, Memphis, Tennessee, United States|Texas Children's Hospital CRS, Houston, Texas, United States|Seattle Children's Research Institute CRS, Seattle, Washington, United States|University of Puerto Rico Pediatric HIV/AIDS Research Program CRS, San Juan, Puerto Rico|San Juan City Hosp. PR NICHD CRS, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT00992017"
355,"Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects","Completed","Has Results","Influenza|Orthomyxoviruses|Myxovirus Infection","Biological: Influenza virus vaccine - cell based (2007-2008 Formulation)|Biological: Influenza virus vaccine - cell-based (2007-2008 Formulation)|Biological: Influenza virus vaccine (2007-2008 Formulation)","Hoover, Alabama, United States|Mobile, Alabama, United States|Tucson, Arizona, United States|Milford, Connecticut, United States|Pinellas Park, Florida, United States|Chicago, Illinois, United States|Wichita, Kansas, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Mt Pleasant, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00845429"
356,"Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years","Completed","Has Results","Influenza","Biological: A/turkey H5N1 vaccine|Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)|Biological: Placebo","GSK Investigational Site, Denver, Colorado, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Kansas City, Missouri, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Winston-Salem, North Carolina, United States|GSK Investigational Site, Bristol, Tennessee, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00719043"
357,"Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth","Completed","Has Results","HIV Infections|H1N1 Influenza Virus","Biological: Influenza A (H1N1) 2009 monovalent vaccine","UAB Pediatric Infectious Diseases CRS, Birmingham, Alabama, United States|Usc La Nichd Crs, Alhambra, California, United States|University of California, UC San Diego CRS, La Jolla, California, United States|Miller Children's Hosp. Long Beach CA NICHD CRS, Long Beach, California, United States|UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States|Univ. of California San Francisco NICHD CRS, San Francisco, California, United States|Harbor UCLA Medical Ctr. NICHD CRS, Torrance, California, United States|Univ. of Colorado Denver NICHD CRS, Aurora, Colorado, United States|Children's National Med. Ctr. Washington DC NICHD CRS, Washington, District of Columbia, United States|Howard Univ. Washington DC NICHD CRS, Washington, District of Columbia, United States|South Florida CDTC Ft Lauderdale NICHD CRS, Fort Lauderdale, Florida, United States|Univ. of Florida Jacksonville NICHD CRS, Jacksonville, Florida, United States|Pediatric Perinatal HIV Clinical Trials Unit CRS, Miami, Florida, United States|USF - Tampa NICHD CRS, Tampa, Florida, United States|Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago, Illinois, United States|Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS, Chicago, Illinois, United States|Univ. of Maryland Baltimore NICHD CRS, Baltimore, Maryland, United States|Johns Hopkins Univ. Baltimore NICHD CRS, Baltimore, Maryland, United States|Children's Hosp. of Boston NICHD CRS, Boston, Massachusetts, United States|Boston Medical Center Ped. HIV Program NICHD CRS, Boston, Massachusetts, United States|WNE Maternal Pediatric Adolescent AIDS CRS, Worcester, Massachusetts, United States|Children's Hospital of Michigan NICHD CRS, Detroit, Michigan, United States|Rutgers - New Jersey Medical School CRS, Newark, New Jersey, United States|Bronx-Lebanon CRS, Bronx, New York, United States|Jacobi Med. Ctr. Bronx NICHD CRS, Bronx, New York, United States|Nyu Ny Nichd Crs, New York, New York, United States|Metropolitan Hosp. NICHD CRS, New York, New York, United States|Columbia IMPAACT CRS, New York, New York, United States|Strong Memorial Hospital Rochester NY NICHD CRS, Rochester, New York, United States|SUNY Stony Brook NICHD CRS, Stony Brook, New York, United States|DUMC Ped. CRS, Durham, North Carolina, United States|The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States|St. Jude Children's Research Hospital CRS, Memphis, Tennessee, United States|Texas Children's Hospital CRS, Houston, Texas, United States|Seattle Children's Research Institute CRS, Seattle, Washington, United States|University of Puerto Rico Pediatric HIV/AIDS Research Program CRS, San Juan, Puerto Rico|San Juan City Hosp. PR NICHD CRS, San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT00992836"
358,"Safety Study to Evaluate FluMist in Immunocompromised Children","Completed","Has Results","Cancer","Biological: FluMist|Biological: Placebo","University of Rochester School of Medicine & Dentistry, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|St. Jude's Children's Research Hospital, Memphis, Tennessee, United States|Vanderbilt University, Nashville, Tennessee, United States|Children's Hospital Regional Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00112112"
359,"Influenza Vaccine Revaccination in Ambulatory Elderly Subjects","Completed","Has Results","Influenza|Orthomyxovirus Infection|Myxovirus Infection","Biological: Influenza Virus Vaccine USP Trivalent Types A and B","Hoover, Alabama, United States|Mobile, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|San Diego, California, United States|Milford, Connecticut, United States|Pembroke Pines, Florida, United States|Pinellas Park, Florida, United States|Chicago, Illinois, United States|Wichita, Kansas, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|St. Louis, Missouri, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Mt. Pleasant, South Carolina, United States|Fort Worth, Texas, United States|Galveston, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00775450"
360,"Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older","Completed","Has Results","Influenza","Biological: GSK2340274A|Biological: GSK2340273A|Biological: Saline placebo","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Meridian, Idaho, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Edison, New Jersey, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Surrey, British Columbia, Canada|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Pointe-Claire, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00985088"
361,"Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age","Completed","Has Results","Influenza","Biological: Influenza A (H5N1) Virus monovalent vaccine|Biological: Saline placebo","GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Newton, Kansas, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Henderson, Nevada, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Coquitlam, British Columbia, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada|GSK Investigational Site, Khon Kaen, Thailand","https://ClinicalTrials.gov/show/NCT01310413"
362,"Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age","Completed","Has Results","Influenza","Biological: GSK2340274A|Biological: GSK2340273A","GSK Investigational Site, Conway, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Frisco, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Arkansas City, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, S. Jordan, Utah, United States|GSK Investigational Site, Coquitlam, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Saint John's, Newfoundland and Labrador, Canada|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Brampton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Newmarket, Ontario, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Quebec City, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00976820"
363,"Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older","Completed","Has Results","Influenza","Biological: GSK2340274A|Biological: GSK2340273A","GSK Investigational Site, Mesa, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, DeLand, Florida, United States|GSK Investigational Site, Delray Beach, Florida, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Columbia, Maryland, United States|GSK Investigational Site, Rockville, Maryland, United States|GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Kansas City, Missouri, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Binghamton, New York, United States|GSK Investigational Site, Camillus, New York, United States|GSK Investigational Site, Winston-Salem, North Carolina, United States|GSK Investigational Site, Willoughby Hills, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States|GSK Investigational Site, Spartanburg, South Carolina, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Wenatchee, Washington, United States|GSK Investigational Site, Coquitlam, British Columbia, Canada|GSK Investigational Site, Bay Roberts, Newfoundland and Labrador, Canada|GSK Investigational Site, Saint John's, Newfoundland and Labrador, Canada|GSK Investigational Site, Brampton, Ontario, Canada|GSK Investigational Site, London, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Gatineau, Quebec, Canada|GSK Investigational Site, Quebec City, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada|GSK Investigational Site, St-Romulad, Quebec, Canada|GSK Investigational Site, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00979602"
364,"A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly","Completed","Has Results","Influenza|Swine-origin A/H1N1 Influenza","Biological: Monovalent Subvirion A/H1N1 influenza vaccine with adjuvant|Biological: Monovalent Subvirion A/H1N1 influenza vaccine|Biological: Normal saline solution","Anaheim, California, United States|Fountain Valley, California, United States|South Miami, Florida, United States|Springfield, Missouri, United States|Rochester, New York, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Grove City, Pennsylvania, United States|Jefferson Hills, Pennsylvania, United States|Warwick, Rhode Island, United States|Jackson, Tennessee, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|Springville, Utah, United States","https://ClinicalTrials.gov/show/NCT00952276"
365,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine","Alabaster, Alabama, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|Pinellas Park, Florida, United States|Chicago, Illinois, United States|Springfield, Missouri, United States|Brooklyn, New York, United States|New York, New York, United States|Bensalem, Pennsylvania, United States|Grove City, Pennsylvania, United States|Johnstown, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Fort Worth, Texas, United States|Galveston, Texas, United States|Layton, Utah, United States|South Jordan, Utah, United States|Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00388583"
366,"Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age","Completed","No Results Available","Influenza","Biological: FluMist","SFBC International, Inc, Miami, Florida, United States|Children's Memorial Hospital, Chicago, Illinois, United States|Kentucky Pediatric / Adult Research, Inc, Bardstown, Kentucky, United States|University of Maryland, School of Medicine, Baltimore, Maryland, United States|Center for Vaccine Development, Saint Louis, Missouri, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Pediatric Clinical Trials International, Columbus, Ohio, United States|Primary Physician's Research Inc., Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center North, Nashville, Tennessee, United States|University of Virginia, Elson Student Health Center, Charlottesville, Virginia, United States|Marshall University Medical Center, Huntington, West Virginia, United States","https://ClinicalTrials.gov/show/NCT00192140"
367,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine|Biological: Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)","Harrisburg, Arkansas, United States|Little Rock, Arkansas, United States|Trumann, Arkansas, United States|Bellflower, California, United States|Downey, California, United States|Fountain Valley, California, United States|Paramount, California, United States|Owensboro, Kentucky, United States|Bossier City, Louisiana, United States|Shreveport, Louisiana, United States|Brainerd, Minnesota, United States|Cleveland, Ohio, United States|Erie, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Wexford, Pennsylvania, United States|Fort Worth, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00391391"
368,"A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years","Completed","Has Results","Influenza|Swine-origin A/H1N1 Influenza","Biological: Monovalent Subvirion A/H1N1 Influenza vaccine|Biological: Normal saline solution (placebo)","Miami Beach, Florida, United States|Marietta, Georgia, United States|Woodstock, Georgia, United States|Crestview Hills, Kentucky, United States|Louisville, Kentucky, United States|Maddisonville, Kentucky, United States|Metairie, Louisiana, United States|Las Vegas, Nevada, United States|Rochester, New York, United States|Hermitage, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Cranston, Rhode Island, United States|Barnwell, South Carolina, United States|Austin, Texas, United States|Fort Worth, Texas, United States|San Angelo, Texas, United States|Orem, Utah, United States|South Jordan, Utah, United States|Springville, Utah, United States","https://ClinicalTrials.gov/show/NCT00952419"
369,"A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly","Completed","Has Results","Influenza|Swine-origin A/H1N1 Influenza","Biological: Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA)|Biological: Monovalent Subvirion A/H1N1 Influenza vaccine (15 µg of HA)|Biological: Monovalent Subvirion A/H1N1 Influenza vaccine (30 µg of HA)|Biological: Normal saline solution (placebo)","Hoover, Alabama, United States|Chandler, Arizona, United States|Phoenix, Arizona, United States|Anaheim, California, United States|South Miami, Florida, United States|Maddisonville, Kentucky, United States|Springfield, Missouri, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Mt. Pleasant, South Carolina, United States|Knoxville, Tennessee, United States|Austin, Texas, United States|Salt Lake City, Utah, United States|Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00953524"
370,"Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: High-Dose Inactivated, Split-Virion Influenza Vaccine|Biological: Inactivated, Split-Virion Influenza Vaccine","Mesa, Arizona, United States|Phoenix, Arizona, United States|Tempe, Arizona, United States|Tucson, Arizona, United States|San Diego, California, United States|Stratford, Connecticut, United States|Clearwater, Florida, United States|Coral Gables, Florida, United States|Orlando, Florida, United States|Pembroke Pines, Florida, United States|Wichita, Kansas, United States|Rockville, Maryland, United States|Rochester, Minnesota, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Endwell, New York, United States|Rochester, New York, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Downington, Pennsylvania, United States|Erie, Pennsylvania, United States|Warwick, Rhode Island, United States|Dallas, Texas, United States|Plano, Texas, United States|West Jordan, Utah, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00391053"
371,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014|Biological: ActHIB|Biological: Pediarix/Infanrix Penta","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Hot Springs, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Madera, California, United States|GSK Investigational Site, Slinas, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Boulder, Colorado, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Plantation, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Oaklawn, Illinois, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, West Desmoines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Jamaica Plain, Massachusetts, United States|GSK Investigational Site, Nies, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, St. Paul, Minnesota, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Clyde, North Carolina, United States|GSK Investigational Site, Deerfield, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Akron, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, North Canton, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Wexford, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Katy, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Ogden, Utah, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Pleasant Gorve, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States|GSK Investigational Site, Madison, Wisconsin, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Mexico city, Mexico|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00345579"
372,"Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine|Biological: ActHIB|Biological: PedvaxHIB|Biological: Pediarix|Biological: Prevnar|Biological: M-M-R II|Biological: Varivax","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Bryant, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, East Artesia, California, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Oakland, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Rolling Hills Estates, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Cocoa Beach, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Rockledge, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Arkansas City, Kansas, United States|GSK Investigational Site, Kansas City, Kansas, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Jamaica Plain, Massachusetts, United States|GSK Investigational Site, Kalamazoo, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Brainerd, Minnesota, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, North Las Vegas, Nevada, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Ithaca, New York, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Stony Brook, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Columbus, Ohio, United States|GSK Investigational Site, Huber Heights, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Gresham, Oregon, United States|GSK Investigational Site, Beaver Falls, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Sellersville, Pennsylvania, United States|GSK Investigational Site, Providence, Rhode Island, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Lexington, South Carolina, United States|GSK Investigational Site, Amarillo, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Temple, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Pleasant Grove, Utah, United States|GSK Investigational Site, Saint George, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, Mechanicsville, Virginia, United States|GSK Investigational Site, Norfolk, Virginia, United States|GSK Investigational Site, Vancouver, Washington, United States|GSK Investigational Site, La Crosse, Wisconsin, United States|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, South Brisbane, Queensland, Australia|GSK Investigational Site, Carlton, Victoria, Australia|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00289783"
373,"PRO#0118: Decitabine Plus Mini Flu-Bu","Completed","No Results Available","Acute Myeloid Leukemia|Myelodysplastic Syndrome","Drug: Decitabine plus Fludarabine and Busulfan","Hackensack University Medical Center - John Theurer Cancer Center, Hackensack, New Jersey, United States","https://ClinicalTrials.gov/show/NCT01455506"
374,"Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: Influenza Virus Vaccine USP Trivalent Types A and B","Hoover, Alabama, United States|Huntsville, Alabama, United States|Mobile, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|San Diego, California, United States|Milford, Connecticut, United States|Melbourne, Florida, United States|Pembroke Pines, Florida, United States|Pinellas Park, Florida, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Iowa City, Iowa, United States|Wichita, Kansas, United States|Lexington, Kentucky, United States|Madisonville, Kentucky, United States|Rockville, Maryland, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|St. Louis, Missouri, United States|Albuquerque, New Mexico, United States|Binghamton, New York, United States|Endwell, New York, United States|Rochester, New York, United States|Rochester, New York, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Allentown, Pennsylvania, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Mt. Pleasant, South Carolina, United States|Nashville, Tennessee, United States|Austin, Texas, United States|Fort Worth, Texas, United States|Fort Worth, Texas, United States|Galveston, Texas, United States|San Angelo, Texas, United States|Salt Lake City, Utah, United States|Salt Lake, Utah, United States|West Jordan, Utah, United States|Seattle, Washington, United States|Marshfield, Wisconsin, United States|Castellana Gardens, Carolina, Puerto Rico|San Juan, Puerto Rico|San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT00772109"
375,"Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study","Completed","No Results Available","Influenza|Severe Acute Respiratory Distress Syndrome|Smallpox|Ebola|Unknown Respiratory Viruses","Drug: Poly-ICLC","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00646152"
376,"Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza","Completed","Has Results","Virus Diseases","Drug: GSK1325756 (Danirixin)|Drug: Placebo To Match GSK1325756|Drug: Oseltamivir Phosphate|Drug: Placebo To Match Oseltamivir Phosphate","GSK Investigational Site, Palmetto Bay, Florida, United States|GSK Investigational Site, Blackfoot, Idaho, United States|GSK Investigational Site, Oklahoma City, Oklahoma, United States|GSK Investigational Site, Medford, Oregon, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Baulkham Hills, New South Wales, Australia|GSK Investigational Site, Brookvale, New South Wales, Australia|GSK Investigational Site, Hinchinbrook, New South Wales, Australia|GSK Investigational Site, Liverpool, New South Wales, Australia|GSK Investigational Site, Browns Plains, Queensland, Australia|GSK Investigational Site, Everton Plaza, Queensland, Australia|GSK Investigational Site, Kedron, Queensland, Australia|GSK Investigational Site, Springfield, Queensland, Australia|GSK Investigational Site, Glenelg East, South Australia, Australia|GSK Investigational Site, Happy Valley, South Australia, Australia|GSK Investigational Site, Berwick, Victoria, Australia|GSK Investigational Site, Lynbrook, Victoria, Australia|GSK Investigational Site, Noble Park, Victoria, Australia|GSK Investigational Site, Pakenham, Victoria, Australia|GSK Investigational Site, Tarneit, Victoria, Australia|GSK Investigational Site, Applecross, Western Australia, Australia|GSK Investigational Site, Baldivis, Western Australia, Australia|GSK Investigational Site, Claremont, Western Australia, Australia|GSK Investigational Site, Morley, Western Australia, Australia|GSK Investigational Site, Yokine, Western Australia, Australia|GSK Investigational Site, Port Elizabeth, Eastern Cape, South Africa|GSK Investigational Site, Johannesburg, Gauteng, South Africa|GSK Investigational Site, Johannesburg, Gauteng, South Africa|GSK Investigational Site, Moloto South, Gauteng, South Africa|GSK Investigational Site, Pretoria, Gauteng, South Africa|GSK Investigational Site, Middelburg, Mpumalanga, South Africa|GSK Investigational Site, Western Cape, Western Province, South Africa|GSK Investigational Site, Reiger Park, South Africa","https://ClinicalTrials.gov/show/NCT02469298"
377,"Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza","Completed","Has Results","Seasonal Influenza|Cough|Sore Throat|Nasal Congestion|Myalgia|Headache|Fatigue","Drug: Peramivir","Dothan, Alabama, United States|Mobile, Alabama, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Fountain Valley, California, United States|Harbor City, California, United States|La Mesa, California, United States|Long Beach, California, United States|Los Angeles, California, United States|Modesto, California, United States|Oceanside, California, United States|Orange, California, United States|Palo Alto, California, United States|Sacramento, California, United States|San Diego, California, United States|San Francisco, California, United States|San Jose, California, United States|Denver, Colorado, United States|Wheat Ridge, Colorado, United States|Washington, District of Columbia, United States|Brandon, Florida, United States|Ft. Lauderdale, Florida, United States|Gainsville, Florida, United States|Ocoee, Florida, United States|Orlando, Florida, United States|West Palm Beach, Florida, United States|Columbus, Georgia, United States|Decatur, Georgia, United States|Honolulu, Hawaii, United States|Idaho Falls, Idaho, United States|Chicago, Illinois, United States|Rock Island, Illinois, United States|Springfield, Illinois, United States|Indianapolis, Indiana, United States|South Bend, Indiana, United States|Topeka, Kansas, United States|Hazard, Kentucky, United States|Natchitoches, Louisiana, United States|Shreveport, Louisiana, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Royal Oak, Michigan, United States|Troy, Michigan, United States|Minneapolis, Minnesota, United States|St. Louis, Missouri, United States|Butte, Montana, United States|Omaha, Nebraska, United States|Englewood, New Jersey, United States|Hackensack, New Jersey, United States|Neptune, New Jersey, United States|New Brunswick, New Jersey, United States|Somers Point, New Jersey, United States|Albuquerque, New Mexico, United States|Albany, New York, United States|Bronx, New York, United States|Brooklyn, New York, United States|Buffalo, New York, United States|Jamaica, New York, United States|New York, New York, United States|Valhalla, New York, United States|Akron, Ohio, United States|Cleveland, Ohio, United States|Lima, Ohio, United States|Toledo, Ohio, United States|Portland, Oregon, United States|Philadelphia, Pennsylvania, United States|Providence, Rhode Island, United States|Charleston, South Carolina, United States|Sioux Falls, South Dakota, United States|Houston, Texas, United States|San Antonio, Texas, United States|Tomball, Texas, United States|Salt Lake City, Utah, United States|Norfolk, Virginia, United States|Salem, Virginia, United States|Bellevue, Washington, United States|Seattle, Washington, United States|Milwaukee, Wisconsin, United States|Brisbane, Queensland, Australia|Cairns, Queensland, Australia|Southport, Queensland, Australia|Clayton, Victoria, Australia|Melbourne, Victoria, Australia|Parkville, Victoria, Australia|Kelowna, British Columbia, Canada|Winnipeg, Manitoba, Canada|Hamilton, Ontario, Canada|Kingston, Ontario, Canada|Ottawa, Ontario, Canada|Toronto, Ontario, Canada|Chicoutimi, Quebec, Canada|Montréal, Quebec, Canada|Sainte-Foy, Quebec, Canada|Sherbrooke, Quebec, Canada|Trois-Rivieres, Quebec, Canada|Saskatoon, Saskatchewan, Canada|Edmonton, Canada|Aguascalientes, AGS, Mexico|Distrito Federal, DF, Mexico|Guadalajara, JAL, Mexico|Zapopan, JAL, Mexico|Monterrey, NL, Mexico|San Luis Potosi, SLP, Mexico|Durango, Mexico|Auckland, Wellington, New Zealand|Christchurch, New Zealand|Hamilton, New Zealand|Tauranga, New Zealand|San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT00957996"
378,"Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines","Completed","Has Results","Rheumatoid Arthritis","Other: Placebo|Biological: Certolizumab pegol","Birmingham, Alabama, United States|Huntsville, Alabama, United States|Tuscaloosa, Alabama, United States|Peoria, Arizona, United States|Scottsdale, Arizona, United States|Tucson, Arizona, United States|Los Angeles, California, United States|Palm Desert, California, United States|Santa Maria, California, United States|Santa Monica, California, United States|Aventura, Florida, United States|Fort Lauderdale, Florida, United States|Melbourne, Florida, United States|Orange Park, Florida, United States|Palm Harbor, Florida, United States|Venice, Florida, United States|Vero Beach, Florida, United States|Zephyrhills, Florida, United States|Idaho Falls, Idaho, United States|Meridian, Idaho, United States|Cedar Rapids, Iowa, United States|Kalamazoo, Michigan, United States|Lansing, Michigan, United States|Hattiesburg, Mississippi, United States|Florissant, Missouri, United States|Reno, Nevada, United States|Brooklyn, New York, United States|Smithtown, New York, United States|Syracuse, New York, United States|Asheville, North Carolina, United States|Charlotte, North Carolina, United States|Middleburg Heights, Ohio, United States|Oklahoma City, Oklahoma, United States|Duncansville, Pennsylvania, United States|Erie, Pennsylvania, United States|West Reading, Pennsylvania, United States|Myrtle Beach, South Carolina, United States|Orangeburg, South Carolina, United States|San Antonio, Texas, United States|Seattle, Washington, United States|Oak Creek, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00993668"
379,"Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age","Completed","Has Results","Influenza","Biological: Flublok Quadrivalent|Biological: Inactivated Influenza Vaccine (IIV4)","Benchmark Research - Sacramento, Sacramento, California, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|Meridian Clinical Research, Savannah, Georgia, United States|Heartland Research Associates, LLC, Wichita, Kansas, United States|Benchmark Research, Metairie, Louisiana, United States|Meridian Research, Bellevue, Nebraska, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Meridian Research, Dakota Dunes, South Dakota, United States|Benchmark Reseach, Austin, Texas, United States|Benchmark Research - Fort Worth, Fort Worth, Texas, United States","https://ClinicalTrials.gov/show/NCT02290509"
380,"A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age","Completed","Has Results","Influenza","Biological: MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]|Biological: Placebo","Coastal Clinic Research, Inc., Mobile, Alabama, United States|Benchmark Research, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research, San Francisco, California, United States|Kentucky Pediatric Research Center, Bardstown, Kentucky, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|Sundance Clinical Research, St. Louis, Missouri, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Clinical Research Center of Nevada, Henderson, Nevada, United States|Rochester Clinical Research Inc., Rochester, New York, United States|Primary Physicians Research, Inc., Pittsburgh, Pennsylvania, United States|Omega Medical Research, Warwick, Rhode Island, United States|Spartanburg Medical Research, Spartanburg, South Carolina, United States|Benchmark Research, Austin, Texas, United States|Benchmark Research Ft. Worth, Ft. Worth, Texas, United States|Benchmark Research San Angelo, San Angelo, Texas, United States","https://ClinicalTrials.gov/show/NCT00946101"
381,"Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults","Completed","No Results Available","Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections","Biological: 30 µg/strain of Quadrivalent VLP Vaccine|Biological: 60 µg/strain of Quadrivalent VLP Vaccine|Biological: FluLaval® Tetra (15 µg/strain)|Biological: Fluzone® High-Dose (60 µg/strain)","Paradigm Research - Redding, Redding, California, United States|Broward Research Group (BRG), Hollywood, Florida, United States|Miami Research Associates (MRA), South Miami, Florida, United States|Meridian Clinical Research - Savannah, Savannah, Georgia, United States|Meridian Clinical Research - Omaha, Omaha, Nebraska, United States|Regional Clinical Research (RCR), Endwell, New York, United States|INC Research Toronto, Toronto, Ontario, Canada|Topstone Research, Toronto, Ontario, Canada|Manna Research, Lévis, Quebec, Canada|Omnispec Clinical Research, Mirabel, Quebec, Canada|Diex Research Montreal, Montreal, Quebec, Canada|McGill University Health Center - Vaccine Study Center (MUHC), Pierrefonds, Quebec, Canada|Diex Research Sherbroooke, Sherbroooke, Quebec, Canada|Équipe de recherche en vaccination du CHU de Québec-Université Laval (CHU), Quebec, Canada|Centre de Recherche St-Louis, Quebec, Canada","https://ClinicalTrials.gov/show/NCT02831751"
382,"Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants","Completed","Has Results","Haemophilus Influenzae Type b","Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)|Biological: ActHIB™|Biological: Pentacel™|Biological: Pediarix™|Biological: Prevnar 13™|Biological: Rotarix™|Biological: Engerix™-B|Biological: Infanrix™","GSK Investigational Site, Dothan, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Antioch, California, United States|GSK Investigational Site, Daly City, California, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fremont, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Hayward, California, United States|GSK Investigational Site, Huntington Beach, California, United States|GSK Investigational Site, Oakland, California, United States|GSK Investigational Site, Redwood City, California, United States|GSK Investigational Site, Roseville, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Jose, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Santa Rosa, California, United States|GSK Investigational Site, Vallejo, California, United States|GSK Investigational Site, Walnut Creek, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Boulder, Colorado, United States|GSK Investigational Site, Colorado Springs, Colorado, United States|GSK Investigational Site, Orange City, Florida, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Woodstock, Georgia, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Waipio, Hawaii, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Mineola, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Utica, New York, United States|GSK Investigational Site, Fargo, North Dakota, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cincinnati, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Dayton, Ohio, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Hermitage, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Amarillo, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Sugar Land, Texas, United States|GSK Investigational Site, Bountiful, Utah, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Roy, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, Syracuse, Utah, United States|GSK Investigational Site, Madison, Wisconsin, United States|GSK Investigational Site, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01000974"
383,"Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults","Completed","No Results Available","Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections","Biological: 15 µg/strain of Quadrivalent VLP Vaccine|Biological: 30 µg/strain of Quadrivalent VLP Vaccine|Biological: 15 µg/strain of the licensed quadrivalent vaccine","Broward Research Group (BRG), Hollywood, Florida, United States|Miami Research Associates (MRA), South Miami, Florida, United States|Regional Clinical Research (RCR), Endwell, New York, United States|Topstone Research, Toronto, Ontario, Canada|Diex Research Montreal, Montreal, Quebec, Canada|McGill University Health Center - Vaccine Study Center (MUHC), Pierrefonds, Quebec, Canada|Diex Research Sherbroooke, Sherbrooke, Quebec, Canada|Équipe de recherche en vaccination du CHU de Québec-Université Laval (CHU), Quebec, Canada|Centre de Recherche St-Louis, Quebec, Canada","https://ClinicalTrials.gov/show/NCT02768805"
384,"Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.","Completed","Has Results","PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE","Biological: 13-valent pneumococcal conjugate vaccine|Biological: Seasonal Inactivated Influenza Vaccine|Other: Placebo","Achieve Clinical Research, LLC, Birmingham, Alabama, United States|Optimal Research (Formerly Accelovance), Huntsville, Alabama, United States|Radiant Research, Inc., Scottsdale, Arizona, United States|Kaiser Permanente Vaccine Study Center, Oakland, California, United States|Kaiser Permanante South. Sacramento, Sacramento, California, United States|Benchmark Research, San Francisco, California, United States|Kaiser Pemanente Santa Clara, Santa Clara, California, United States|Avail Clinical Research, LLC, DeLand, Florida, United States|Westside Center for Clinical Research, Jacksonville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Radiant Research, Inc., Pinellas Park, Florida, United States|Meridian Clinical Research, Savannah, Georgia, United States|Optimal Research, LLC, Mishawaka, Indiana, United States|Clinical Research Advantage, Inc/Ridge Family Practice, Council Bluffs, Iowa, United States|Johnson County Clin-Trials, Inc., Lenexa, Kansas, United States|Benchmark Research, Metairie, Louisiana, United States|Meridian Clinical Research, Bellevue, Nebraska, United States|Meridian Clinical Research, Norfolk, Nebraska, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Clinical Research Advantage, Inc., Las Vegas, Nevada, United States|United Medical Associates, Binghamton, New York, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|PMG Research of Raleigh, LLC d/b/a PMG Research of Cary, Cary, North Carolina, United States|PharmQuest, Greensboro, North Carolina, United States|PMG Research of Hickory, LLC, Hickory, North Carolina, United States|Clinical Trials of America, Inc., Winston-Salem, North Carolina, United States|PMG Research of Winston-Salem, Winston-Salem, North Carolina, United States|Radiant Research, Inc, Columbus, Ohio, United States|Prestige Clinical Research, Franklin, Ohio, United States|Preferred Primary Care Physicians, Inc., Carnegie, Pennsylvania, United States|Brandywine Clinical Research, Downingtown, Pennsylvania, United States|Omega Medical Research, Warwick, Rhode Island, United States|PMG Research of Charleston, Mt. Pleasant, South Carolina, United States|Internal Medicine and Pediatric Associates of Bristol, PC, Bristol, Tennessee, United States|Volunteer Research Group, Knoxville, Tennessee, United States|Benchmark Research, Austin, Texas, United States|Benchmark Research, Fort Worth, Texas, United States|Diagnostics Research Group, San Antonio, Texas, United States|Radiant Research, Inc., Murray, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Jordan River Family Medicine, South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT02124161"
385,"Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults","Completed","Has Results","Acellular Pertussis|Diphtheria|Tetanus","Biological: Fluarix®|Biological: Boostrix®","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Chandler, Arizona, United States|GSK Investigational Site, Mesa, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Inverness, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Peoria, Illinois, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Bristol, Tennessee, United States|GSK Investigational Site, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00385255"
386,"A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo","Completed","Has Results","Rheumatoid Arthritis","Drug: CP-690,550|Drug: placebo","Pfizer Investigational Site, Gilbert, Arizona, United States|Pfizer Investigational Site, Paradise Valley, Arizona, United States|Pfizer Investigational Site, Jonesboro, Arkansas, United States|Pfizer Investigational Site, Fair Oaks, California, United States|Pfizer Investigational Site, Los Angeles, California, United States|Pfizer Investigational Site, Roseville, California, United States|Pfizer Investigational Site, Upland, California, United States|Pfizer Investigational Site, Boulder, Colorado, United States|Pfizer Investigational Site, Trumbull, Connecticut, United States|Pfizer Investigational Site, Jacksonville, Florida, United States|Pfizer Investigational Site, Naples, Florida, United States|Pfizer Investigational Site, New Port Richey, Florida, United States|Pfizer Investigational Site, Port Richey, Florida, United States|Pfizer Investigational Site, Tampa, Florida, United States|Pfizer Investigational Site, Zephyrhills, Florida, United States|Pfizer Investigational Site, Morton Grove, Illinois, United States|Pfizer Investigational Site, Rockford, Illinois, United States|Pfizer Investigational Site, Vernon Hills, Illinois, United States|Pfizer Investigational Site, Wichita, Kansas, United States|Pfizer Investigational Site, Lexington, Kentucky, United States|Pfizer Investigational Site, Cumberland, Maryland, United States|Pfizer Investigational Site, Leominster, Massachusetts, United States|Pfizer Investigational Site, Worcester, Massachusetts, United States|Pfizer Investigational Site, Worcester, Massachusetts, United States|Pfizer Investigational Site, Bingham Farms, Michigan, United States|Pfizer Investigational Site, Edina, Minnesota, United States|Pfizer Investigational Site, Columbia, Missouri, United States|Pfizer Investigational Site, Columbia, Missouri, United States|Pfizer Investigational Site, Lebanon, New Hampshire, United States|Pfizer Investigational Site, Albany, New York, United States|Pfizer Investigational Site, Binghamton, New York, United States|Pfizer Investigational Site, Olean, New York, United States|Pfizer Investigational Site, Rochester, New York, United States|Pfizer Investigational Site, Charlotte, North Carolina, United States|Pfizer Investigational Site, Rocky Mount, North Carolina, United States|Pfizer Investigational Site, Minot, North Dakota, United States|Pfizer Investigational Site, Dayton, Ohio, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, United States|Pfizer Investigational Site, Bethlehem, Pennsylvania, United States|Pfizer Investigational Site, Duncansville, Pennsylvania, United States|Pfizer Investigational Site, Wyomissing, Pennsylvania, United States|Pfizer Investigational Site, Greenville, South Carolina, United States|Pfizer Investigational Site, Knoxville, Tennessee, United States|Pfizer Investigational Site, Austin, Texas, United States|Pfizer Investigational Site, Dallas, Texas, United States|Pfizer Investigational Site, Mesquite, Texas, United States|Pfizer Investigational Site, Seattle, Washington, United States|Pfizer Investigational Site, Seattle, Washington, United States|Pfizer Investigational Site, Tacoma, Washington, United States|Pfizer Investigational Site, Vancouver, Washington, United States|Pfizer Investigational Site, Clarksburg, West Virginia, United States|Pfizer Investigational Site, Cieszyn, Poland|Pfizer Investigational Site, Koscian, Poland|Pfizer Investigational Site, Poznan, Poland|Pfizer Investigational Site, Torun, Poland|Pfizer Investigational Site, Warszawa, Poland|Pfizer Investigational Site, Wroclaw, Poland","https://ClinicalTrials.gov/show/NCT01359150"
387,"Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older","Completed","Has Results","Herpes Zoster","Biological: Herpes Zoster vaccine GSK 1437173A|Biological: GSK Biologicals' quadrivalent seasonal influenza vaccine FLU-D-QIV GSK2321138A","GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Brampton, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Weinheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Floersheim, Hessen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Goch, Nordrhein-Westfalen, Germany|GSK Investigational Site, Dippoldiswalde, Sachsen, Germany|GSK Investigational Site, Freiberg, Sachsen, Germany|GSK Investigational Site, Freital, Sachsen, Germany|GSK Investigational Site, Luebeck, Schleswig-Holstein, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany","https://ClinicalTrials.gov/show/NCT01954251"
388,"Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)","Completed","Has Results","Relapsing Multiple Sclerosis","Drug: BIIB017|Drug: naproxen","Research Site, Gilbert, Arizona, United States|Research Site, Phoenix, Arizona, United States|Research Site, Phoenix, Arizona, United States|Research Site, Tucson, Arizona, United States|Research Site, Boulder, Colorado, United States|Research Site, Fort Collins, Colorado, United States|Research Site, Dover, Delaware, United States|Research Site, Newark, Delaware, United States|Research Site, Jacksonville, Florida, United States|Research Site, Melbourne, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Kansas City, Kansas, United States|Research Site, Lexington, Kentucky, United States|Research Site, Louisville, Kentucky, United States|Research Site, Boston, Massachusetts, United States|Research Site, Lexington, Massachusetts, United States|Research Site, Worcester, Massachusetts, United States|Research Site, Detroit, Michigan, United States|Research Site, Chesterfield, Missouri, United States|Research Site, St. Louis, Missouri, United States|Research Site, Great Falls, Montana, United States|Research Site, Lincoln, Nebraska, United States|Research Site, Latham, New York, United States|Research Site, Plainview, New York, United States|Research Site, Asheville, North Carolina, United States|Research Site, Akron, Ohio, United States|Research Site, Dayton, Ohio, United States|Research Site, Uniontown, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Portland, Oregon, United States|Research Site, Greenville, South Carolina, United States|Research Site, Franklin, Tennessee, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Salt Lake City, Utah, United States|Research Site, Newport News, Virginia, United States|Research Site, Roanoke, Virginia, United States|Research Site, Spokane, Washington, United States","https://ClinicalTrials.gov/show/NCT01939002"
389,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014)|Biological: PedvaxHIB|Biological: Prevnar|Biological: M-M-R II|Biological: Varivax","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Madera, California, United States|GSK Investigational Site, Slinas, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Boulder, Colorado, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Plantation, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, West Desmoines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Nies, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, St. Paul, Minnesota, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Ithaca, New York, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, North Canton, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Wexford, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Ogden, Utah, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Pleasant Gorve, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States|GSK Investigational Site, Madison, Wisconsin, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Mexico city, Mexico|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00345683"
390,"Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB","Completed","Has Results","Neisseria Meningitidis|Haemophilus Influenzae Type b","Biological: MenHibrix (Hib-MenCY-TT)|Biological: Hib conjugate vaccine (ActHIB)","GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Woodstock, Georgia, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Pittsford, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00359983"
391,"Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age","Completed","Has Results","Neisseria Meningitidis|Haemophilus Influenzae Type b","Biological: Hib-MenCY-TT (MenHibrix®)|Biological: Pediarix®|Biological: Rotarix®|Biological: Prevnar 13®|Biological: PedvaxHIB®|Biological: Havrix®","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Huntington Beach, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Pleasanton, California, United States|GSK Investigational Site, Roseville, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Jose, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Walnut Creek, California, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Woburn, Massachusetts, United States|GSK Investigational Site, Niles, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Dayton, Ohio, United States|GSK Investigational Site, Hermitage, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Murray, Utah, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Roy, Utah, United States|GSK Investigational Site, Syracuse, Utah, United States","https://ClinicalTrials.gov/show/NCT01978093"
392,"Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine|Biological: ActHIB|Biological: Pediarix|Biological: Prevnar|Biological: Menomune","GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Centennial, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, New Bedford, Massachusetts, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, University Heights, Ohio, United States|GSK Investigational Site, Beaver Falls, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Norristown, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Rydal, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT00129129"
393,"A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children","Completed","Has Results","Healthy","Biological: Trivalent influenza virus vaccine live, intranasal","Little Rock Allergy & Asthma Clinic, PA, Little Rock, Arkansas, United States|Pediatric and Adolescent Medicine, PA (PAMPA), Marietta, Georgia, United States|Kentucky Pediatrics/Adult Research, Bardstown, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Health Sciences Research Center, Cortland, New York, United States|Health Sciences Research Center, Elmira, New York, United States|Regional Clinical Research Inc., Endwell, New York, United States|Grand Prairie Pediatrics & Allergy Clinic, Oklahoma City, Oklahoma, United States|Primary Physicians Research , Inc, Pittsburgh, Pennsylvania, United States|Med-Pro Research Inc., Houston, Texas, United States|Central Texas Health Research, New Braunfels, Texas, United States|Benchmark Research, San Angelo, Texas, United States|Wee Care Pediatrics, Layton, Utah, United States|Utah Valley Pediatrics, Provo, Utah, United States|PI-Coor Clinical Research, LLC, Burke, Virginia, United States|Advanced Pediatrics, Vienna, Virginia, United States","https://ClinicalTrials.gov/show/NCT00344305"
394,"A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children","Completed","Has Results","Healthy or Stable Chronic Illness","Biological: Q/LAIV (MEDI3250)|Biological: FluMist/B/Yamagata|Biological: FluMist/B/Victoria","Research Site, Birmingham, Alabama, United States|Research Site, Mobile, Alabama, United States|Research Site, Tucson, Arizona, United States|Research Site, Bentonville, Arkansas, United States|Research Site, Benton, Arkansas, United States|Research Site, Fayetteville, Arkansas, United States|Research Site, Jonesboro, Arkansas, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Anaheim, California, United States|Research Site, Fountain Valley, California, United States|Research Site, Fresno, California, United States|Research Site, Long Beach, California, United States|Research Site, Paramount, California, United States|Research Site, Sacramento, California, United States|Research Site, San Francisco, California, United States|Research Site, West Covina, California, United States|Research Site, Wilmington, Delaware, United States|Research Site, Boca Raton, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Ponte Vedra, Florida, United States|Research Site, South Miami, Florida, United States|Research Site, St. Petersburg, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Dalton, Georgia, United States|Research Site, Marietta, Georgia, United States|Research Site, Woodstock, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Dekalb, Illinois, United States|Research Site, Newton, Kansas, United States|Research Site, Overland Park, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Bardstown, Kentucky, United States|Research Site, Lexington, Kentucky, United States|Research Site, Metairie, Louisiana, United States|Research Site, Kalamazoo, Michigan, United States|Research Site, Niles, Michigan, United States|Research Site, Stevensville, Michigan, United States|Research Site, Plymouth, Minnesota, United States|Research Site, St. Paul, Minnesota, United States|Research Site, Kansas City, Missouri, United States|Research Site, St. Louis, Missouri, United States|Research Site, St. Louis, Missouri, United States|Research Site, Omaha, Nebraska, United States|Research Site, Omaha, Nebraska, United States|Research Site, Papillion, Nebraska, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Lebanon, New Hampshire, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Binghamton, New York, United States|Research Site, Brooklyn, New York, United States|Research Site, Mineola, New York, United States|Research Site, Rochester, New York, United States|Research Site, Rochester, New York, United States|Research Site, Asheboro, North Carolina, United States|Research Site, Boone, North Carolina, United States|Research Site, Clyde, North Carolina, United States|Research Site, Mount Pleasant, North Carolina, United States|Research Site, Raleigh, North Carolina, United States|Research Site, Raleigh, North Carolina, United States|Research Site, Winston-Salem, North Carolina, United States|Research Site, Bismark, North Dakota, United States|Research Site, Fargo, North Dakota, United States|Research Site, Akron, Ohio, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Dayton, Ohio, United States|Research Site, Huber Heights, Ohio, United States|Research Site, Norman, Oklahoma, United States|Research Site, Yukon, Oklahoma, United States|Research Site, Altoona, Pennsylvania, United States|Research Site, Erie, Pennsylvania, United States|Research Site, Greenville, Pennsylvania, United States|Research Site, Harleysville, Pennsylvania, United States|Research Site, Hermitage, Pennsylvania, United States|Research Site, Latrobe, Pennsylvania, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Scotland, Pennsylvania, United States|Research Site, Sellersville, Pennsylvania, United States|Research Site, Charleston, South Carolina, United States|Research Site, Charleston, South Carolina, United States|Research Site, Mt. Pleasant, South Carolina, United States|Research Site, Bristol, Tennessee, United States|Research Site, Clarksville, Tennessee, United States|Research Site, Kingsport, Tennessee, United States|Research Site, Nashville, Tennessee, United States|Research Site, Arlington, Texas, United States|Research Site, Ft. Worth, Texas, United States|Research Site, Ft. Worth, Texas, United States|Research Site, Longview, Texas, United States|Research Site, New Branfels, Texas, United States|Research Site, Sugarland, Texas, United States|Research Site, Draper, Utah, United States|Research Site, Layton, Utah, United States|Research Site, Orem, Utah, United States|Research Site, Roy, Utah, United States|Research Site, Salt Lake City, Utah, United States|Research Site, South Jordan, Utah, United States|Research Site, Syracuse, Utah, United States|Research Site, Burke, Virginia, United States|Research Site, Charlottesville, Virginia, United States|Research Site, Vienna, Virginia, United States|Research Site, Virginia Beach, Virginia, United States|Research Site, Huntington, West Virginia, United States|Research Site, Franklin, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01091246"
395,"Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects","Completed","Has Results","Obesity","Drug: Oseltamivir","TKL Research, Paramaus, New Jersey, United States","https://ClinicalTrials.gov/show/NCT01179919"
396,"Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD)","Completed","Has Results","Critically Ill Renal Failure Requiring CVVHD and Oseltamivir|Critically Ill Requiring ECMO and Oseltamivir","Procedure: pharmacokinetic blood sampling|Procedure: pharmacokinetic blood and dialysate sampling","University of Michigan Hospital, Ann Arbor, Michigan, United States","https://ClinicalTrials.gov/show/NCT01048879"
397,"Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine","Completed","No Results Available","Diphtheria|Tetanus|Whooping Cough|Polio|Haemophilus Influenzae Type b","Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)|Biological: Pentacel: DTaP-IPV/Hib","Fayetteville, AR 72703, Arkansas, United States|Jonesboro, AR 72401, Arkansas, United States|Little Rock, AR 72211, Arkansas, United States|Fountain Valley, CA 92708, California, United States|Englewood, CO 80112, Colorado, United States|Norwich, CT 06360, Connecticut, United States|Orlando, FL 32856, Florida, United States|Marietta, GA 30062, Georgia, United States|Chicago, IL 60614, Illinois, United States|Bardstown, KY 40004, Kentucky, United States|Bossier City, LA 71111, Louisiana, United States|Bridgeton, MO 63044, Missouri, United States|Rochester, NY 14620, New York, United States|Chapel Hill, NC 27514, North Carolina, United States|Portland, OR 97201, Oregon, United States|Norristown, PA 19401, Pennsylvania, United States|Pittsburgh, PA 15213, Pennsylvania, United States|Pittsburgh, PA 15241, Pennsylvania, United States|Kingsport, TN 37664, Tennessee, United States|Austin, TX 78758, Texas, United States|Fort Worth, TX 76107, Texas, United States|San Antonio, TX 78205, Texas, United States|Provo, UT 84604, Utah, United States|Spokane, WA 99220, Washington, United States|LaCrosse, WI 54601, Wisconsin, United States|Marshfield, WI 54449, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00662870"
398,"University of Wisconsin Meditation & Exercise Cold Study","Completed","Has Results","Acute Respiratory Infection","Other: Mindfulness Meditation|Other: Exercise","University of Wisconsin Department of Family Medicine, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01654289"
399,"A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age","Completed","Has Results","Healthy or Stable Underlying Chronic Medical Condition","Biological: Q/LAIV (MEDI3250)|Biological: FluMist/B/Yamagata|Biological: FluMist/B/Victoria","Benchmark Research, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research, San Francisco, California, United States|University Clinical Research-Deland, LLC, Deland, Florida, United States|Pharmax Research Clinic, Inc, Miami, Florida, United States|University Clinical Research, Inc, Pembroke Pines, Florida, United States|Miami Research Associates, South Miami, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Vince and Associates Clinical Research, Overland Park, Kansas, United States|Kentucky Pediatric / Adult Research, Bardstown, Kentucky, United States|The Center for Pharmaceutical Research, PC, Kansas City, Missouri, United States|Sundance Clinical Research, St. Louis, Missouri, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|Clinical Research Associates, Inc, Nashville, Tennessee, United States|Benchmark Research, Austin, Texas, United States|Benchmark Research, Ft. Worth, Texas, United States|Advanced Clinical Research, West Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00860067"
400,"Meditation and Exercise for Prevention of Acute Respiratory Infection","Completed","No Results Available","Acute Respiratory Infection","Behavioral: Meditation|Behavioral: Exercise","University of Wisconsin, Madison, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT01057771"
401,"Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants","Completed","Has Results","Poliomyelitis|Diphtheria|Haemophilus Influenzae Type b|Tetanus|Acellular Pertussis|Hepatitis B","Biological: Infanrix hexa|Biological: Pediarix|Biological: ActHIB|Biological: Pentacel|Biological: Engerix-B|Biological: Infanrix|Biological: Hiberix|Biological: Prevnar13|Biological: Rotarix","GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Daly City, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Hayward, California, United States|GSK Investigational Site, Oakland, California, United States|GSK Investigational Site, Pleasanton, California, United States|GSK Investigational Site, Roseville, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Jose, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Walnut Creek, California, United States|GSK Investigational Site, Colorado Springs, Colorado, United States|GSK Investigational Site, Altamonte Springs, Florida, United States|GSK Investigational Site, Orange City, Florida, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Woodstock, Georgia, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Augusta, Kansas, United States|GSK Investigational Site, Newton, Kansas, United States|GSK Investigational Site, Topeka, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Nicholasville, Kentucky, United States|GSK Investigational Site, Columbia, Maryland, United States|GSK Investigational Site, Kansas City, Missouri, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Dayton, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Sellersville, Pennsylvania, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Payson, Utah, United States|GSK Investigational Site, Provo, Utah, United States|GSK Investigational Site, Saint George, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Ellensburg, Washington, United States","https://ClinicalTrials.gov/show/NCT02096263"
402,"Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age","Completed","Has Results","Meningitis|Meningococcal Infection|Diphtheria|Tetanus|Pertussis|Haemophilus Influenzae Serotype b (Hib)","Biological: Meningococcal polysaccharide diphtheria toxoid conjugate|Biological: Meningococcal polysaccharide diphtheria toxoid conjugate + Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed|Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate","Birmingham, Alabama, United States|Pinson, Alabama, United States|Tucson, Arizona, United States|Fayetteville, Arkansas, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Chino, California, United States|Downey, California, United States|La Puente, California, United States|Lakewood, California, United States|Paramount, California, United States|Norwich, Connecticut, United States|Marietta, Georgia, United States|Woodstock, Georgia, United States|Dekalb, Illinois, United States|Indianapolis, Indiana, United States|Bossier City, Louisiana, United States|Woburn, Massachusetts, United States|Worcester, Massachusetts, United States|Bridgeton, Missouri, United States|Kansas City, Missouri, United States|Elkhorn, Nebraska, United States|Lincoln, Nebraska, United States|Lincoln, Nebraska, United States|Omaha, Nebraska, United States|Clyde, North Carolina, United States|Fargo, North Dakota, United States|Cincinnati, Ohio, United States|Fairfield, Ohio, United States|Huber Heights, Ohio, United States|Kettering, Ohio, United States|Tulsa, Oklahoma, United States|Erie, Pennsylvania, United States|Harleysville, Pennsylvania, United States|Hermitage, Pennsylvania, United States|Scranton, Pennsylvania, United States|Sellersville, Pennsylvania, United States|Jackson, Tennessee, United States|Kingsport, Tennessee, United States|Austin, Texas, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Hurst, Texas, United States|San Antonio, Texas, United States|Layton, Utah, United States|Layton, Utah, United States|Murray, Utah, United States|Orem, Utah, United States|Payson, Utah, United States|Roy, Utah, United States|Spanish Fork, Utah, United States|Syracuse, Utah, United States|Midlothian, Virginia, United States|Spokane, Washington, United States|Spokane, Washington, United States|Ponce, Puerto Rico|San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT01659996"
403,"GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)","Completed","No Results Available","Amyotrophic Lateral Sclerosis","Drug: GM604|Drug: Placebo comparator","Massachusetts General Hospital, Boston, Massachusetts, United States|Columbia Medical Center NY, New York, New York, United States","https://ClinicalTrials.gov/show/NCT01854294"
404,"Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™","Completed","Has Results","Diphtheria|Tetanus|Haemophilus Infection|Pertussis|Polio","Biological: Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®","Montgomery, Alabama, United States|Fayetteville, Arkansas, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Fountain Valley, California, United States|Oakland, California, United States|Rolling Hills Estate, California, United States|Norwich, Connecticut, United States|Bardstown, Kentucky, United States|Louisville, Kentucky, United States|Boston, Massachusetts, United States|Kansas City, Missouri, United States|Brooklyn, New York, United States|Norristown, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Austin, Texas, United States|Fort Worth, Texas, United States|San Antonio, Texas, United States|San Antonio, Texas, United States|Layton, Utah, United States|Spokane, Washington, United States|Vancouver, Washington, United States|Lacrosse, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00772928"
405,"Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™","Completed","Has Results","Diphtheria|Tetanus|Pertussis|Polio|Haemophilus Infection","Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)","Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Oakland, California, United States|Torrance, California, United States|Orlando, Florida, United States|Atlanta, Georgia, United States|Boston, Massachusetts, United States|Woburn, Massachusetts, United States|Omaha, Nebraska, United States|Albany, New York, United States|Rochester, New York, United States|Chapel Hill, North Carolina, United States|Sylva, North Carolina, United States|Pittsburgh, Pennsylvania, United States|Nashville, Tennessee, United States|San Antonio, Texas, United States|Layton, Utah, United States|Vancouver, Washington, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00802867"
406,"Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia","Completed","Has Results","Bacterial Pneumonia","Drug: Ceftaroline fosamil for Injection|Drug: IV Ceftriaxone|Drug: Placebo|Drug: Clarithromycin","Investigational site, Los Angeles, California, United States|Investigational Site, Pasadena, California, United States|Investigational Site, Sacramento, California, United States|Investigational Site, San Diego, California, United States|Investigational Site, Orlando, Florida, United States|Investigational Site, Fort Gordon, Georgia, United States|Investigational Site, Peoria, Illinois, United States|Investigational Site, Baltimore, Maryland, United States|Investigational site, Minneapolis, Minnesota, United States|Investigational Site, Butte, Montana, United States|Investigational Site, Akron, Ohio, United States|Investigational Site, Houston, Texas, United States|Investigational Site, Buenos Aires, C.a.b.a., Argentina|Investigational Site, San Miguel de Tucuman, Tucuman, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Vicente Lopez, Argentina|Investigational Site, Vienna, Austria|Investigational Site, Wien, Austria|Investigational Site, Goiania, G.o., Brazil|Investigational Site, Porto Alegre, RS, Brazil|Investigational Site, Porto Alegre, RS, Brazil|Investigational Site, Sao Jose do Rio Preto, SP, Brazil|Investigational Site 1, Belo Horizonte MG, Brazil|Investigational Site 2, Belo Horizonte, Brazil|Investigational Site, Campinas, Brazil|Investigational Site, Curitiba-PR, Brazil|Investigational Site, Juiz de Fora, Brazil|Investigational site, Porto Alegre, Brazil|Investigational Site, Sao Paolo, Brazil|Investigational Site, Sao Paolo, Brazil|Investigational Site, Burgas, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Varna, Bulgaria|Investigational Site, Tallinn, Estonia|Investigational Site, Tallinn, Estonia|Investigational Site, Tartu, Estonia|Investigational Site, Annecy, France|Investigational Site, Argenteuil, France|Investigational Site, Paris, France|Investigational Site, Paris, France|Investigational Site, Paris, France|Investigational Site, Tbilisi, Georgia|Investigational Site, Tbilisi, Georgia|Investigational Site, Lindenberger, Berlin, Germany|Investigational Site, Berlin, Germany|Investigational Site, Bochum, Germany|Investigational Site, Bochum, Germany|Investigational Site, Erfurt, Germany|Investigational Site, Heppenheim, Germany|Investigational Site, Lich, Germany|Investigational Site, Lubeck, Germany|Investigational Site, Luedenscheid, Germany|Investigational Site, Paderborn, Germany|Investigational Site, Schkeuditz, Germany|Investigational Site, Ulm, Germany|Investigational Site, Wiesbaden, Germany|Investigational Site, Tatabanya, Szanatorium, Hungary|Investigational Site, Budapest, Hungary|Investigational Site, Matrahaza, Hungary|Investigational Site, Miskolc, Hungary|Investigational Site, Pecs, Hungary|Investigational Site, Sopron, Hungary|Investigational Site, Tatabanya, Hungary|Investigational Site, Torokbalint, Hungary|Investigational Site, Vellore, Tamilnadu, India|Investigational Site, Kaunas, Lithuania|Investigational Site, Kaunas, Lithuania|Investigational Site, Klaipeda, Lithuania|Investigational Site, Klaipeda, Lithuania|Investigational Site, Siauliai, Lithuania|Investigational Site, Vilnius, Lithuania|Investigational Site, Johor Bahru, Johor, Malaysia|Inestigational Site, Cheras, Kuala Lumpur, Malaysia|Investigational Site, Georgetown, Penang, Malaysia|Investigational Site, Kedah, Malaysia|Investigational Site, Kuala Lumpur, Malaysia|Investigational Site, Bedzin, Poland|Investigational Site, Brzesku, Poland|Investigational Site, Bytom, Poland|Investigational Site, Chodziez, Poland|Investigational Site, Czestochowa, Poland|Investigational Site, Katowice-Ochojec, Poland|Investigational Site, Krakow, Poland|Investigational Site, Lublin, Poland|Investigational Site, Lublin, Poland|Investigational Site, Poznan, Poland|Investigational Site, Poznan, Poland|Investigational Site, Tychy, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Wroclaw, Poland|Inestigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Cluj Napoca, Romania|Investigational Site, Constanta, Romania|Investigational Site, Oradea, Romania|Investigational Site, St. Brasov, Romania|Investigational Site, Targu Mures, Romania|Investigational Site, Timisoara, Romania|Investigational Site, Petrozavodsk, Republic of Karelia, Russian Federation|Investigational Site, Arkhangelsk, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Rostov-on-Don, Russian Federation|Investigational Site, Saratov, Russian Federation|Investigational Site, St Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, Tatarstan, Russian Federation|Investigational Site, Yekaterinburg, Russian Federation|Investigational Site, Yekaterinburg, Russian Federation|Investigational Site, Belgrade, Serbia|Investigational Site, Knez Selo, Serbia|Investigational Site, Kragujevac, Serbia|Investigational Site, Bratislava, Slovakia|Slovakia, Nitra-Zobor, Slovakia|Investigational Site, Bellville, Capetown, South Africa|Investigational Site, Benomi, South Africa|Investigational Site, Cape Town, South Africa|Investigational Site, Cape Town, South Africa|Investigational Site, Krugersdorp, South Africa|Investigational Site, Port Elizabeth, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Somerset West, South Africa|Investigational Site, Worcester, South Africa|Investigational Site, Barcelona, Spain|Investigational Site, Barcelona, Spain|Investigational Site, Elche, Spain|Investigational Site, Leon, Spain|Investigational Site, Madrid, Spain|Investigational Site, Valencia, Spain|Investigational Site, Vizcaya, Spain|Investigational Site, Biel, Switzerland|Investigational Site, Geneve, Switzerland|Investigational Site, La Chaux-de-Fonds, Switzerland|Investigational Site, Lugano, Switzerland|Investigational Site, Bangkok, Thailand|Investigational Site, Bangkok, Thailand|InvestigationalSite, Bangkok, Thailand|Investigational Site, Bangkok, Thailand|Investigational Site, Chiang Mai, Thailand|Investigational Site, Khonkaen, Thailand|Investigational Site, Nonthaburi, Thailand|Investigational Site, Aviv, Ukraine|Investigational Site, Dnipropetrovsk, Ukraine|Investigational Site, Dnipropetrovsk, Ukraine|Investigational Site, Donetsk, Ukraine|Investigational Site, Ivano-Frankivsk, Ukraine|Investigational Site, Kharkiv, Ukraine|Investigational Site, Kharkiv, Ukraine|Inestigational Site, Kyiv, Ukraine|Investigational Site, Kyiv, Ukraine|Investigational Site, Lugansk, Ukraine|Investigational Site, Odesa, Ukraine|Investigational Site, Poltava, Ukraine|Investigational Site, Uzhorod, Ukraine","https://ClinicalTrials.gov/show/NCT00621504"
407,"Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers","Completed","Has Results","Meningococcal Meningitis|Measles|Mumps|Rubella|Varicella","Biological: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate|Biological: Measles-mumps-rubella-varicella vaccine|Biological: Routine paediatric vaccine - Pneumococcal conjugate (PCV)|Biological: Routine paediatric vaccine - Hepatitis A","Birmingham, Alabama, United States|Birmingham, Alabama, United States|Dothan, Alabama, United States|Pinson, Alabama, United States|Tuscaloosa, Alabama, United States|Chandler, Arizona, United States|Bentonville, Arkansas, United States|Conway, Arkansas, United States|Hardy, Arkansas, United States|Jonesboro, Arkansas, United States|Downy, California, United States|Fountain Valley, California, United States|Huntington Beach, California, United States|Huntington Park, California, United States|LaCosta, California, United States|LaJolla, California, United States|Pico Rivera, California, United States|Centennial, Colorado, United States|Longmont, Colorado, United States|Thornton, Colorado, United States|Lake Mary, Florida, United States|Tampa, Florida, United States|Stone Mountain, Georgia, United States|Boise, Idaho, United States|Evansville, Indiana, United States|Arkansas City, Kansas, United States|Wichita, Kansas, United States|Lexington, Kentucky, United States|Louisville, Kentucky, United States|Louisville, Kentucky, United States|Louisville, Kentucky, United States|Fall River, Massachusetts, United States|Clifton, New Jersey, United States|Endwell, New York, United States|Liverpool, New York, United States|Utica, New York, United States|Garner, North Carolina, United States|Raleigh, North Carolina, United States|Winston-Salem, North Carolina, United States|Fargo, North Dakota, United States|Minot, North Dakota, United States|Cincinnati, Ohio, United States|Fairfield, Ohio, United States|Huber Heights, Ohio, United States|Kettering, Ohio, United States|Mason, Ohio, United States|Poland, Ohio, United States|Youngstown, Ohio, United States|Meadowbrook, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Barrington, Rhode Island, United States|Providence, Rhode Island, United States|Warwick, Rhode Island, United States|Barnwell, South Carolina, United States|Mount Pleasant, South Carolina, United States|Watertown, South Dakota, United States|Bristol, Tennessee, United States|Jackson, Tennessee, United States|Tullahoma, Tennessee, United States|Amarillo, Texas, United States|Amarillo, Texas, United States|Carrollton, Texas, United States|Fort Worth, Texas, United States|Grapevine, Texas, United States|Houston, Texas, United States|Houston, Texas, United States|San Antonio, Texas, United States|Sugar Land, Texas, United States|Tomball, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States|West Valley City, Utah, United States|Newport News, Virginia, United States|Norfolk, Virginia, United States|Vienna, Virginia, United States|Bellingham, Washington, United States|Santiago de Chile, Chile|Santiago, Chile","https://ClinicalTrials.gov/show/NCT00483574"
408,"Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers","Completed","Has Results","Meningococcal Meningitis|Measles|Mumps|Rubella|Varicella","Biological: Meningococcal Polysaccharide Diphtheria Conjugate Vaccine|Biological: Measles, Mumps, Rubella and Varicella","Tuscaloosa, Alabama, United States|Tucson, Arizona, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Atascadero, California, United States|Fresno, California, United States|Paramount, California, United States|Roseville, California, United States|Sacramento, California, United States|San Jose, California, United States|Torrance, California, United States|Aurora, Colorado, United States|Norwich, Connecticut, United States|Viera, Florida, United States|West Palm Beach, Florida, United States|Dalton, Georgia, United States|Marietta, Georgia, United States|Tifton, Georgia, United States|Woodstock, Georgia, United States|Chicago, Illinois, United States|Chicago, Illinois, United States|Fishers, Indiana, United States|Dubuque, Iowa, United States|Dubuque, Iowa, United States|Owensboro, Kentucky, United States|Bossier City, Louisiana, United States|Perry Hall, Maryland, United States|Woburn, Massachusetts, United States|Niles, Michigan, United States|Stevensville, Michigan, United States|Bridgeton, Missouri, United States|Kansas City, Missouri, United States|St. Charles, Missouri, United States|St. Louis, Missouri, United States|Bellevue, Nebraska, United States|La Vista, Nebraska, United States|Omaha, Nebraska, United States|Omaha, Nebraska, United States|Omaha, Nebraska, United States|Omaha, Nebraska, United States|Henderson, Nevada, United States|Whitehouse Station, New Jersey, United States|Brooklyn, New York, United States|Fishkill, New York, United States|Hopewell Junction, New York, United States|Ithaca, New York, United States|Lake Success, New York, United States|Mineola, New York, United States|New York, New York, United States|Poughkeepsie, New York, United States|Syracuse, New York, United States|Boone, North Carolina, United States|Clyde, North Carolina, United States|Durham, North Carolina, United States|Durham, North Carolina, United States|Beachwood, Ohio, United States|Cleveland, Ohio, United States|Cleveland, Ohio, United States|Independence, Ohio, United States|Strongsville, Ohio, United States|Harleysville, Pennsylvania, United States|Hershey, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Sellersville, Pennsylvania, United States|Wexford, Pennsylvania, United States|Clarksville, Tennessee, United States|Kingsport, Tennessee, United States|Houston, Texas, United States|Longview, Texas, United States|San Antonio, Texas, United States|San Antonio, Texas, United States|Lehi, Utah, United States|Ogden, Utah, United States|Pleasant Grove, Utah, United States|Provo, Utah, United States|South Jordan, Utah, United States|Springville, Utah, United States|St. George, Utah, United States|Urem, Utah, United States|Charlottesville, Virginia, United States|Charlottesville, Virginia, United States|Charlottesville, Virginia, United States|Midlothian, Virginia, United States|Richmond, Virginia, United States|Huntington, West Virginia, United States|Morgantown, West Virginia, United States|Marshfield, Wisconsin, United States|San Juan, Puerto Rico","https://ClinicalTrials.gov/show/NCT00422292"
409,"A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers","Completed","Has Results","Meningococcal Meningitis|Measles|Mumps|Rubella|Varicella","Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine|Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate","Montgomery, Alabama, United States|Fayetteville, Arkansas, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Little Rock, Arkansas, United States|Norwich, Connecticut, United States|Cocoa Beach, Florida, United States|Viera, Florida, United States|Atlanta, Georgia, United States|Marietta, Georgia, United States|Bardstown, Kentucky, United States|Woburn, Massachusetts, United States|Bridgeton, Missouri, United States|St. Louis, Missouri, United States|Las Vegas, Nevada, United States|Rochester, New York, United States|Syracuse, New York, United States|Chapel Hill, North Carolina, United States|Goldsboro, North Carolina, United States|Laurinburg, North Carolina, United States|Sylva, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Tulsa, Oklahoma, United States|Pittsburgh, Pennsylvania, United States|Sellersville, Pennsylvania, United States|Kingsport, Tennessee, United States|Ft. Worth, Texas, United States|Layton, Utah, United States|Ogden, Utah, United States|Pleasant Grove, Utah, United States|Provo, Utah, United States|Salt Lake City, Utah, United States|Charlottesville, Virginia, United States|Midlothian, Virginia, United States|Norfolk, Virginia, United States|Spokane, Washington, United States|La Crosse, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00384397"
410,"Regimen for the Treatment of Cachexia in Subjects With NSCLC","Completed","Has Results","Cachexia","Drug: VT-122 low dose|Drug: VT-122 high dose","First Dynamic Health Care Services, Inc., Waco, Texas, United States|Rajalakshmi Nursing Home, Bangalore, India|Nizam Institute of Medical Sciences, Hyderabaad, India|Orchid Nursing Home, Kolkata, India|Shatabdi Super Specialty Hospital, Nashik, India|All India Institute of Medical Sciences, New Delhi, India|Indraprastha Apollo Hospital, New Delhi, India|Deenanath Mangeshkar Hospital, Pune, India","https://ClinicalTrials.gov/show/NCT00527319"
411,"Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia","Completed","Has Results","Bacterial Pneumonia","Drug: Ceftaroline fosamil for Injection|Drug: Ceftriaxone|Drug: Placebo","Investigational Site, Durham, North Carolina, United States|Investigational Site, Autonoma, Buenos Aires, Argentina|Investigational Site, Mar del Plata, Buenos Aires, Argentina|Investigational Site, Merlo, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Invetigational Site, Buenos Aires, Argentina|Investigational Site, Cordoba, Argentina|Investigational Site, Cordoba, Argentina|Investigational Site, Cordoba, Argentina|INvestigational Site, Cordoba, Argentina|Investigational Site, Cordoba, Argentina|Investigational Site, Entre Rios, Argentina|Investigational Site, Granadero Baiggoria, Argentina|Investigational Site, Parana, Argentina|Investigational Site, Santa Fe, Argentina|Investigational Site, Santa Fe, Argentina|Investigational site, Grieskirchner, Wels, Austria|Investigational Site, Steyr, Austria|Investigational Site, Wels, Austria|Investigational Site, Wien, Austria|Investigational Site, Plovdiv, Bulgaria|Investigational Site, Rousse, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Drug, Varna, Bulgaria|Investigational Site, San Ignacio, Valparaiso, Chile|Investigational Site, Santiago, Chile|Investigational Site, Santiago, Chile|Investigational Site, Santiago, Chile|Investigational Site, Talcahuano, Chile|Investigational Site, Temuco, Chile|Inestigational Site, Valdivia, Chile|Investigational Site, Valdivia, Chile|Investigational Site, Valparaiso, Chile|Investigational Site, Aachen, Germany|Investigational Site, Aachen, Germany|Investigational Site, Berlin, Germany|Inestigational Site, Berlin, Germany|Investigational Site, Berlin, Germany|Investigational Site, Berlin, Germany|Investigational Site, Dachau, Germany|Investigational Site, Frankfurt am Main, Germany|Investigational Site, Frankfurt, Germany|Investigational Site, Greifswald, Germany|Investigational Site, Halle/Saale, Germany|Investigtional Site, Hannover, Germany|Investigational Site, Heidelberg, Germany|Investigational Site, Hofheim, Germany|Investigational Site, Immenhausen, Germany|Investigational Site, Lubeck, Germany|Investigational Site, Rotenburg (Wuemme), Germany|Investigational Site, Rotenburg, Germany|Investigational Site, Wuppertal, Germany|Investigational Site, Gyor, Hungary|Investigational Site, Nyiregyhaza, Hungary|Investigational Site, Nyiregyhaza, Hungary|Investigational Site, Seregelyesi, Hungary|Investigational Site, Sostoi, Hungary|Investigational Site, Szekesfehervar, Hungary|Investigational Site, Szent Instvan, Hungary|Investigational Site, Vasvari Pal, Hungary|Investigational Site, Bangalore, India|Investigational Site, Gujarat, India|Investigational Site, Karnataka, India|Investigational Site, Karnataka, India|Investigational Site, Noida, India|Investigational Site, Pradesh, India|Investigational Site, Daugavpils, Latvia|Investigational Site, Latvia, Latvia|Investigational Site, Liepaja, Latvia|Investigational Site, Riga, Latvia|Investigational Site, Chihuahua, Mexico|Investigational Site, Chihuahua, Mexico|Investigational Site, Jalisco, Mexico|Investigational Site, Jalisco, Mexico|Investigational Site, Jalisco, Mexico|Investigational Site, Lima, Mexico|Investigational Site, Sonora, Mexico|Investigational Site, Lima, Peru|Investigational Site, Lima, Peru|Investigator Site, Bialystok, Poland|Investigational Site, Bystra, Poland|Investigational Site, Chrzanow, Poland|Investigational Site, Krakow, Poland|Investigational Site, Krakow, Poland|Investigtional Site, Krakow, Poland|Investigational Site, Krakow, Poland|Investigational Site, Lodz, Poland|Investigational Site, Lodz, Poland|Investigational Site, Lublin, Poland|Investigational Site, Poznan, Poland|Investigational Site, Poznan, Poland|Investigational Site, Skierniewice, Poland|Inestigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Wilkowice-Bystra, Poland|Investigational Site, Wroclaw, Poland|Investigational Site, Zabrze, Poland|Investigational Site, Zabrze, Poland|Investigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Craiova, Romania|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Smolensk, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, ST. Petersburg, Russian Federation|Investigational Site, Yaroslavl, Russian Federation|Investigational Site, Dnipropetrovsk, Ukraine|Investigational Site, Kharkiv, Ukraine|Investigational site, Kyiv, Ukraine|Investigational Site, Kyiv, Ukraine|Investigational site, Kyiv, Ukraine|Investigational Site, Vinnytsya, Ukraine|Investigational Site, Zaporizhya, Ukraine|Investigational Site, Zhytomyr, Ukraine","https://ClinicalTrials.gov/show/NCT00509106"
